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Abstract 
 
This thesis describes how targeted chemical modification can enhance the properties 
of nucleic acids for use in (i) nanopore analytics and (ii) nanobiotechnology. 
In  nanopore  analytics,  individual  molecules  are  detected  as  they  pass  a 
nanoscale pore to give rise to detectable blockades in ionic current. Despite progress 
in the sensing of a multitude of molecular species, the analytical resolution in the 
sensing of DNA is poor as individual bases in passing strands cannot be resolved due 
to the high speed of translocation. Here a new approach is presented which slows 
down  single  stranded  DNA  and  enables  the  detection  of  multiple  separate  bases. 
Chemical  tags  are  attached  to  bases,  which  cause  a  steric  blockade  each  time  a 
modified base passes a narrow pore. The resulting characteristic current signatures are 
specific for the chemical composition and the size of the tags. The unique electrical 
signatures can be exploited to encode sequence information as demonstrated for the 
discrimination between drug resistance-conferring point mutations. In addition, the 
generation of nucleotides with tailored properties may help develop a fast nanopore 
approach to size highly repetitive DNA sequences for forensic applications.  
In  DNA  nanobiotechnology,  oligonucleotides  are  self-assembled  via 
hybridization  to  generate  higher-order  structures  of  defined  geometry.  Here,  the 
functional range of DNA nanostructures is expanded by chemically modifying the 
constituent nucleic acids. Firstly, tetrahedron-shaped nanostructures are demonstrated 
to act as a scaffold to assemble a multitude of different chemical groups at tunable 
stoichiometry and at geometrically defined sites. The new molecular entities exhibit 
functional  properties  beneficial  in  biosensing  and  diagnostics.  In  addition,  an 
approach is presented to achieve self-assembly between DNA-strands via covalently 
attached tags that form reversible yet tight metal chelate complexes. This chemical 
strategy to form supramolecular structures can potentially be extended to protein or 
peptide networks of interest in basic science and technology.  
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Chapter One  
 
Introduction 
 
 
1.1  Deoxyribose Nucleic Acid (DNA) 
 
The biopolymer deoxyribose nucleic acid (DNA) is at the basis of the central dogma 
in molecular biology.
1 It underpins all processes that occur within the cell, carrying 
the genetic blueprint for life and with it the information that determines our traits as 
both  a  species  and  as  individuals.  It  is  a  molecule  that  has  fascinated  both  the 
scientific and non-scientific communities since its discovery in 1869, the image of the 
double helix has become an icon of popular science in the twentieth century. DNA 
continues to be at the forefront of medical diagnostics, healthcare and forensics. As 
well as playing an important role in current medical advances, it is presumed that 
several future technologies improving the diagnosis and treatment of disease will be 
based around this remarkable molecule. 
The timeline for the discovery of DNA stretches over 100 years; the molecule 
was first discovered by the Swiss biochemist Johann Friedrich Miescher in 1869.
2 He 
extracted a phosphorus-containing compound found in the nucleus of white blood 
cells of human pus that he obtained from bandages of wounded soldiers. He named  
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this material nuclein due to its position of residence inside the cell. In 1919, Phoebus 
Levene  identified  phosphate,  deoxyribose  and  the  nucleobases  as  the  chemical 
constituents of the material.
3 He suggested that the molecule is comprised of a string 
of monomer units linked together through the phosphate groups. In 1937 William 
Astbury produced the first X-ray diffraction patterns of DNA proving that it possessed 
a repeating structure.
4 The theory that DNA carried the genetic blueprint for life was 
first demonstrated by Frederick Griffith when, in 1928, he transferred the traits of the 
‘smooth’ form of the bacteria Streptococcus Pneumococcus to the ‘rough’ by mixing 
the killed smooth form with live rough.
5 The suggestions put forward by this work 
were later proven when Alfred Hershey and Martha Chase showed that DNA is the 
genetic material of the T2 phage.
6 With the publication of their seminal paper in 
Nature  in  1953
7  Watson  and  Crick  announced  a  molecular  structure  of  what  was 
thereafter  known  as  deoxyribose  nucleic  acid  (DNA)  using  X-ray  diffraction  data 
produced by Rosalind Franklin and Raymond Gosling. Later X-ray analysis of the 
compound  proved  this  theory  to  be  correct  and  with  it  emerged  the  new  field  of 
molecular biology.  
 
1.1.1  DNA in Healthcare 
 
DNA  is  central  to  the  processes  of  the  cell,  carrying  the  information  required t o 
synthesize the proteins essential for life. The manipulation and application of DNA 
therefore plays an important role in the biomolecular sciences. By using DNA as the 
blueprint  and  production  line  for  proteins  one  can  learn  more  about  the  intricate 
workings of the cell. Using DNA as a molecular tool, scientists have been able to 
interject when these processes go wrong, enabling diagnosis and treatment of disease. 
By  understanding  the  genomes  from  biological  pathogens  such  as  viruses  and 
bacteria,  it  is  possible  to  identify  and  neutralize  these  potentially  life-threatening 
organisms. Modern sequencing techniques allowed the genomes of pathogens such as 
the H5N1 and H1N1 avian and swine flu viruses to be decoded quickly allowing 
vaccines to be prepared thereby helping to avoid, or at least mitigate the effect of, 
global pandemics. 
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1.1.2  Chemical  Modification  Tailor  the  Properties  of  DNA  for  Molecular 
Biology 
 
Advances in both the solid phase synthesis of oligonucleotides and the enzymatic 
incorporation of nucleotides into a template have allowed researchers to synthesize 
DNA carrying non-biogenic bases. Via incorporation of bases that carry designed 
functional groups, scientists are able to probe the nature of DNA and to enhance the 
properties of the molecule to suit a particular application.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. Chemical structures of the G-C and A-T Watson and Crick base pairs and 
labeling of the purines, pyrimidines and deoxyribose sugar units. 
  
The structure of the nucleic acids fulfills several important biochemical and 
genetic tasks. The functional groups on both the purine and pyrimidine bases allow 
for  hydrogen  bonding  to  their  corresponding  complementary  base,  as  indicated 
(Figure 1.1). This specificity and the formation of a double helical structure underpins 
the role of DNA as an efficient carrier of genetic information as well as the semi-
conservative nature of the replication process. Furthermore, the 3' and 5' hydroxyl 
groups  on  the  deoxyribose  sugar  are  attached  to  phosphate  groups  to  form  the 
phospodiester  backbone  of  the  polymer.  Any  man-made  chemical  modification  of 
DNA  should  retain  these  structural/functional  properties  of  DNA  if  the  biological 
function of the molecule is to remain unaffected.  
It  is  advantageous  in  some  cases,  however,  to  functionalize  nucleotides  at 
these  positions.  The  development  of  the  antiretroviral  drug  AZT  (Azidothymine,  
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Figure  1.2)
8,  for  example,  disrupts  the  action  of  the  reverse  transcriptase  RNA 
polymerase enzyme that helps to incorporate the HIV viral genome into a DNA of the 
host cell. Omission of the 3' hydroxyl group – replaced instead with the azide moiety 
–  causes  termination  of  the  transcription  process  of  viral  RNA.  This  dramatically 
slows down the propagation of the virus in the host.  
 
 
 
 
 
 
Figure 1.2. Azidothymine (AZT). 
 
If  it  is  not  the  intention  to  disrupt  the  process  of D N A   replication  then 
chemical  modification  is  usually  conducted  at  position  5  in  the  pyrimidines  and 
position 7 of the purines (Figure 1.1). Chemical groups attached to these sites are 
exposed  to  the  major  groove  in  the  duplex  and  do  not  interfere  with  either  the 
enzymatic  incorporation  of  the  nucleotide  into  a  strand  or  the  base  pairing  when 
duplexes are formed.
9 If modified nucleosides are to be used as biological agents then 
they must first be converted into their corresponding triphosphate to allow enzymatic 
incorporation  of  the  monomer  into  a  template  strand.  In  the  lab  the  enzyme 
polymerase is used, as it is in nature, to link the triphosphate to the 3’ terminus of the 
DNA  strand.  Different  polymerases  can  be  more  promiscuous  than  others  and 
therefore  allow  a  wider  range  of  groups  attached  to  the  base  to  be  tolerated. 
Researchers  also  have  the  option  of  incorporating  a  modified  base  into  a  DNA 
template via solid phase synthesis. These options give scientists a broader tool-kit for 
the application of non-biogenic DNA to modern scientific problems.  
 
1.1.3  Non-Biogenic Nucleotides   
 
Examples  of  the  modification  of  DNA  to  enhance  its  scope  of  application  are 
ubiquitous  in  molecular  biology.  Historically  an  important  method  of  sequencing 
DNA is the so-called chain termination methods developed by Sanger et al.
10 This  
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procedure  is  based  on  the  use  of  2',3'-dideoxy  analogues  (ddNTP)  of  natural 
triphosphates (Figure 1.3). Given the triphosphate group at 5' position of the ribose 
sugar unit, these ddNTPs can be incorporated into a DNA strand by the 5'->3' activity 
of DNA polymerase enzymes. However, since the ddNTPs do not carry a hydroxyl 
group at the 3' position of the sugar they cannot be linked to further nucleotides via a 
phosphodiester bond. This results in termination of the strand at this position. The 
DNA strand to be sequenced and associated reagents and compounds are split into 
four aliquots. To each sample one of the ddNTP’s is added in slight excess to the 
other  dNTP’s.  Heating  and  cooling  cycles  anneal  the  primer  to  the  template  and 
facilitate chain extension using the polymerase enzyme. Incorporation of the ddNTP 
in the sample causes chain termination leading to a truncated strand. Incorporation of 
the dNTP analogue, however, allows the extension to progress. This process continues 
until the polymerase reaches the end of the strand. Once the sequencing is complete 
the four samples are denatured and analyzed on a poly-acrylamide denaturing gel.  
 
 
 
 
 
 
 
       
     1                               2 
 
Figure 1.3. (1) ddATP utilized in Sanger sequencing; (2) ddA-PA-5dR6G nucleotide used 
for dye – terminator sequencing diagnostics.
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The truncated strands present in each sample separate by size on the gel, the 
DNA  can  be  visualized  in  bands  due  to  the 
32P  labeling  of  either  the  primers  or 
nucleotides. By reading the bands off by order of size from each of the four samples 
the sequence of the strand can be deduced (Figure 1.4). 
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Figure 1.4. An example of a Sanger chain termination sequencing gel
12. 
 
These ddNTP were originally synthesized
13,14,15,16 but became commercially 
available  as  the  technique  gained  popularity.  Since  Sanger  et  al.  published  these 
results  the  chain  termination  sequencing  became  the  method  of  choice.  Modern 
scientific  advancements  have  led  to  fluorescence  techniques  replacing 
32P 
radiolabeling of the extended strands. First primers carrying fluorescent tags
17 and 
then ddNTP’s
18 were developed (Figure 1.3) and employed to terminate the chain 
extension. The synthesis of the four ddNTP’s each carrying a fluorophore that emits at 
a different wavelength has allowed sequencing to take place in one single reaction 
vessel. Each truncated strand carries a fluorophore representing one of the four bases 
at its 3’ terminus. The strands are again separated by size usually using capillary 
electrophoresis and the particular emission of the tagged strand allows identification 
of the terminating base. In this way the sequence of a strand can be deduced from a 
one-pot reaction and set up as a fully automated system. 
 
 
 
 
 
 
Figure  1.5.  The  sequencing  output  from  fluorescently  labeled  chain  termination 
sequencing
19. 
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This  research  has  paved  the  way  for  such  scientific  milestones a s   the 
sequencing of the complete human genome in 2003.
20 Since Sanger based sequencing 
is only viable for fairly short reads, (4000 – 7000 base pairs) a method known as 
shotgun sequencing
21,22 was used for whole genome sequencing. In this method the 
genome is broken up randomly and sequenced using the dye – terminator method. The 
fragments  are  then  computationally  pieced  back  together  to  form  the  completed 
genome. Such developments have revolutionized modern medicine and science, each 
one relying on the synthesis and application of non – biogenic nucleotides. 
 
1.1.4  Antisense Therapeutics  
 
A vitally important application of DNA is in the regulation of gene expression - the 
control  of  potentially  pathogenic  protein  translation  allowing  treatment  of  both 
genetic  (heritable)  disorders  and  various  forms  of  cancer.
23  This  type  of  therapy 
allows treatment, not of the symptoms but of the causes of the disease itself.  
Protein biosynthesis (i.e. transcription and translation) relies on the section of 
DNA that carries the appropriate gene initially being unzipped by the protein DNA 
Helicase. The enzyme RNA polymerase then reads out the non-coding DNA strand of 
the gene, resulting in an RNA copy of the coding sequence i.e. the sense strand, 
termed messenger RNA (mRNA). This strand diffuses out of the nucleus and into the 
cytoplasm. It then enters the Ribosome and each trinucleotide ‘codon’ carried by the 
mRNA  sequence  binds  to  a  specific  amino  acid  linked  transfer  RNA ( tRNA) 
component. As the Ribosome reads the mRNA strand the specific amino acids that are 
bound to the tRNA molecules link together to form a nascent polypeptide chain. Once 
the translation is complete the polypeptide folds into a tertiary structure forming the 
active protein. 
DNA can be used to interfere with this process of protein biosynthesis. By 
synthesizing  oligonucleotides  that  are  complementary  in  sequence  to  the  mRNA 
strand the oligo can bind to the mRNA preventing it from entering the ribosome and 
effectively  silencing  translation  of  the  gene  (a  process  known  as  steric  blocking). 
Although  this  method  has  been  shown  to  silence  protein  production  it  has  its 
drawbacks. Since the antisense strand will bind in a 1:1 stochiometry with the mRNA 
it  must  be  present  in  at  least  the  equivalent  molarity  to  that  of  the  mRNA.  It  is  
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difficult to ascertain the amount of mRNA released and so an excess of the antisense 
strand must be employed. This requires, in biological terms at least, a large amount of 
the DNA to be delivered. 
An alternative method of gene silencing is to exploit the cells own natural 
regulatory processes. When a protein is being over expressed or if a cell needs to 
down  regulate  gene  expression  it  uses  a  process  called  RNA  interference.
24  This 
involves two types of small RNA molecules, either double stranded small interfering 
RNA  (siRNA)  or  single  stranded  micro  RNA  (miRNA).  These  molecules  are 
processed from non – coding RNA (i.e. RNA which is not translated into protein) 
transcribed from genes carried in our DNA. Both strands are then processed by a 
variety of enzymes to produce the active RNA components. Both siRNA and miRNA 
effect  gene  knockdown  via  activation  of  a  protein  complex  called  RISC  (RNA 
induced  silencing  complex).  The  ‘guide  strand’  of  the  miRNA  or  siRNA  is 
incorporated into this complex and is complementary to the target mRNA. Once it 
hybridizes to its target the Argonaute protein (the catalytic component of the RISC 
complex) is activated and degrades the mRNA. The siRNA differs to that of miRNA 
in  that  the  latter  demonstrates  incomplete  base  pairing  to  the  mRNA  target.  This 
allows  the  miRNA  a  wider  target  base  whereas  the  siRNA’s  are  more  specific  – 
degrading just the one mRNA target strand. In this way the cell can regulate gene 
expression via an effective catalytic mechanism. 
These processes can be used to efficiently silence targeted genes and therefore 
decrease  the  output  of  potentially  pathogenic  proteins.  It  is  also  a  very  important 
method in the investigation of biological processes. The ability to ‘knock-out’ specific 
genes is vital in helping researchers gain a better understanding of complex biological 
processes. Transfection of viral plasmids carrying the siRNA duplex or introduction 
of small miRNA single strands made synthetically can target specific mRNA strands 
and  silence  the  corresponding  gene.  However,  RNA  is  liable  to  enzymatic 
degradation,  therefore  short  oligonucleotides  can  be  used  in  place  of  their  RNA 
counterparts  to  increase  serum  and  cytoplasm  stability.  The  DNA  can  be  further 
stabilized via the synthesis of a phosphothioate backbone. This reduces its liability 
towards DNA degradation enzymes (Figure 1.6). 
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Figure  1.6.  The  phosphothioate  backbone  of  an  oligonucleotide  synthesized  via  solid 
phase. 
 
Antisense  Therapy  could  be  potentially  very  effective;  however,  the  first 
hurdle in this type of therapy is the introduction of the DNA into the cell. The net 
negative  charge  of  the  oligonucleotide  poses  a  number  of  issues  relating  to  cell 
delivery.  Due  to  its  large  net  negative  charge  the  oligonucleotide  cannot  diffuse 
through the lipid bilayer and acting alone will not be recognized by the cell surface 
proteins. Therefore to effect cell delivery the oligonucleotides must carry a separate 
component, one that will either allow the compound to pass though the bilayer or 
encourage recognition by the proteins on the surface. Since these biological processes 
involve proteins it seems natural to assume that they would also make good agents for 
cell delivery. However, proteins are fairly large components to attach to an oligo 
strand. Peptides carrying the specific amino acid sequences that possess the relevant 
biological qualities required are much more feasible as cell delivery agents.  
 
1.1.5  Peptide – Oligonucleotide Conjugates 
 
Due  to  their  use  in  biological  signaling  peptides  are  ideal  tags  to  assist  in 
transmembrane penetration and localization to the sub-cellular compartments where 
the oligos are most effective. The therapeutic efficacy of the DNA can be greatly 
enhanced by attaching peptides with biologically relevant amino acid sequences. It is 
generally believed that oligonucleotides are transported into cells via an endocytic  
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mechanism and so components that may enhance this process will increase cellular 
uptake and therefore efficacy of the therapeutic DNA. 
Peptides can help improve DNA delivery in two ways; firstly by mitigating the 
net charge of the molecule. Since the lipid bilayer does not allow charged species to 
diffuse through it, the DNA must be neutralized in a complex before introduction to a 
cell. Poly-L-lysine containing peptides, for example, will bind electrostatically to the 
negatively charged backbone of the oligonucleotide to effectively cancel out its net 
charge (Table 1.1). Although the DNA is able to enter the cell as a neutral complex, it 
does so inefficiently. The cellular uptake is therefore increased, secondly, by using 
special cell-penetrating or cell-targeting peptides.
25 
 
Table 1.1. Examples of biologically active peptide sequences. 
 
In the latter method, the peptide-DNA conjugate is targeted to cell surface 
proteins.  When  the  peptide  moiety  is  recognized  by  a  given  receptor,  the  whole 
conjugate is likely to be taken up by the cell. Peptides that localize the DNA cargo in 
the nucleus i.e. Nuclear Localization Signals (NLS), have also been used to good 
effect. The most successful strategies harness a combination of approaches i.e. cell 
surface binding peptides, nuclear localizing peptides, as well as covalently attached 
lipids to assist membrane fusion.
33 
The  peptide-oligonucleotide  conjugates  (POCs)  are  usually  prepared  using 
either a complete ‘in-line’ solid phase synthesis or via a convergent strategy in which 
DNA and peptide are synthesized separately and then conjugated. The first procedure 
Function  Target  Sequence 
     
Cell surface binding  Fc receptor  TQPREEQYNSTFRV
26 
  IGF-1 receptor  D-GCSKAPKLPAALC
27 
  Beta-endorphin receptor  YGGFLRRG
28 
Membrane fusion  Viral fusion  AVGAIGALFLGFLGAAG
29 
Localizing peptides  ER localizing  YGEEDTSEKDEL
30 
  Nuclear localizing  CNSAAFEDLRVLS
31 
DNA binding  Cationic peptides  KKAAKKACAKKAAKK
32  
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attempts to achieve the convenient all-encompassing solid phase approach available 
for modern peptide and oligonucleotide synthesis.  
 
 
 
 
 
 
 
 
 
Figure 1.7. Duel peptide and oligonucleotide solid phase linker.
34 
   
  A  duel  linker  was  developed  by  M.  Antopolsky  et  al.
34,35,36  to  facilitate  the 
synthesis of the POC via solid phase (Figure 1.7). The linker contains a standard 
fluorenylmethyloxycarbonyl (Fmoc) protected amine for initiating peptide synthesis 
and a dimethoxy trityl (DMT) protected hydroxyl group for the DNA synthesis.  The 
conventionally  used  chemistries  for  DNA  and  peptide  synthesis,  however,  are 
incompatible. The usually harsh final acidic deprotection of the peptide from the resin 
via TFA may result in depurination of the oligonucleotide while the milder acidic 
deprotection of the DMT groups at the 5' hydroxyl of the oligos may effect unwanted 
deprotection of the protected peptide R groups. In addition, it was also postulated that 
the ammonium cleavage of the oligo may result in residue racemization or hydrolysis 
of the peptide, however, this assumption has since been proved as unfounded.
37, 38 
  Despite these problems, the solid phase method has been used successfully to 
generate POCs comprised of poly-dT and poly-Ala components.
39 The problems often 
encountered with the combined solid-phase route could be avoided since no R group 
amino acid protection was needed. To develop a successful in-line solid phase method 
capable of preparing more complicated conjugates alternative protecting groups and 
resin linkers must be employed, thereby restricting the range of accessible sequences. 
Due to the limitations of this method many researchers have chosen to employ a 
convergent strategy to prepare their POCs. 
  In the convergent approach, the peptide and oligonucleotide components are 
synthesized  separately.  Using  appropriate  functionality  the  two  compounds  are 
conjugated  together  post  solid-phase.  To  be  of  synthetic  utility,  the  intended 
conjugating reaction must firstly be able to propagate in an aqueous solvent as the  
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DNA is buffered to prevent acidic depurination. In addition, the reaction has to be 
chemoselective  to  prevent  non-specific  reactions  with  the  deprotected  amino  acid 
groups. The most commonly used functional group is usually a thiol since its reaction 
range tends to be specific to the sulfur group. Usually, a thiol is incorporated into the 
peptide  via  the  inclusion  of  a  cysteine  residue.  Consequently,  the  complementary 
electrophilic group capable of reacting with the thiol is attached to a non-biogenic 
functionality  (Figure  1.8)  on  the  oligonucleotide.  A  common  route  is  the  use  of 
heterobifunctional linkers (Figure 1.9)
40,41 containing groups such malemides
42, iodo 
acetamides
43, and orthopyridyl disulfides to enable reaction with the peptide under 
mild conditions.
33 
 
 
 
 
 
 
 
 
 
Figure 1.8. Examples of chemically modified nucleotides for solid phase inclusion. 
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Figure 1.9. Examples of heterobifunctional linkers; (1) N -Succinimidyl 3-(2-pyridyldithio)-
propionate  (SPDP);  (2)  Succinimidyl-4-(p-maleimidophenyl)buterate  (SMPB);  (3)  N-
Succinimidyl (4-iodoacetyl)aminobenzoate (SIAB). 
 
  The  heterobifunctional  crosslinkers  also  usually  feature  the  amine-reactive 
group  N-hydroxysuccinimide  for  coupling  to  amine-modified  nucleotides  (Figure 
1.9). Alternative chemistry such as oxime formation,
44 native ligation,
45 Click
46 and 
Diels Alder
47 have also been employed. Amide coupling methods using water-soluble 
coupling  reagents  such  as  EDC  have  been  successful  previously
48  but  due  to  the 
likelihood of multiple amine groups being present on the peptide moiety this strategy  
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is not always viable. 
 
 
 
 
 
Figure 1.10. Linkages formed from mild thiol-specific reactions; (1) thioether bridge formed 
by reaction between maleimide and thiol group; (2) disulfide formed via disulfide exchange; 
(3) thioether formed via thiol attack on Iodo acetimide. 
 
Since the modified base and cysteine residues can be placed at any point along 
the  oligo  or  peptide  sequence  the  conjugate  can  be  synthesized  with  an  internal 
peptide (or oligonucleotide) at no extra effort. Because of these benefits a convergent 
strategy is currently the method of choice for the synthesis of peptide-oligonucleotide 
conjugates.  
  Once synthesized the conjugate is usually purified by Reverse Phase High 
Performance  Liquid  Chromatography  (RP-HPLC)  or  Anion  Exchange 
Chromatography (AEC). Poly-acrylamide electrophoresis (PAGE) or size exclusion 
chromatography (SEC) can also be used. Given its large net negative charge, the oligo 
usually  dictates  the  behavior  of  the  conjugate  during  chromatography  while  the 
success of the purification depends on the peptide moieties’ ability to add sufficient 
charge or alter the lipophilic nature of the compound enough to achieve analytical 
resolution between the modified and non-modified oligonucleotides.  
 
1.1.6  Chemical Modification for Nanoscale Devices 
 
Employment of non-biogenic nucleotides has enabled researchers to impart functions 
and interactions in DNA other than that of Watson and Crick base pairing. Due to the 
nanometer dimensions of a DNA duplex and its inherent physical properties i.e. its 
ability to self assemble and its relatively high persistence length, DNA is a suitable 
material for the preparation of nano-scale assemblies. The application of DNA in 
nanotechnology  has  therefore  been  explored  with  great  interest  over  the  last  few 
decades.  
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An  example  of  this  research  is  the  use  of  DNA  in  the  preparation  of 
nanoelectronic devices. It has been suggested that DNA could be turned into a nano-
scale wire by increasing the conductivity of a DNA duplex. One of the advantages of 
DNA in this area is the ability to self-assemble in a repeating pattern and its versatile 
means of synthesis (i.e. via enzymatic or solid phase means). To endow the duplex 
with electrical properties, the biogenic bases are to be modified to carry metallic ions 
able to impart the appropriate properties to the duplex. A number of different bases 
have been synthesized and incorporated for this purpose.
49, 50, 51, 52  
 
 
 
 
 
 
 
Figure 1.11. Nucleotides modified with M(II) complexing bases for nano-wire construction. 
 
  The nucleosides shown in Figure 1.11 have been equipped with the ability to 
conjugate to either Cu(II) or Hg(II) metal ions. This functionality has replaced the exo 
groups on the bases that allow specific base pairing. Instead of the hydrogen bonded 
Watson and Crick base pairing, the duplex is now stabilized using metal ions. This 
allows a duplex to self–assemble via the incorporation of alternate metal ions running 
through the central axis of the helix (Figure 1.12).  
 
 
 
 
 
Figure  1.12.  Metalized  DNA  duplex  via  incorporation  of  non  – b i o g e n i c  m e t a l  b i n d i n g  
nucleotides.
52 
 
Research by Carell et al.
53 has utilized alkyne-modified nucleotides to allow 
efficient ‘Click’ reactions post incorporation. This allows the DNA template to be 
functionalized  with  groups  that  can  be  metalized  with  Ag  ions  as  a  base  for  the  
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development  of  wires.  Further  work  has  investigated  the  incorporation  of  bulky 
porphyrin  groups
54  into  oligonucleotides,  which  allows  efficient  resonance  energy 
transfer between chromophores and serves to stabilize the formation of the duplex. 
Chelation of metal ions within the porphyrin chromophores would again enable the 
generation  of  nano-scale  electronic  devices.  Alternative  functionalization  such  as 
multiple  spin  labeled  bases  for  EPR  detection
55  and  modification  with  multiple 
functional groups
56,57,58 have also been investigated to further enhance the scope of 
application of nucleotides and DNA.  
 
1.1.7  Areas not yet been Exploited by Chemical Modification 
 
Two areas of biotechnological interest that have not yet been fully exploited using 
chemical modifications of nucleic acids are: (1) the sensing of DNA strands with 
nanopore recordings and (2) the functionalization of DNA nanostructures. Both are 
emerging areas of biotechnology and will likely benefit from chemical modification 
of DNA. 
 
 
1.2  Nanopore Sensing  
 
The advancement of modern technologies has given rise to the emergence of single-
molecule techniques. Most conventional analytical methods rely on the observation of 
average changes in the bulk solution, for example, the increase in fluorescence in a 
majority  of  soluble  dye  molecules.  However,  with  advances  in  the  sensitivity  of 
fluorescence detection schemes and a drop in the price of equipment, researchers are 
now  able  to  follow  changes  at  the  single-molecule  level.  This  development  has 
revolutionized analytics, especially in the field of molecular biology. The ability to 
detect single molecules of DNA for example, allows minute amounts of material to be 
analyzed without the cost, time and accuracy issues of PCR amplification. In 2004 the 
National Institute of Health (NIH) set the challenge of $1000 as the cost of complete 
human  genome  sequencing.  This  would  allow  personalized  genomics,  which  is 
predicted  to  revolutionize  personalized  medicine.  Among  the  single-molecule  
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methods, the two most advanced are based on fluorescence.  The first technique was 
developed  at  Helicos  Biosciences  (http://www.helicosbio.com)  and  termed 
‘sequencing  by  synthesis
59  while  SMRT  sequencing  (single  molecule  real-time 
sequencing)
60  technology  was  developed  at  Pacific  Bioscience 
(http://www.paciﬁcbiosciences.com).  Whilst  different,  both  techniques  involve  the 
incorporation  of  fluorescently  tagged  nucleotides  into  the  DNA  template  to  be 
sequenced and the detection of the incorporation at the single molecule level.  
Nanopore recording is an alternative single-molecule technique that also has 
the potential to reach this $1000 benchmark. It is an electrical analytical technique in 
which  an  electrical  field  drives  charged  species  through  a  biological  or  inorganic 
nanopore.
61 As the translocating molecules displace electrolyte ions flowing through 
the pore, the measurement of the passing ionic current can enable identification of the 
molecules. The technique is able to detect individual molecules since (i) only one pore 
is used and (ii) the dimensions of the pore are chosen to only enable the passage of 
one molecule at a time.  
 
1.2.1  Nanoscale Protein Pores 
 
A commonly used biological pore is that of the heptameric protein α-Hemolysin. The 
αHL protein from the gram-positive bacterium Staphylococcus Aureus is an exotoxin 
which causes the lysis of red blood cells. Bacteria use these toxins to obtain nutrients, 
such as iron, from host cells. The structure of this heptameric protein pore has been 
characterized to 1.9 Å resolution using X-ray crystallography.
62 The protein has a cap 
and a membrane inserted stem region. The inner vestibule in the cap region has an 
inner diameter of 42 Å, while a transmembrane β-barrel stem measures 14 Å at the 
tightest constriction positioned at the boundary between the cap and the stem region 
(Figure 1.13).  
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Figure 1.13. Ribbon representation of the protein pore α – hemolysin.
63  
 
The nanopore apparatus is comprised of a lipid bilayer deposited over a µm-
sized  hole  in  a  teflon  sheet.  This  section  divides  two  buffer-filled  compartments 
connected by an electrical circuit. A voltage is induced and the protein is introduced 
to one compartment. Once the αHL pore has inserted into the bilayer, a current is 
detected and the compartments can be replaced with fresh buffer to flush out excess 
protein  pores.  The  simple  electrical  set-up  enables  researchers  to  follow  the 
translocation of molecules across a single pore. 
 
 
 
 
 
 
 
 
 
     
                          1                       2 
 
Figure 1.14. (1) Schematic of the Nanopore set up
64; (2) molecular model of a DNA strand 
translocating through a nanopore
65.  
 
This  single-molecule  approach  has  been  exploited  to  analyze  a  number  of 
molecular species such as toxins
66, chemical reactions, drug molecules
67 and protein  
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analytes.
68 However it is the analysis of DNA strands where the technique has gained 
the  most  interest.  Due  to  the  size  of  the  proteins  aperture  at  its  most  constricted 
(approximately  1.4  nm)  it  is  possible  to  translocate  single  strands  of  DNA/RNA 
through (the approximate diameter of a DNA strand is 0.9 – 1.2 nm). It was noted by 
Kasianowicz et al.
61 and others
69 that although it was possible to discriminate between 
different homo-polynucleotides due to the different characteristic current blockades, it 
was  not  however,  possible  to  detect  individual  bases.  The  DNA  translocates  too 
quickly  for  information  about  the  sequence  to  be  determined.  A  number  of 
developments have since been made. Specific DNA sequences have been identified 
by tethering an oligo within the pore and translocating the complementary strand to 
observe specific binding.
70 Further research has shown that single point mutations can 
be detected in static double stranded DNA.
71,72 It was observed that the structural 
differences between the purines and pyrimidines are sufficient to alter the current 
characteristically in a static strand. However, it has so far not been possible to identify 
individual bases on a translocating strand.   
One potential approach to this issue of translocation speed has been to fit a 
‘molecular adaptor’ composed of a cyclodextrin into the β-barrel of the protein pore.
73 
This further decreases the diameter of the constriction allowing more subtle structural 
differences to be identified, yet not at single-base resolution. The approach using the 
molecular adapter can also be exploited for a related approach, which does not thread 
DNA through the pore but is rather based on individual nucleotides.
74 The proposed 
strategy uses an exonuclease, which cleaves the phosphodiester backbone of the DNA 
strands  allowing  individual  nucleotides  to  enter  the  pore.  With  the  molecular 
cyclodextrin  adaptor  fitted  (Figure  1.15),  it  has  been  demonstrated  that  individual 
bases can be resolved based on the different current blockades. While the step of 
attaching a fully functional enzyme to the pore awaits experimental implementation, 
the successful detection of nucleotides is nevertheless a large step towards a whole 
genome sequencing method using the nanopore technique. Due to the speed of the 
process it is postulated that a complete genome could be analyzed in a matter of days 
using parallel nanopore devices. Due to the low cost of materials, and since this is a 
single – molecule technique it is expected that this method may be able to reach the 
benchmark of whole genome sequencing at under $1000 set by the National Institue 
of Health (NIH) in 2004.  
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Figure 1.15. The α-hemolysin pore carrying a cyclodexdrin filter.
74 
 
1.2.2  Chemical Modification of DNA to Increase the Resolution of Nanopore 
Recording 
 
The approaches detailed above tackle the identification of individual nucleotides via 
alteration of the protein pore itself. An alternative approach is to instead modify the 
translocating DNA. By attaching various bulky or charged groups to the individual 
bases  of  the  strand  it  may  be  possible  to  engineer  each  nucleotide  to  produce  a 
different current modulation. Given the requirement to chemically label the strands, it 
is  envisaged  that  this  method  would  not  necessarily  be  useful  for  whole  genome 
sequencing but rather be applicable in point-of-care genetic diagnostics i.e. testing at 
or  near  the  site  of  patient  care.  Due  to  its  minimal  technical  requirements,  the 
nanopore  apparatus  can  be  miniaturized.  For  example,  it  may  be  possible  use 
chemical  tagging  of  DNA  to  analyze  forensic  DNA  samples  using  portable 
equipment.  
  A central hypothesis is that attaching chemical tags to separate bases would 
increase the cross-sectional diameter of the DNA and hence slow down translocation 
each time a modified base passes the narrow pore constriction. 
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Figure 1.16. Schematic translocation of unmodified and modified DNA. The open channel 
current (1) is interrupted via translocation of a DNA strand (2) leading to a fast event. The 
tagging of the DNA strands should slow down the dwell time of the strand through the pore 
(3). 
 
In this way it should be possible to identify the tagged DNA from untagged 
using the characteristic current modulations observed. Further research should enable 
tagging of multiple bases and identification using this technique. Depending on the 
ability of the chosen tags to resolve the translocating bases it may be viable to detect 
multiple repeating bases such as trinucleotide repeats found in forensically important 
DNA samples. 
 
 
1.3  DNA nanotechnology 
 
A second area yet to be fully exploited using chemical modification is that of higher-
order DNA nanostructures. This is a rapidly expanding research topic within the area 
of  nanotechnology.  Its  nanoscale  size  and  inherent  biophysical  properties  such  as 
sequence-specific  self-assembly,  high  persistence  length  of  approx.  50  nm  and 
manipulation  via  enzymes  make  DNA  an  attractive  building  block  for  nanoscale 
structures.
75,76  Indeed,  using  the  complementary  nature  of  Watson  and  Crick  base 
pairing,  DNA  strands  have  been  sequence-specifically  assembled  into  artificial 
higher-order  nanoscale  structures
77,78  that  are  of  use  in  biotemplating,
79,80 
biocomputing,
81  sensing,
82  and  biophysical  studies.
83  As  well  as  ‘inert’  structures, 
hybridization of chemically modified strands into DNA duplexes has been utilized to  
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bring chemical groups into defined contact to, for example, enhance their reaction.
84 
These  complex  and  impressive  two  and  three  dimensional  higher  order  structures 
could be further functionalized by the incorporation of chemically modified groups. 
This would allow researchers to widen the scope of application of these nano-scale 
structures further still. 
 
1.3.1    Higher Order DNA Based Nanoscale Structures 
 
As early as 1982 Nadrian Seeman published a paper postulating the use of DNA for 
the construction of 3D nanoscale objects.
85 He recognised the potential this molecule 
had due to the specificity of its Watson and Crick base pairings. Since a DNA strand 
will only hybridise to its complement this provides a way to programme structural 
formation via self-assembly. Seeman suggested using ‘junctions’ from which 3 – 8 
double helices may propagate forming the basis of these complex structures. Since 
this  proposal  a  large  variety  of  incredibly  complex  structures  have  be  formed  by 
clever design of the DNA sequences. Although complex in design the formation of 
these structures simply requires the heating and cooling of the relevant DNA strands. 
Compared to the synthesis of non-biological nanostructures this method is incredibly 
economical. By utilizing the properties inherent to the storage of genetic information 
researchers are able to easily form complex architecture.  
 
1.3.2  Two-Dimensional DNA Based Arrays 
 
The application of DNA to the formation of templated arrays has attracted a great deal 
of interest. These complexes could be used for molecular electronics, or patterned 
surfaces to which proteins, for example, could potentially be attached. A successful 
method for the formation of these arrays is in the application of double
86,87 (DX) and 
triple
88 (TX) crossover ‘tiles’ (Figure 1.17). These tiles consist of two or three double 
helices that link by crossover of one of their strands to another helix. In this way 
planer, rigid tiles are formed that carry sticky ends to link tiles together. 
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Figure 1.17. Schematic of a DX crossover tile.
89  
 
A  number  of  arrays  have  been  generated  in  this  way;
  moreover  tubular 
structures
90  can  be  formed  via  the  folding  of  these  sheets.  Functional  arrays  that 
perform  computation
81 a nd  mechanical
91  actions  for  example  have  also  been 
investigated  along  with  sheets  that  are  able  to  conjugate  proteins  and 
nanoparticles.
83,92  The  junctions  specified  in  Seemans  1982  paper  have  also  been 
utilised extensively, for example in the formation of lattices that can be functionalized 
with proteins and metalized with silver to form highly conductive nanowires
93 (Figure 
1.18).  
 
 
 
 
 
 
 
 
Figure 1.18. DNA based arrays based on DNA junctions able to form nano-wires.
93 
 
1.3.3  Three-Dimensional DNA Based Structures  
 
 Various  three-dimensional  structures  have  been  prepared  by  exploiting  the  base 
pairing specificity of DNA. By designing oligonucleotide strands to carry sequences 
complementary to sections of the partnering oligos complex structures can be formed 
such as tetrahedrons
94,95, cubes
96 and octahedral structures.
97 Previous research has  
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also demonstrated that a selection of these structures are capable of encapsulating 
nanoparticles for possible application in drug delivery.
98,99 
 
       
 
 
 
 
 
Figure  1.19. E xamples  of  DNA  based  structures;  (1)  tetrahedron
94; ( 2 )  c u b e
96;  (3) 
octahedron.
97 
 
  Visualisation  of  these  structures  is  of  importance  for  characterisation  – 
electrophoresis  provides  a  good  indication  of  correct  formation  however  direct 
visualization using such high-resolution techniques as AFM and TEM is ideal. As 
well as the design and formation of these structures, researchers have also generated 
impressive high-resolution images (Figure 1.20). 
 
 
 
 
 
 
 
 
 
Figure 1.20. AFM and TEM visualization of (1) DNA tet
95; (2) Octahedral geometries
97; (3) 
DNA lattice.
93 
 
Chemical functionalization has been explored in this area to impart designed 
functionality onto these structures. Examples of the functionalization of DNA nano-
structures  via  chemical  modification  include;  attachment  of  fluorophore-tagged 
oligonucleotide into a DNA ring
100,101 and the addition of a linker enabling two nano-
scale rings to be joined.
102   
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Figure 1.21. DNA based nano-circles joined by a polyamide ‘anchor’ enabling formation of 
double-ring structures.
102  
 
 
1.6  Aims of Thesis 
 
This  thesis  is  concerned  with  the  application  of  chemically  modified  DNA  in 
emerging  areas  of  biotechnological  research,  specifically;  Nanopore  analytics  and 
DNA-based nano-scale structures.  
The first aim of this thesis is to improve single-molecule DNA sensing using 
nanopores. Nanopore recording is a relatively new technique, which senses charged 
compounds that are electrophoretically driven through a nano-scale pore. As no bulky 
optical equipment is needed, nanopore analytics can be miniaturized and potentially 
used for point-of-care applications. However, the sensing of important analyte-type 
DNA is hampered by poor analytical resolution. Individual bases cannot, currently, be 
detected  as  the D N A   strands  translocate  too  quickly  through  the  pore  for  any 
sequence  information  to  be  read.  Chemical  modification  could  help  enhance  the 
resolution of this single-molecule technique. By attaching bulky chemical tags to the 
DNA strands it may be possible to slow down its translocation. This should enable 
identification of those strands carrying a tag from those that remain unmodified. The 
modification  of  multiple  bases  should  allow  identification  of  multiple  tags  and 
therefore sensing of specific bases, which has so far not been achieved using this 
technology. Strategies to attain the aim of improving nanopore analytics via chemistry 
are described in Chapter 2. 
The second aim of the thesis is to enhance DNA-nanobiotechnology using 
chemically modified oligonucleotides. Due to its interesting physical properties, DNA  
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has been used widely as a building block to form higher-order structures. Most of the 
new  architectures  have  been  built  by  utilizing  the  base-specific  hybridization  of 
complementary DNA strands. Whilst these constructs are a fascinating example of the 
versatility of DNA, functionalization by attachment of chemical tags would create a 
new area within DNA-nanobiotechnology. For example, chemical modification may 
help impart new functions, namely the ability to form DNA structures by a chemical 
trigger.  It  is  also  conceivable  that  DNA  structures  could  enhance  chemistry  by 
providing a nanoscale scaffold onto which different functional groups are placed. The 
results of this endeavor are described in Chapters 3 and 4. 
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Chapter Two   
 
Single Molecule Sensing   
 
 
2.1  Summary   
 
In nanopore analytics, individual DNA strands are electrophoretically driven through 
a  nanopore.  Despite  progress  in  this  general  area  the  analytical  resolution  in  the 
sensing of DNA strands is poor as individual bases in translocating DNA strands 
cannot be resolved.  This chapter describes how nanopore analytics can be enhanced 
by chemically tagging DNA strands. In particular, it is demonstrated that short peptide 
tags  attached  to  internal  base  positions  can  help  discriminate  individual  bases  in 
translocating synthetic DNA strands. Furthermore, the chemical tagging strategy can 
be  applied  in  a  biological  context  to  discriminate  between  single  nucleotide 
polymorphisms (SNP), as shown using template-directed DNA polymerization with 
peptide-tagged nucleotides. Finally, adamantane-tagged nucleotides are synthesized to 
lay the foundations for a fast point-of-care method to detect highly repetitive DNA 
strands of forensic importance.  
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2.2  Introduction 
 
Nanopore recording is an attractive electrical analytical technique in which individual 
molecules block a nanometer-scale pore leading to detectable modulations in ionic 
current.  The  single-molecule  approach  has  been  exploited  to  analyse  toxins
66, 
chemical reactions/drug molecules
67, proteins
68 and single point mutations in double 
stranded DNA.
71,72 Despite progress in the sensing of isolated nucleotides
73,74 and a 
single base position in static DNA strands, it has so far not been possible to detect 
multiple bases in an individual translocating strand. One of the main technical hurdles 
towards this aim is the high speed with which the voltage-driven DNA strands pass 
through the pore leading to insufficient analytical resolution. In order to address this 
shortcoming, a new approach was developed to slow down single stranded DNA and 
thereby enable the detection of multiple separate bases.  
This approach consisted of attaching chemical tags to individual bases in order 
to increase their size in comparison to the non-modified bases. It was anticipated that 
the chemical tags would facilitate the detection of the specific bases. As the first of 
three aims, it was investigated whether the chemical tags cause a steric blockade each 
time a modified base passes a narrow pore, and whether chemical tags of different 
composition and size give rise to different characteristic current signatures. This first 
aim  was  experimentally  pursued  by  covalently  attaching  short  oligopeptides  to  a 
synthetic oligonucleotide. After establishing the proof-of-principle with a synthetic 
system, the second aim was to show that tagging of bases can help infer biomedically 
relevant  sequence  information  from  DNA  templates.  The  viability  of  the  tagging 
approach was tested with peptide-modified nucleotide triphosphates in combination 
with template-directed DNA polymerisation. The third aim was to develop the tagging 
approach into a sensing technique that can compete with state-of-the art technologies 
and advance the general field of bioanalysis. In particular, the chemical foundations 
were to be created to enable the electrical sizing of repetitive DNA sequences that are 
of relevance in the identification of forensic samples. This final aim was investigated 
using nucleotides which carry the small and compact adamantane tag instead of the 
longer peptide tag.  
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2.3  Materials and Methods 
 
2.3.1  Reagents  
 
All reagents were purchased from Sigma-Aldrich Co. Ltd. unless otherwise stated, 
and used without further purification. All solvents were of commercial anhydrous 
quality and used as received. Ethanol refers to absolute ethanol (> 99.7%) and brine 
refers to a saturated solution of sodium chloride. For all moisture sensitive reactions, 
glassware  was  dried  in  an  oven  at  120  °C  and  an  argon  atmosphere  used. 
  Oligonucleotides  were  purchased  from  Integrated  DNA  Technologies 
(Leuven,  Belgium;  www.idtdna.com),  all  amino  acids  and  resins  purchased  from 
NovaBioChem  (EMD  bioscience,  Gibbstown,  NJ,  USA;  www.novabiochem.com). 
Peptides  were  synthesized  on  a  Syro  automated  machine  (see  section  2.3.10  for 
details).  Anion  Exchange  (AEC),  Size  Exclusion  (SEC)  and  Immobilised  Metal 
Affinity  (IMAC)  were  all  performed  on  an  AktaPurifier  10  FPLC  system  (GE 
Healthcare). HPLC was performed on a Varian ProStar system with a Model 210 
solvent delivery module and a Model 320 UV detector using Varian analytical, semi – 
prep  and  prep  columns.  Thin  Layer  Chromatography  (TLC)  was  performed  on 
aluminium  backed  Sigma-Aldrich  TLC  plates  with  F254  fluorescent  indicator. 
Visualisation  was  done  by  absorption  of  UV  light  or  by  staining  the  plates  with 
phosphomolybdic acid (PMA) solution [PMA hydride (12 g), conc. sulphuric acid (10 
mL),  ethanol  (250  mL)]  or  potassium  permanganate  solution  [KMnO4  (1.25  g), 
Na2CO3 (6.25 g), water (250 mL)]. Normal phase flash chromatography was carried 
out  using  silica  gel  (43  –  60  µm)  supplied  by  Merck.  Flash  chromatography  on 
alumina was carried out using alumina activated from Brockman activity I to III (via 
addition of 6% v/w of water to the dry Alumina powder).  
  MALDI MS was performed on a Waters MALDI MicroMX machine using 
2’,4’,6’-trihydroxyacetophenone (THAP) as the matrix (1 mg/mL in methanol) and 
ammonium acetate or citrate as the co-matrix. LC/MS was performed on a Waters 
Acquity uPLC SQD using HPLC grade water and Acetonitrile (both with 0.1% formic 
acid) as the solvents. NMR (
1H and 
13C) was performed on both 300 and 500 MHz 
AMX Bruker Spectrometers (as stated). The chemical shifts (δ) were given in units of  
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ppm relative to tetramethylsilane (TMS), where δ (TMS) = 0 ppm. Coupling constants 
(J)  were  measured  in  Hertz  using  the  Mestrec®  analysis  program  (Mestrelab 
Research, Santiago de Compostela, Spain). Multiplicities for 
1H coupling are shown 
as s (singlet), d (doublet), t (triplet), m (multiplet), or a combination of the above. 
Deuterated  chloroform  (CDCl3),  dimethylsulfoxide  (d6-DMSO)  and  methanol 
(CD3OD) were used as solvents (as stated) for all NMR analysis.  
 
2.3.2  Preparation of peptide-tagged DNA strands for Aims 1 and 2 
 
Oligopeptides of different length and composition were covalently attached to one or 
two internal base positions of a synthetic oligonucleotide. Scheme 2.1 summarises the 
two-step procedure to prepare a single-modified peptide-DNA conjugate.  
 
  
 
 
 
 
     SPDP 
 
 
 
 
 
 
 
Scheme 2.1. Conjugation of peptide tags to an internal base. The initial modification of non-
biogenic  amine-carrying  thymine  with  the  heterobifunctional  crosslinker  SPDP  and 
subsequent attachment of cysteine containing peptide sequence.  
 
Using  the  heterobifunctional  linker  N-Succinimidyl  3-(2-pyridyldithio)-
propanoate  (SPDP;  synthesis  in  Scheme  2.2)  an  internal  thymine  carrying  a  non-
biogenic  amine  linker  was  coupled  to  an  activated  pyridyl  disulfide  group.  This  
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moiety  is  particularly  liable  to  attack  from  thiols  and  therefore  introduction  of  a 
cysteine containing peptide allows formation of the conjugate. 
 
 
Scheme 2.2. Synthesis of SPDP; (i) DPDS, mercapto-propionic acid, DCM, RT; (ii) DCC, N-
hydroxysuccinimide, DCM, RT. 
 
2.3.3  3-(2-Pyridyldithio)-propanoic acid (2) 
 
 
 
 
 
2’-2’-Dipyridyldisulfide  (DPDS,  10.98  g,  0.0498  mol)  was  dissolved  in  80  mL 
anhydrous ethanol. Acetic acid (1.5 mL) and 3-mercapto-propanoic acid (2.64 g, 2.16 
ml, 0.0249 mol) were added and the solution left stirring at room temperature for 2 
hours. After this time the solvent was removed under reduced pressure to yield a 
viscous yellow oil, this was placed under high vacuum to remove all traces of acetic 
acid. The crude product was purified using a basic Al2O3 column (Brockman activity 
III)  with  dichloromethane/ethanol  (3/2)  as  the  eluent.  Once  the  yellow  band 
corresponding to the thione by-product had eluted from the column, 4 ml of acetic 
acid per 100 ml solvent was added to elute the desired product.  Fractions containing 
this compound were pooled and the solvent removed under reduced pressure. The 
resulting viscous oil was dried on a high vacuum line to yield the title compound 2 
(4.1 g, 0.019 mol, 77% yield). Calculated mass (C8H9NO2S2) 215.01; observed mass 
(ESI
+) m / z  –  216.04  (MH
+),  238.03  (M  +  Na
+). 
1H  NMR  (300  MHz;  d6-DMSO) 
δ/ppm 2.59 (2H, t, J = 7.0), 2.98 (2H, t, J = 7.0), 7.23 (1H, ddd, J = 7.1, 4.8, 1.2), 7.75 
(1H, d, J = 8.0), 7.8 (1H, td, J = 7.9, 1.4), 8.4 (1H, d, J = 4.9), 12.43 (1H, broad s). 
13C 
NMR  (75  MHz,  d6-DMSO)  δ/ppm  33.6,  33.7,  119.2,  121.1,  137.7,  149.5,  159.0, 
172.7.  
  53 
2.3.4  N-Succinimidyl 3-(2-pyridyldithio)-propanoate (3) 
 
 
 
 
 
 
3-(2-Pyridyldithio)-propanoic  acid  2  (3.45  g,  0.016  mol)  in  anhydrous  DCM  was 
cooled to 0°C in an ice bath. N-hydroxysuccinimde (2.03 g, 0.0176 mol) was added 
followed by DCC (3.64 g, 0.0176 mol), both in anhydrous DCM. The solution was 
brought back up to room temperature and left stirring for 3 hours After the reaction 
had reached completion (followed by TLC) the solution was filtered under vacuum 
from the urea precipitate and the solvent removed from the filtrate under reduced 
pressure to yield a crude yellow oil. This crude material was purified via silica gel 
column chromatography using dichloromethane/methanol (50/2) as the eluent. The 
fractions  containing  the  product  were  combined  and  the  solvent  removed  under 
reduced pressure to yield a colourless oil that crystallized overnight at -20°C (3.93 g, 
0.0126  mol,  79%  yield).  Calculated  mass  (C12H12N2O4S2)  312.36;  observed  mass 
(ESI
+) m/z – 313.35 (MH
+), 335.36 (M + Na
+).  
1H NMR (300 MHz; d6-DMSO) 
δ/ppm 2.81 (4H, s), 3.12 (4H, m, ABsys), 7.25 (1H, ddd, J = 6.4, 4.8, 1.6), 7.76 (1H, d, 
J = 7.1), 7.82 (1H, td, J = 7.5, 1.6), 8.48 (1H, d, J = 4.9). 
13C NMR (75 MHz; d6-
DMSO) δ/ppm 25.4, 30.2, 32.8, 119.5, 121.4, 137.8, 149.7, 158.5, 167.4, 170.0.  
 
2.3.5  Solid Phase Peptide Synthesis (SPPS) 
 
This section will describe in detail the synthesis of peptides via Fmoc solid phase 
peptide synthesis (SPPS) using an automated synthesizer. To rationalize the reagents 
and  conditions  used  during  the  preparation,  the  general  technique  will  be  briefly 
introduced.  
Since the development of the Merrifield resin
103 modern peptide synthesis has 
been  carried  out  via  a  solid  phase  peptide  synthesis  (SPPS)  method,  making  the 
synthesis  of  peptides  of  up  to  around  50  amino  acids  routine.  Modern  peptide 
synthesizers can make multiple peptides in parallel so a large number of compounds 
may be prepared overnight. SPPS involves the step-wise attachment of amino acid  
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residues to an appropriately modified polystyrene (PS) resin. The PS beads are held in 
a small inert reaction vessel (a PTFE syringe, for example) that contains a frit and is 
attached to a vacuum system. This allows the beads to sit at the bottom of the syringe 
whilst solutions containing the reagents are deposited via an automated system and 
allowed to react. Once the reaction is complete, the syringe is put under vacuum to 
evacuate the solution, leaving the beads in the vessel. In this way the peptide can be 
prepared via addition and evacuation of sequential reagents, a procedure know as 
flow-through synthesis. The chemistry involved is repetitive and orthogonal, allowing 
the process to be simplified and conducted robotically. Scales in the hundreds of mg 
of each peptide are usually prepared however industrial processes can produce g – kg 
of material. Once the synthesis is complete the peptide can be cleaved from the resin 
and  all  protecting  groups  removed  in  a  single  step  to  yield  the  target  compound. 
Depending  on  the  success  of  the  synthesis,  which  usually  relies  on  the  specific 
sequence being attempted, the peptide may not require any further purification. 
 
2.3.6  Resins and Linkers 
 
The  resins  used  for  SPPS  are  usually  1%  divinylbenzene  cross-linked 
polystyrene  (PS)  based  and  packed  as  porous  beads.  Modern  resins  can  be 
functionalized with PEG (polyethylene glycol) to increase the characteristics of the 
resin  i.e.  hydrophilicity.  These  resins  must  then  be  functionalized  with  ‘linker’ 
compounds which allow attachment of the amino acid residues forming the peptide 
chain. The choice of linker dictates the ease and conditions with which the peptide is 
cleaved from the resin. The most commonly used linker/resin combination tends to be 
the  Wang  resin  (a  hydroxymethyl  benzene  linker  attached  to  a  PS  resin)  but 
chlorotrityl and Rink amide are also regularly used (Figure 2.1). 
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Figure 2.1. Examples of common linkers and their cleavage conditions; (1) Wang (strong 
acid); (2) Chlorotrityl (weak acid); (3) Rink amide (allows cleavage of peptide with inclusion of 
an amine group at its Carboxy terminus). 
 
As the coupling steps that make up the peptide compound are base-initiated, 
the cleavage of the peptide from the linker tends to be acid labile. Depending on the 
linker used, different conditions will effect cleavage. In the case of the Wang resin, a 
strong acidic solution such as 95% TFA in DCM is employed. This condition causes 
protonation  of  the  C-terminal  ester  and  cleavage  from  the  linker  via  electron 
resonance (Scheme 2.3). Alternative linkers, such as chlorotrityl, require milder acidic 
conditions allowing the peptide to be cleaved without deprotection of the side chain 
groups. 
 
 
 
Scheme 2.3. Acid-initiated cleavage of a peptide from a Wang linker. 
 
The first amino acid residue must be attached to the linker via an esterification 
coupling. This initial attachment step is very important for several reasons. Firstly, the 
yield of the peptide depends on the degree of functionalization of the resin i.e. the 
loading of the resin. Secondly, the remaining hydroxyl sites that do not react may be 
acylated later on in the synthesis leading to C-terminally truncated peptides. Due to 
the  harshness  of  this  initial  esterification,  required  to  achieve  optimal  loading, 
enantiomerisation  can  be  an  issue.  The  strong  bases  involved  ensure  an  efficient 
coupling of the hydroxyl to the activated amino acid but may deprotonate the alpha 
carbon of the incoming amino acids in solution. This will lead to the enolate product  
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which, when picking up another proton, may give rise to the undesired enantiomer 
(Scheme 2.4). 
 
 
Scheme 2.4. Enantiomerisation of the first amino acid residue due to deprotonation of the 
alpha carbon and formation of the enolate intermediate leading to racemization. 
 
This  problem  is  especially  prevalent  when  attaching  an  initial  cysteine  or 
histindine, as the side chain groups on these amino acids are able to stabilize the 
enolate  and  thereby  facilitate  deprotonation  and  subsequent  racemisation. 
Racemisation can also occur during the synthesis, activation of the C-terminus of the 
peptide chain can be followed by the deprotonation of an amide and the subsequent 
formation  of  an  oxazole  (Scheme  2.5).  This  in  turn  encourages  enolate  formation 
which may lead to the alternative, undesired enantiomer. This is most likely to occur 
during convergent coupling of peptide fragments. 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2.5. Oxazole formation and subsequent racemisation. 
 
Premature  cleavage  from  the  resin  is  also  an  issue  during  solid  phase 
synthesis. Sequences containing proline as the first residue may present problems due  
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to the ease of which diketopiperazine is formed. Due to its positioning, attack from 
the terminal amine of the residue coupled to the proline (Scheme 2.6) to the ester 
linking the peptide to the resin is possible. This results in the cleavage of these initial 
two residues leaving the hydroxyl exposed for potential alkylation further on in the 
synthesis.  
 
 
Scheme 2.6. Diketopiperazine formation leading to cleavage of the peptide chain from the 
resin. 
 
Due to these issues, the resin is usually purchased with the linker and first 
residue already attached. In addition, mild bases are used during the synthesis. The 
residues are also coupled one amino acid at a time to minimize enatiomerization via 
ozaxolone formation.  
 
2.3.7  FMOC SPPS 
 
The development of Fmoc peptide synthesis
104 has allowed large peptide compounds 
to be prepared under mild condition. The solid-phase synthesis of peptides relies on 
orthogonal chemistry. Base-initiated reactions lead to the formation of the peptide 
while  acidic  conditions  effect  its  deprotection  and  cleavage.  Each  amino  acid  is 
purchased (or synthesized) protected at its N-terminus by a fluorenylmethoxycarbonyl 
(Fmoc) group (Figure 2.2). If necessary, the functional side chain group of the amino 
acid is also protected by a moiety that is usually acid labile (i.e. tert-butyl ester or 
trityl  groups).  However,  many  of  these  protecting  groups  are  available  to  suit  a 
specific  type  of  amino  acid  R  group  and  its  own  deprotection  conditions.  It  is 
therefore possible to plan the synthesis of a peptide so selected R groups remain 
protected  even  during  the  cleavage  conditions.  This  is  especially  useful  when 
employing non-biogenic amino acids. 
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Figure 2.2. An example of a glutamic amino acid carrying a tert-butyl protecting group on its 
carboxy R group and an fmoc group at its amino terminus. 
 
As  the  Fmoc  group  is  base-labile,  the  coupling  steps  can  proceed  without 
cleavage of the R protecting groups or the ester linking the peptide to the resin. The 
deprotection of the Fmoc group is initiated via a solution of 20% piperidine, which 
deprotonates the acidic chiral proton on the Fmoc group. This leads to the resonance-
stabilized  anion,  which  is  able  to  cleave  from  the  peptide  chain  resulting  in  the 
evolution of CO2(g) and an alkene which may subsequently undergo reaction with the 
piperidine base (Scheme 2.7). 
 
 
 
 
 
 
 
 
Scheme  2.7.  Mechanism  for  FMOC  removal;  deprotonation  of  the  acidic  chiral  proton 
shown leads to the evolution of CO2 and release of the free amine. The resulting fluorenyl 
alkene is attacked by any free piperidine to prevent side reactions. 
 
2.3.8  Coupling Step 
 
Once the Fmoc group on the first residue has been deprotected, the next amino acid 
can be attached. This incoming residue must first be activated. This is achieved by 
reacting  the  unprotected  C-terminus  carboxyl  group  with  a  coupling  reagent  to  
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generate the ester in situ. Carbodiimide based compounds (dicyclohexylcarbodiimide 
– DCC, for example) were the first coupling agents to be used, and are still very 
effective. Due to their increased yield, the alternative aminium/phosphonium salts are 
now more widely utilized (e.g. HBTU, see Figure 2.3). 
 
 
 
 
 
 
             1      2 
 
 
Figure  2.3.  Examples  of  two  commonly  used  coupling  agents;  (1) 
Dicyclohexylcarbodiimide;  (2)  HBTU ( O-Benzotriazol-1-yl-N,N,N',N'-tetramethyluronium 
hexafluorophosphate). 
 
In the case of the phosphonium salt-based coupling agent (Scheme 2.6), the 
reaction is initiated via the deprotonation of the amino acid carboxyl group via a 
tertiary  base  such  as  DIPEA  (N,N-diisopropylethylamine).  The  carboxylate  then 
attacks  the  carbocation  of  the  activating  group  kicking  out  HOBt  forming  the 
activated ester. At this point the Fmoc-deprotected amine can attack the activated 
ester to create the stable amide bond. 
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Scheme 2.8. HBTU coupling of an amino acid residue to the resin linked peptide chain; 
Deprotonation  of  the  carboxylic  acid  of  the  incoming  amino  acid  allows  it  to  attack  the 
coupling agent forming an activated ester in situ. The free amine terminus of the immobilized 
peptide chain can then attack this ester to displace the urea by-product and form of the new 
amide bond. 
 
The yield of each coupling step is especially important in this type of solid 
phase  synthesis.  It  is  the  deciding  factor  in  the  total  length  of  peptide  strand  the 
technique is able to prepare. For example, if each step goes to 99% completion then a 
25-mer  will  be  synthesized  in  77%  yield.  Any  decrease  in  yield  per  step  will 
dramatically  decrease  the  yield  of  the  final  peptide  and  increase  the  amount  of 
unwanted truncated by-products. As the yield of this step is very important, additional 
compounds  may  be  added  to  achieve  high  yield.  1-hydroxy-7-azabenzotriazole 
(HOAt), for example, has been shown to improve yields. This group acts to encourage 
attack on the activated ester by hydrogen bonding with the N-terminus amine of the 
resin-bound peptide. This brings the groups into close proximity allowing for a more 
efficient reaction.  
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Figure 2.4. Hydrogen bonding of HOAt to the peptide chain bringing its terminal amine 
closer  to  the  activated  ester  and  keeping  both  moieties  static  relative  to  one  another 
increasing the efficiency of the coupling reaction. 
 
2.3.9  Peptide Cleavage and Work-Up  
 
The cycling of the synthetic procedure involves the FMOC group of a newly coupled 
residue first being taken off with 20% piperidine and the next amino acid activated 
and coupled. This process continues until the desired number of residues have been 
coupled  to  the  resin.  The  beads  are  then  washed  with  the  appropriate  solvents  to 
remove any reagents still remaining in the resin meshwork. The solid phase is then 
treated with a cleavage solution (95% TFA in DCM for the Wang linker) including 
scavenger agents such as triethyl silane (TES) and compounds such as ethylene dithiol 
(EDT). These reagents react with any carbocations (arising, for example, from the 
deprotection  of  tert  -  Butyl  groups)  and  ensure  that  thiol  groups  (e.g.  cysteines) 
remain reduced. After cleavage from the resin, the peptide is precipitated in diethyl 
ether and analyzed via RP-HPLC and ESI-MS. If there are no truncated sequences, 
the peptide may be pure enough to use without need for further HPLC purification. 
 
 
Figure  2.5.  RP-HPLC  (left)  and  ESI  MS  (right)  examples  of  a  CysHis6  peptide  – s e e  
experimental methods section 2.3.10 for details.  
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2.3.10  General SPPS Procedure 
 
All  peptides  employed  for  the  chemical  tagging  of  DNA  were  synthesized  using 
standard Fmoc solid-phase peptide synthesis on a Syro automated system. Pre-loaded 
Wang resin was used with standard HBTU/DIPEA coupling chemistry. All amino 
acids  were  purchased  as  N-protected  Fmoc  and  appropriately  protected  R  group 
compounds.  Each  coupling  step  was  conducted  for  40  mins  and  each  Fmoc 
deprotection allowed to proceed for 10 min in 20% piperidine. Four equivalents of 
amino acids were used. After completion of the synthesis, peptides were deprotected 
and cleaved from the resin by incubation in TFA/TES/EDT/H2O (2500:150:75:150 
µL) for 3 hours. The collected peptide solution was mixed with diethyl ether and 
allowed to precipitate at -20°C. The suspension was centrifuged at 4000 rpm, and the 
pellet was re-dissolved in diethyl ether. This purification process was repeated three 
times  after  which  the  precipitate  was  dissolved  in  deionized  H2O  or  0.1%  TFA 
containing  HPLC  grade  water  if  necessary,  frozen  in  liquid  N2  and  freeze-dried 
overnight. The peptides were analyzed and if necessary purified via reversed phase 
HPLC using a Varian ProStar system with a Model 210 solvent delivery module and a 
Model 320 UV detector. The preparative purification was performed using a Varian 
column (100 x 21.2 mm, 5 µm beads, flow rate of 10 mL/min) loaded with 100 µL 
aliquots of a 20 mg/mL solution of peptide dissolved in 0.1% TFA containing water. 
The mobile phase was a linear gradient beginning with 98:2 water (0.1% TFA) / 
acetonitrile (0.1% TFA) to 40:60 water (0.1% TFA) / acetonitrile (0.1% TFA) over 30 
min, this gradient was adapted when necessary. The analysis of the chromatograms 
was  conducted  using  Star  Chromatography  Workstation  software  Version  1.9.3.2. 
Fractions containing the correct peak were pooled, the solvent removed under reduced 
pressure  to  approximately  2  mL,  and  the  solution  freeze-dried  overnight.  The 
resulting white powder was analyzed via HPLC using a Gemini column (250 x 4.6 
mm,  5  µm  beads,  flow  rate  of  1  mL/min)  using  the  solvent  system  and  gradient 
detailed  above.  ESI-MS  analysis  was  performed  on  a  Waters  Acquity  Ultra 
Performance LC/MS machine in positive ion mode using the same solvent system and 
gradient as the analytical HPLC procedure detailed above (0.6 ml/min, 0.1% formic 
acid used in place of TFA).  
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2.3.11  Coupling of Cysteine-Terminated Peptides to SPDP-Activated DNA 
 
For oligonucleotide activation, a 1 mM solution of oligonucleotide (25 µL, 25 nmol) 
in 10 mM Tris, 1 mM EDTA, pH 8.0 was diluted with 0.1 M NaHCO3, 50 mM NaCl, 
pH 9.0 (65 µL). The mixture was combined with a 250 mM solution of SPDP in 
DMSO  (10  µL,  2.5  µmol)  leading  to  a  white  precipitate,  which  immediately  re-
dissolved  upon  agitation.  The  reaction  was  incubated  at  room  temperature  for  30 
mins.  Unreacted  SPDP  was  removed  by  size  exclusion  chromatography  using  an 
AKTA purification system. A Sephadex column with a volume of 5 mL was loaded 
with 100 µL of the reaction mixture at a flow rate of 5 mL/min. The mobile phase was 
buffer A (20 mM Tris, 50 mM NaCl, pH 8.0), and the DNA containing fraction was 
collected using an isocratic gradient. 
  A cysteine-terminated peptide was covalently coupled to SPDP-activated DNA 
oligonucleotides. Peptide (5 µmol) was dissolved in distilled H2O containing 0.1 % 
TFA (100 µL, final concentration of 50 mM). An aliquot (10 µL, 0.5 µmol) was 
combined  with  an  aqueous  solution  of  purified  SPDP-activated  DNA  (2  mL,  25 
nmol).  In  the  case  of  R7C1-O1,  50%  v/v  of  formamide  was  added  to  the  buffer 
containing  the  SPDP-activated  oligonucleotide  and  the  peptide  to  improve  the 
solubility  of  the  conjugate.  The  solutions  for  all  peptide  oligonucleotide  mixtures 
were agitated on a shaker at room temperature for 2 hours followed by purification via 
anion exchange chromatography on an AKTA purifier system using a Resource Q 
column (volume 1 mL). A linear gradient was employed beginning with buffer B (20 
mM Tris, pH 8.0) to 60:40 buffer B / buffer C (buffer B plus 2 M NaCl) over 45 min 
at  a  flow  rate  of  1  mL/min.  Product-containing  fractions  were  desalted  and 
concentrated to a volume of 200 µL using ultrafiltration spin-columns (Amicon, 5 
mL, 5KDa MW cut-off).  
  The  concentration  of  the  purified  conjugates  were  determined  using  UV/vis 
spectroscopy (Cary Eclipse, Varian), and their purity assessed using analytical AEC. 
The purity of the His6-tagged conjugate was also controlled via immobilized metal 
affinity chromatography (IMAC) on an AKTA system with a Ni-NTA containing His-
Trap  column  (1  mL/min).  The  conjugate  was  loaded  onto  the  column  using  ten 
column volumes of buffer D (0.1 M Na2HPO4, 50 mM NaCl, pH 8.0) and eluted 
using  a  step  gradient  to  buffer  E  (buffer  D  plus  1  M  imidazole).  The  mass  of 
conjugates were determined via MALDI MS analysis (Section 2.4.3)  
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2.3.12  Ligation of peptide-modified oligonucleotides 
 
To prepare an oligonucleotide carrying two peptide tags, a convergent method was 
applied  (Scheme  2.9).  Two  single-modified  27-mers  were  initially  prepared,  one 
containing  a  phosphorylated  5'-terminus.  Using  the  enzyme  T4  Liagase  and  a 
complementary bridging 20-mer strand, the duplex was ligated to form a continuous 
strand with 54-nt in length. 
 
 
 
 
 
 
 
 
 
 
Scheme 2.9. Convergent synthesis of a double modified 54-mer oligonucleotide via ligation 
of  two  single-modified  27-mers  using  T4  Ligase  and  a  complementary  bridging  20mer 
oligonucleotide. 
  
The  synthesis  of  Tyr3/Tyr3-O4  (Table  2.1)  was  performed  with  27-mer 
oligonucleotides O4A of sequence 5’ – ACA TTC CTA ACA TCA CTA ACT AAT 
CTT -3' and O4B of sequence 5'-/5Phos/TCA ACT CGA TAC GTA CCT ATC AAT 
CTA -3’. The two internal amine-modified thymine bases (underlined) were activated 
with  SPDP  and  coupled  to  Gly1Tyr3Cys1  as  described  previously.  The  chemical 
analysis of resulting POCs Gly1Tyr3Cys1-O4A and Gly1Tyr3Cys1-O4B was conducted 
via anion exchange chromatography and MALDI MS. To ligate the two POCs, a 
bridging oligonucleotide O4C was added. O4C with the sequence 5'-A TCG AGT 
TGA AAG ATT AGT T-3' was complementary to the 3' end of O4A and to the 5' end 
of  O4B.  Equimolar  amounts  of  Gly1Tyr3Cys1-O4A,  Gly1Tyr3Cys1-O4B,  and  O4C 
(12.5 nmol) were diluted in 50 mM Tris, 10 mM MgCl2, 1 mM ATP, pH 7.5 (370 
µL). The mixture was heated in a PCR block to 95 ºC for 2 min and cooled to room  
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temperature. The duplex was ligated by adding T4 ligase (16 µL, 6400 units) followed 
by incubation at room temperature for 16 hours. The resulting 54-mer POC Tyr3/Tyr3-
O4 was separated from bridging O4C using denaturing 15% PAGE. The peptide-
modified DNA strands were used to achieve the first two aims, namely the proof-of-
principle demonstration that peptide tags can slow down DNA translocation through a 
nanopore,  and  the  application  of  the  technology  to  discriminate  between  single 
nucleotide polymorphism (SNP). 
 
2.3.13  Preparation of Adamantane-Tagged Nucleosides for Aim 3. 
 
The third aim in this section of the thesis is concerned with the incorporation of a 
smaller, more versatile tag into an oligonucleotide for sizing highly repetitive DNA 
sequences of forensic importance. The chemical foundations towards this aim were 
laid  by  preparing  an  adamantane-derivatized  nucleotide.  The  synthesis  of  the 
nucleoside form of the analogue is outlined in Scheme 2.10 and encompasses the 
Sonogashira-mediated coupling of an appropriately modified adamantane-acetylene 
compound 5b with 5-iodo-2'-deoxyuridine. In addition to this compound a maleimide 
modified adamantane compound (5a) was also synthesized to allow coupling onto an 
appropriately modified oligonucleotide. 
 
 
 
 
 
 
Scheme 2.10. Synthesis of 5-adamantane-2’-deoxyuridine (6); HBTU mediated coupling of 
an appropriate acetylene with adamantane carrying a primary amine. Sonogashira coupling of 
this compound 5b with 5-iodo-2’-deoxyuridine yields the desired nucleotide 6. 
   
Sonogashira coupling
105 allows an alkyne to be attached to an alkyl halide 
(Scheme 2.11); it is an efficient, versatile and high yielding reaction that must be 
conducted  under  an  inert  atmosphere  to  prevent  oxidation  of  the  palladium.  The  
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mechanism initially involves the Pd(0) carrying two triphenyl phosphine ligands. The 
Pd metal oxidatively inserts into the carbon – halide bond of the starting compound 
(oxidizing to Pd(II) in the process). Meanwhile the terminal proton of the alkyne is 
replaced by the Cu metal of CuI via association of the metal first with the triple bond 
and with the help of triethyl amine removal and replacement of the hydrogen. This 
organo-metallic then displaces the halide on the Pd complex. 
 
   
                        1. 
    4. 
 
 
 
 
                       2. 
          3. 
 
 
 
 
 
 
 
 
 
Scheme  2.11. P d ( I I )  c a t a l y z e d  S o n o g a s h i r a  r e a c t i o n ;  (1)  oxidative  insertion;  (2)  trans 
metallation; (3) trans – cis isomerization; (4) reductive elimination. 
 
The ligands then orientate so the reacting compounds are cis to one another 
allowing reductive elimination to produce the desired compound and eliminating the 
starting Pd(0) catalyst. Since the Pd complex is prone to oxidation all solutions must 
be thoroughly degassed with Argon and the reaction must be conducted under an inert 
atmosphere throughout.  
The resulting compound 6 isolated from the Sonogashira coupling can then be 
phosphorylated  to  give  the  triphosphate  nucleotide  analogue  for  enzymatic  
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incorporation into a DNA template. Alternatively the corresponding phosphoramidite 
can be prepared via protection of the 5' hydroxyl group with dimethoxytrityl (DMT) 
(Scheme  2.12)  and  subsequent  phosphitylation  of  the  3'  hydroxyl  group  using 
cyanoethyl diisopropylphosphoramidite (CEP). 
 
 
 
 
Scheme 2.12. Dimethoxytrityl protection of the 5’ hydroxyl group. 
 
2.3.14  Maleimide propyl amino adamantane (5a) 
 
 
 
 
 
 
 
To 338 mg (2 mmol) of N-maleoyl-β-alanine in anhydrous DCM (10 mL) was added 
412 mg (2 mmol) of DCC also in anhydrous DCM. To this solution, 321.5 µL (300 
mg,  1.82  mmol)  of  1-adamantane  methyl  amine  was  added,  and  the  reaction  left 
stirring under an atmosphere of argon at RT overnight. After this period, the solvent 
was removed under reduced pressure, the crude was dissolved in neat methanol and 
reduced onto silica. The crude was purified via flash chromatography using a solvent 
system of 2% methanol in DCM. The fractions containing the desired product were 
pooled, and the solvent removed under reduced pressure to yield the title compound 
5a (356 mg, 64.5% yield). 
1H NMR (500 MHz; d6-DMSO) δ/ppm 1.35 (6H, s), 1.6 
(6H, dd, J = 12.0), 1.9 (3H, m), 2.35 (2H, t, J = 7.3), 2.68 (2H, d, J = 6.3), 3.6 (2H, t, J  
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= 7.3), 7.0 (2H, s), 7.7 (1H, t, J = 6.0). 
13C NMR (125 MHz; d6-DMSO) δ/ppm 24.5, 
25.3, 27.7, 33.3, 33.5, 33.9, 34.4, 36.5, 47.5, 50.1, 134.6, 156.6, 169.5, 170.7. 
 
2.3.15  Propiolic (adamantane-1-yl methyl) amide (5b) 
 
 
 
 
 
 
To 2.137 g (6.65 mmol) of TBTU in 30 mL anhydrous DCM was added 0.466 g (6.65 
mmol)  of  propiolic  acid  (also  in  DCM).  The  solution  was  stirred  in  ice  for  the 
duration of the reaction. 2.107 mL (12.1 mmol) of DIPEA was added to the reaction,  
followed by the dropwise addition of 1 g (6.05 mmol) of 1-aminomethyladamantane 
in anhydrous DCM. The solution was stirred on ice for 4 hours. During this period, 
the  solution  turned  bright  yellow.  The  solvent  was  then  removed  under  reduced 
pressure and residue was purified via column chromatography using a solvent system 
of 1:4 ethyl acetate:hexane, The fractions containing the desired product were pooled 
and the solvent removed under reduced pressure to yield the titled compound 5b (0.74 
g 56.3% yield). 
1H NMR (500 MHz; d6-DMSO) δ/ppm 1.4 (6H, s), 1.6 (6H, dd, J = 
12.3), 1.9 (3H, m), 2.8 (2H, d, J = 6.4), 4.1 (1H, s), 8.6 (1H, t, J = 6.4). 
13C NMR (125 
MHz; d6-DMSO) δ/ppm 13.9, 24.3, 25.0, 25.0, 25.4, 30.3, 31.6, 33.2, 49.5, 52.8, 71.2, 
153.2, 167.7. 
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2.3.16  5-Adamantane-2'-deoxyuridine 
 
 
 
 
 
 
 
5-Iodo-2'-deoxyuridine (0.677 g, 1.91 mmol), palladium tetrakis triphenyl phosphine 
(221 mg, 0.191 mmol) and copper iodide (72.8 mg, 0.382 mmol) were placed in a 
dried round bottom flask. The flask was purged and flushed with argon, followed by 
the addition of 30 mL of degassed anhydrous DMF and a degassed solution of TEA 
(0.968 g, 1.33 mL, 9.56 mmol) in 10 mL of degassed DMF. 0.829 g (3.82 mmol) of 
propiolic  (adamantane-1-ylmethyl)  amide  (5b)  dissolved  in  20  mL  of  degassed 
anhydrous DMF was then added dropwise, and the reaction allowed to proceed at RT 
under argon. After 22 h, the solvent was removed under high vacuum to yield a crude 
brown oil. This crude product was diluted in 1:1 DCM:MeOH, reduced onto silica 
and purified via flash chromatography using a 5% MeOH in DCM solvent system. 
The fractions containing the desired product were pooled, and the solvent removed 
under  reduced  pressure  to  yield  the  titled  compound  6  (0.72  g,  85.4%  yield). 
Calculated mass (C23H29N3O6) 443.5 m/z; observed mass (ESI
-) m/z – 442.6 (MH
-). 
1H NMR (500 MHz; d6-DMSO) δ/ppm 1.4 (6H, m), 1.6 (6H, dd, J = 12.0), 1.9 (3H, 
m), 2.1 (2H, dd, 5.0), 2.8 (2H, d, J = 6.6), 3.6 (2H, m), 3.8 (1H, dd, J = 3.5), 4.2 (1H, 
m), 5.1 (1H, t, J = 4.7), 5.2 (1H, d, J = 4.1), 6.1 (1H, t, J = 6.6), 8.4 (1H, s), 8.5 (1H, t, 
J = 6.6), 11.7 (1H, bs). 
13C NMR (125 MHz; d6-DMSO) δ/ppm 8.8, 27.7, 34.0, 36.5, 
45.8, 48.6, 50.4, 60.9, 70.0, 77.2, 85.1, 87.0, 87.7, 96.0, 146.0, 149.3, 152.6, 161.2. 
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2.3.17  5-Adamantane-5'-DMT-2'-deoxyuridine (7) 
 
 
 
 
 
 
 
 
The adamantane-modified nucleoside 6 (0.5 g, 1.128 mmol) was co-evaporated with 
anhydrous pyridine three times before being re-dissolved in 10 mL of pyridine under 
argon. DMT-Cl (0.42 g, 1.24 mmol) dissolved in argon-flushed pyridine was added 
drop-wise via a syringe. The reaction was allowed to proceed at RT under argon 
overnight. A further 0.1 equivalents of DMT-Cl was added (38.3 mg in 1 mL of 
anhydrous pyridine). After a further 1h, the solvent was removed under high vacuum 
and co-evaporated with toluene three times. The crude oil was dissolved in DCM and 
washed with a saturated solution of NaHCO3 and then brine. The organic phase was 
dried over MgSO4 and the solvent was removed under reduced pressure, followed by 
co-evaporation  with  toluene  (3  x).  The  crude  was  then  purified  via  flash 
chromatography  using  a  solvent  system  of  5:94:1  MeOH:DCM:pyridine.  The 
fractions containing the desired product were pooled and the solvent removed via 
reduced vacuum. The compound was co-evaporated with toluene three times to yield 
the titled compound 7 (0.183 g, 21.8%). Calculated mass (C44H47N3O8) 745.8 m/z; 
observed mass (ESI
-) 744.6 m/z (MH
-). 
1H NMR (500 MHz; d6-DMSO) δ/ppm 1.4 
(6H, m), 1.6 (6H, dd, J = 11.6), 1.9 (3H, m), 2.2 (2H, m), 2.8 (2H, d, J = 6.6), 3.2 (2H, 
m), 3.7 (6H, s), 3.9 (1H, m), 4.2 (1H, m), 5.3 (1H, d, J = 4.6), 6.1 (1H, t, J = 6.6), 7.2 
(13H, m), 8.0 (1H, s), 8.3 (1H, t, J = 6.6), 11.8 (1H, bs). 
13C NMR (125 MHz; d6-
DMSO) δ/ppm 21.0, 27.7, 34.0, 36.4, 50.4, 55.0, 63.8, 70.5, 76.7, 85.7, 85.8, 86.0, 
87.1, 96.2, 113.2, 125.3, 126.7, 127.6, 127.9, 128.2, 128.9, 129.6, 129.8, 135.2, 135.7, 
137.3, 144.7, 145.7, 149.2, 152.5, 158.1, 158.1, 161.2.  
 
  
  71 
2.3.18  Nanopore recordings  
 
Single-channel  current  recordings  were  performed  by  using  a  planar  lipid  bilayer 
apparatus  as  described.
106  Briefly,  a  bilayer  of  1,2-  diphytanoyl-sn-
glycerophosphocholine (Avanti Polar Lipids) was formed on an aperture (80 µm in 
diameter) in a Teflon septum (Goodfellow Corporation, Malvern, PA) separating the 
cis and trans chambers of the apparatus. Each compartment contained 2 M KCl, 50 
mM Tris-HCl, pH 8.0 unless otherwise stated. Gel-purified heptameric αHL protein 
(final  concentration  0.01–  0.1  ng/ml)  was  added  to  the  cis  compartment,  and  the 
electrolyte  in  the  cis  chamber  was  stirred  until  a  single  channel  inserted  into  the 
bilayer. Transmembrane currents were recorded at a holding potential of +100 mV 
(with the cis side grounded) by using a patch–clamp amplifier (Axopatch 200B, Axon  
Instruments, Union City, CA). For analysis, currents were low-pass filtered at 10 kHz 
or 30 kHz and sampled at 50 kHz or 100 kHz, respectively, by computer with a 
Digidata 1200 A/D converter (Axon Instruments), as described.
107  
 
 
2.4  Sensing  of  Chemically  Modified  DNA  using  Nanopore 
Recordings 
 
To enhance the resolution of nanopore recording individual bases were chemically 
modified with tags carrying steric bulk and/or charge. By adding these components to 
the DNA, the energy needed to thread the strand through the pore was expected to 
enlarge. If successful, the strategy should result in the lengthening of the translocation 
time. Furthermore, it was also anticipated that different chemical tags would give rise 
to  characteristic  current  modulations.  In  this  way,  identification  of  differently 
modified bases via the characteristic signatures should be possible.  
Peptides are ideal for this purpose due to their convenient synthesis via solid 
phase and due to the ease of with which their molecular characteristics can be altered 
by employing alternative amino acid sequences.  
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2.4.1  Peptide – Oligonucleotide Conjugates 
 
To test the hypothesis that peptide tags slows the translocation of DNA through the 
nanopore,  a  27-mer  oligonucleotide  was  modified  with  a  variety  of  peptides.  The 
chemical  structure  of  one  conjugate,  focusing  on  the  modified  base,  is  shown  in 
Figure 2.6. The cysteine-terminated peptide is attached via a heterobifunctional SPDP 
crosslinker  to  a  non-biogenic  thymine  base  which  carries  a  primary  amine  group 
linked to position 5. 
 
 
 
 
 
 
   
 
 
Figure 2.6. Chemical structure of an oligonucleotide carrying a peptide modification at an 
internal base position. 
 
2.4.2  Convergent Synthesis 
 
Given the chemical incompatibilities of the synthesis for peptides (acid-based) and 
oligonucleotides  (alkali-based)  previously  discussed,  a  convergent  approach  to  the 
conjugate synthesis was pursued. In this strategy, the oligonucleotide and peptide are 
synthesised and purified separately and, using complementary functionalization on 
each component, reacted to form the conjugate.  
For successful conjugation of the peptide-modified DNA strands, a mild and 
high yielding chemistry based on the heterobifuctional crosslinker N-succinimidyl 3-
(2-pyridyldithio)-propanoate  (SPDP)  was  used.  This  linker  carries  an  N- 
hydroxysuccinimide activated ester that allows attack from the primary amine of the 
modified oligo at room temp. in a buffered solution (pH 9.0) in under 30 min. SPDP 
was coupled to the amine-modified DNA oligonucleotide in a buffered solution, and  
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excess reagent was removed by size exclusion chromatography. Subsequently, the 
orthopyridyl disulfide group of the cross-linker was reacted with the thiol side chain 
group  of  a  cysteine  bearing  peptide  such  as  NH2-Cys-His6-COOH  at  room  temp. 
within 1h.  
  This  strategy  was  found  to  be  successful.  The  final  peptide-conjugated 
oligonucleotides  were  isolated  at  very  high  purity  (>  95%  see  Figure  2.7)  as 
determined  with  anion  exchange  chromatography  without  severe  loss  of  material 
(approx.  50%  yield).  The  ease  of  purification  depended  on  the  charge  and 
hydrophobic steric bulk of the peptide tag, leading to some conjugates being easier to 
purify than others. For example the Arg7 POCs eluted a few minutes before their 
unmodified counterparts on AEC due to the seven positive charges on the backbone 
of the peptide effectively neutralizing seven of the negative charges on the DNA. This 
allows the oligo to elute faster than the unmodified oligo and allows more effective 
purification. The opposite for the poly-Glycine peptides is observed, due to a lack of 
bulk and charge the modified oligonucleotides are hard to purify for the unmodified 
strands. 
 
 
 
 
 
 
 
 
Figure  2.7.  Representative  anion  – e x c h a n g e  c h r o m a t o g r a p h  f o r  C y s T y r 3  – O 1  P O C  
(27mer). 
 
2.4.3  Matrix Assisted Laser Desorption Ionisation Mass Spectrometry (MALDI 
MS) 
 
Due to the high mass and chemical complexity of the conjugates, NMR was not a 
viable method for their chemical characterization. Firstly, a relatively large amount of 
material is needed even when running a 
1H NMR experiment on a powerful machine 
(i.e.  >  600  MHz)  and  it  is  expensive  to  synthesize  a  large  amount  of  modified  
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oligonucleotide.  For  the  nanopore  experiments  described  here  only  25  nmol  (or 
around 0.2 mg) of oligonucleotide was modified (and around 50% of the final product 
isolated). Whereas only picomole amounts of material are needed for electrophoresis 
and mass spec. The complex spectrum resulting from an NMR experiment would also 
take time and expertise to elucidate. Considering these issues NMR is clearly not the 
ideal characterization technique. Mass Spectrometry is in fact the method of choice 
alongside  analytical  chromatographic  methods  for  determination  of  successful 
conjugation. MALDI-MS was used in place of electrospray since it has a higher mass 
range than and importantly is more tolerant to salts. Prior to spotting the DNA onto 
the MS-plate, the samples were desalted using ZipTips© to avoid the unfavorable 
neutralization of the overall negatively charged peptide-DNA conjugates by sodium 
ions. DNA was eluted using NH4OAc buffer as ammonium does not bind as tightly to 
the DNA backbone as sodium. The MS-matrix 2,3,4-trihydroxyacetophenone (THAP) 
was  found  to  give  the  best  results.  Large,  complex  biological  molecules  can  be 
accurately characterised using this technique. Figure 2.8 shows a representative MS-
spectrum for the 37-mer DNA (O3) strand carrying two Cys1Tyr3 peptide tags at over 
13,100 Da in mass. The peaks for the molecular ion  (M
1-) and the M
2- ion were 
observed.  
 
 
 
Figure 2.8; MALDI spectrograph of a peptide – oligonucleotide conjugate, M
1- and M
2-  
peaks observed (calculated mass; 13105 g.mol
-1). 
 
The resolution of the peak depends largely on the desalting procedure and 
concentration of the sample; the more thorough the desalting and the higher the conc. 
the more accurate and well defined the peak. Taking an average of 100 scans an error 
of approx. 0.2% is common; therefore this technique is not as accurate as its ES 
counterpart. However, with proper desalting and by taking the average of a smaller 
data set errors well below this number can be achieved, right down to a mass M – 1  
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i.e. the accurate mass of the M
1- molecular ion. The size of the molecule also effects 
the resolution, oligos containing in excess of 30 residues become harder to resolve 
than those with fewer. 
 
2.4.4  Summary of Synthesized Conjugates 
 
Using the procedures detailed above, a variety of peptide-oligonucleotide conjugates 
(POC) were successfully prepared (Table 2.1). The conjugates were either singly- or 
double-modified. The tags for the single-modified conjugates comprised peptides of 
different composition (glycine, histidine, arginine, tyrosine) and length (2, 4, or 6 
residues in addition to a single cysteine). The double-modified conjugates carried two 
Gly1Tyr3Cys1 tags on DNA oligonucleotides of different length. 
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Oligo- 
nucleotide 
 
  Peptide      POC 
Mass [m/z]
[c]  Mass [m/z]
[e]  Name 
[a] 
Length 
[nt] 
Sequence 
[b]  Expected  Observed 
HPLC 
retention 
time [min]
[d] 
Expected  Observed 
AEC 
retention 
time [min] / 
purity [%]
[f] 
                 
O1  27  n.a.  n.a.  n.a.  n.a.  8380.6  8379.4  25.5 / 99 
O1  27  H6C1  944.00  944.36  9.7
[i]  9411.2  9410.8  24.1 / 96 
O1-term.  27  G3H6C1  1253.00  627.82
[g]  15.0
[j]  9746.6  9759.03  25.4 / 75 
O1  27  H4C1  669.72  670.50  5.2  9136.1  9134.6  24.5 / 93 
O1  27  H2C1  395.44  396.33  4.2  8862.6  8862.4  24.5 / 99 
O1  27  G6C1  463.47  486.41
[h]  3.9  8930.8  8930.5  24.1 / 98 
O1  27  G4C1  349.36  372.24
[h]  3.8  8816.2  8815.2  24.2 / 98 
O1  27  G2C1  235.26  258.31
[h]  3.7  8702.3  8703.8  24.1 / 99 
O1  27  G1R7C1  1271.52  636.55
[g]  13.1
[k]  9738.6  9737.9  21.3 / 99 
O1  27  G1R5C1  959.15  480.48
[g]  12.5  9426.2  - 
[m]  21.8 / 90 
O1  27  G1R3C1  646.80  647.49  11.5  9113.9  - 
[m]  22.5 / 96 
O1  27  G1Y3C1  667.73  668.18  13.3
[l]  9134.6  9135.6  27.4 / 96 
O2  27  G1Y3C1  667.73  668.18  13.3
[l]  9149.6  9148.1  27.4 / 99 
O3  37  2xG1Y3C1  667.73  668.18  13.3
[l]  13105  13102  30.4 / 99 
O5  37  2xG1Y3C1  667.73  668.18  13.3
[l]  13098  13098  29.0 / 99.3 
O4  54  2xG1Y3C1  667.73  668.18  13.3
[l]  18160  18161  28.8 / 96.8 
 
Table 2.1; Chemical Characterization of Peptides and Peptide-Oligonucleotide Conjugates 
(POCs) 
 
n.a.; not applicable; 
[a] For sequences of oligonucleotides see table 2.2.
[b] The peptide sequence is from the C to the 
N terminus. 
[c] Peptide masses were obtained in the ESI+ mode. Peptides were dissolved in HPLC grade water 
containing 0.1% TFA. 
[d] Unless otherwise stated, retention times are for HPLC analysis using C18 column (250 mm x 
4.6 mm) and mobile phases 0.1% TFA in water and 0.1% TFA in acetonitrile with a gradient of 5 %  to 20 %  
acetonitrile/TFA over 10 min at a flow rate of 1 mL/min. 
[e] Oligonucleotide masses were obtained with MALDI–TOF 
using  THAP  as  matrix  and  ammonium  acetate  as  co-matrix. 
[f] A n i o n  e x c h a n g e  c h r o m a t o g r a p h y  ( A E C )  w a s  
performed using a Resource Q column (1 mL) and buffer B (20 mM Tris, pH 8.0) and buffer C (buffer B plus 2 M 
NaCl) with a linear gradient from 0 to 40 % B over 45 min at a flow rate of 1 mL/min. 
[g] M2+ ion. 
[h] Peptide mass for 
the  monosodium  ion; 
[i]  Gradient  of  3  %    to  10  %    acetonitrile/TFA  over  20  min.; 
[j] G r a d i e n t  o f  2  %   t o  5 0  %    
acetonitrile/TFA over 20 min.; 
[k] Gradient of 2 %  to 60 %  acetonitrile/TFA over 20 min.; 
[l] Gradient of 2 %  to 98 %  
acetonitrile/TFA  over  20  min. 
[m] E n t i r e  s a m p l e  r e q u i r e d  f o r  n a n o p o r e  r e c o r d i n g  t h e r e f o r e  s u c c e s s f u l  c o n j u g a t i o n  
inferred from shift in AEC retention time. 
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Oligo.  Sequence 
   
O1  5'-ACA TTC CTA AGT TCT GAA ACA TTA CAG-3' 
O2  5'-TCA ACT CGA TAC GTA CCT ATC AAT CTA-3' 
O3  5'-Phosph-TCA ACT CGA TAC GTA CCT ATC AAT CTA GTA CCT ATC A-3' 
O4  5’ – ACA TTC CTA ACA TCA CTA ACT AAT CTT TCA ACT CGA TAC GTA CCT ATC AAT CTA – 3’ 
O5  5’-Phosph-TCA ACT CGA TAC GTA CCT ATC TAT CTA GTA CCT ATC A – 3’ 
 
Table  2.2;  Oligonucleotide  sequences  used;  underlined  T i n d i c a t e s  a m i n o  l i n k e r  
modification. 
 
 
2.5  Nanopore Analysis of Tagged Oligonucleotides 
 
Once the appropriate peptide modified oligos had been prepared, the first aim of this 
chapter was addressed; to use the tags to slow the translocation of DNA through a 
biological nanopore. It was also intended to identify the tags as they passed the inner 
constriction of the pore via their characteristic current modulations. 
 
2.5.1  Nanopore Traces 
 
As  a  voltage  is  applied  across  a  bilayer  containing  the  biological  nanopore  the 
resulting current flow can be recorded and monitored via the pClamp program. This 
software, usually used by electophysiologists, can analyze the details of the traces and 
deposit  the  data  into  a  spreadsheet  for  further  graphical  analysis.  A  typical  trace 
usually lasts up to 30 mins (see Figure 2.9) after this time the lipid bilayer tends to 
become comprimised due to the effect of the induced voltage. This period, however, 
is long enough to obtain thousands of individual events to give statistically relevant 
data. It is also short enough to utilise in a point-of-care fashion i.e. for swift analysis 
of samples. 
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Figure 2.9. The digital output from a 30 minute nanopore recording of a POC. The black 
sections represent the current traces. 
 
The open channel current is termed τon, once a charged species is introduced 
into the cis compartment and begins to translocate through the pore we observe sharp 
decreases in current termed τoff. It is the duration and amplitude of these τoff events 
that we are interested in analyzing. The pClamp program compresses the τon duration 
i.e. the open channel current between events (seen in green in Figure 2.9 & 2.10) to 
decrease  the  size  of  the  data  file.  Typically  there  are  a  few  translocations  every 
second,  this  frequency  changes  with  increasing  voltage  and  differs  across 
translocating species.  
 
 
 
 
 
 
 
 
 
 
Figure 2.10. A section of the trace magnified, each current blockade represents a single 
molecule of DNA passing through the pore, the τon sections are compressed (green lines) to 
allow for faster processing.  
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  Each  event  is  characterized  via  its  dwell  time  value  (τoff /  m s )   and  its 
amplitude (Ah; meaning high amplitude event) (see Figure 2.11). The latter value is 
processed in pA and normalized so as to represent a decimal value of the open current 
(1 being 100% of the current and therefore a blocked pore). Depending on how the 
software calculates this value it may give the residual current Ires of the event in which 
case [Iopen – Ires] / Iopen = Ah. Alternatively it may represent the amplitude of an event 
as a negative value in pA, setting the open current (200 pA) as 0 pA. In this case Ah is 
calculated via Ievent / Iopen = Ah. Either way the value will be normalized to the open 
current to allow comparisons between tags even at varying voltages.  
 
 
 
 
 
 
 
 
 
 
Figure 2.11. Example of a current modulation arising from the translocation of a peptide 
tagged oligonucleotide. 
   
When translocating ssDNA through a nanopore the current modulations can 
become relatively complicated. The strand may self – associate causing it to linger in 
the inner vestibule of the protein. This leads to a current flow of approx. 50% of the 
open pore current as the strand restricts the flow of ions but cannot yet fully enter the 
inner constriction. The oligo may then fully translocate, blocking the pore completely 
and leading to a stepped event. Alternatively the strand may escape the pore leading 
to  an  incomplete  translocation.  These  complications  are  exacerbated  by  the 
attachment  of  peptide  tags.  For  instance  tags  such  as  poly-glutamic  acid  carry  a 
negative  charge  (at  pH  8.0)  on  each  residue.  The  tag,  although  flexible,  is  held 
perpendicular to the DNA backbone. This could result in the peptide threading into 
the pore first leading to a blockage and a long noisy event. Due to these complexities 
the traces are manually analyzed using the ClampFit program to prevent inconsistent  
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results. The current level and duration of each event is measured individually using 
the program, which saves the data in the form of a spreadsheet. By analyzing separate 
traces  covering  at  least  1000  individual  events  we  can  calculate  the  average 
translocation and pore blockage values for each tagged oligo. It is time consuming 
(considering the traces of a number of DNA strands can be recorded in a single day) 
however  it  is  the  best  way  to  guarantee  that  the  data  accurately  reflect  the 
characteristics of the tags. 
To ensure that the data is statistically valid, and that no miscellaneous pore 
blockages affect the results, averages are not taken. The data is plotted and fit to an 
appropriate trend. The plotted amplitude data always gives a bell curve due to the fact 
that  the  majority  of  events  are  of  a  similar  current.  Any  erroneous  events  with 
uncharacteristically  high  (complete  blockages)  or  low  (incomplete  translocations) 
amplitude will make up only a minority. A Guassian curve is fitted to the plot (see 
Figure 2.12) and the value at the apex of the curve taken as the statistical average 
blockage for that set of results. The dwell time data (τoff) is plotted against ‘number of 
events’,  which  gives  an  exponential  decay  due  to  the  majority  of  the  current 
modulations possessing dwell times in the ms range. The few anomalous complete 
blockages that are registered account for the very few longer events. So taking an 
average of these data points would allow these uncharacteristically long events to 
adversely effect the data set and so the τoff value is taken from an exponential fit of 
the plot. The log10 of the y – axis is taken to ensure the closest fit and this value taken 
as  the  τoff  value.  Error  is  calculated  through  the  standard  deviation  (SD)  of  the 
analyzed data via the spreadsheet. The data for each of the oligonucleotide strands 
under investigation is comprised of at least three separate recordings to ensure its 
validity. Finally the τon data, i.e. the duration between events, can be used to calculate 
the frequency of occurrence. τon is recorded in ms therefore the inverse of this value ( 
1 / τon) gives us the frequency of events per ms (ms
-1).  
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Figure 2.12. τoff (left) and amplitude (right) plots for DNA strand translocation. 
   
Using the collated data we can build up a description of the characteristics for 
each tag. By comparing the dwell time and pore blockage of each of the POCs we can 
select those that may be easily differentiated from; (1) the unmodified strands and (2) 
from one another. 
 
2.5.2  Translocation of Unmodified 27mer Oligonucleotides  
 
The pore recording is conducted in a buffered solution of 2M KCl, at voltages of 100 
– 180 mV. In the absence of DNA, the wild-type αHL pore yielded a conductance of 
1900 ± 120 pS (n = 4; n, number of independent recordings) when a positive potential 
was applied at the trans side. Once an oligonucleotide translocates through the pore 
the current flow is momentarily blocked. By attaching tags to internal bases on these 
strands both the dwell time and the amplitude should increase characteristically for 
each tag. Attaching a tag on the terminus of the strand should have no overall effect 
on the translocation as the tag at this position is not increasing the bulk of the strand 
(Figure 2.13). 
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Figure 2.13. Schematic illustration of oligonucleotide translocation through a nanopore. The 
first  trace  shows  the  open  channel  current.  The  second  illustrates  the  current  blockages 
observed when an un-tagged oligonucleotide translocates through. The third shows the two 
types of events common in translocating tagged oligonucleotide strands; Type I - complete 
translocation & Type II - a stepped event resulting from first incomplete and then complete 
translocation  of  the  strand.  The  fourth  illustration  shows  the  current  events  typical  for  an 
oligonucleotide tagged at its terminus. 
 
The addition of an unmodified oligonucleotide O1 (27mer; see Table 2.2 for 
oligonucleotide sequences) to the cis side of the pore led to short high-amplitude 
blockades.  Over  1000  individual  events  were  analyzed;  the  high-amplitude  events 
were characterized by an average amplitude of 91.7 ± 1.1 % relative to the open pore 
current, and a duration, τoff, of 0.18 ± 0.06 ms (n = 3). The short events represent the 
fast  translocation  of  individual  strands  from  the  cis  to  the  trans  side  of  the  pore 
(Figure 2.13). The recordings also displayed blockades with 50% amplitude, which 
were not pursued further as they most likely represent the reversible threading of a 
strand into and the escape from the cis opening rather than the complete translocation 
to the trans side.  
 
 
 
Figure 2.14. Event modulations characteristic of unmodified 27mer oligos (O1). 
 
  A τoff value of 0.18 ms for a 27mer oligonucleotide confirms the previously 
discussed issues of translocation speed. No information regarding sequence or even  
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length can be derived from this value. Therefore, to enhance the resolution of this 
technique chemical tags must be employed to slow the speed of translocation and 
allow  identification  of  the  DNA  strands.  To  test  the  viability  of  this  hypothesis 
peptides shall initially be used as tags. 
 
2.5.3  Utilizing Peptides as Tags 
 
When considering the sequence of the peptide tags to be employed, the characteristics 
needed  to  effect  a  change  in  the  current  modulations  when  translocation  the 
oligonucleotide through the pore, must first be considered. Charge and sterics will be 
the most prominent features that will alter the translocation events. Therefore bulky, 
aromatic substituents such as histidine, tyrosine, phenylalanine, tryptophan etc would 
be ideal. Charged groups that are able to interact with the residues situated around the 
inner constriction and neutralize the negative charges on the DNA backbone will also 
slow the translocation, such as arginine, lysine, glutamic acid and aspartic acid etc. 
All peptides will be synthesized with a cysteine residue at the N – terminus (for 
chemoselective attack at the activated disulphide group on the DNA) and a glycine at 
the C – terminus (due to use of a pre-loaded Gly Wang resin during the solid phase 
synthesis).  
 
 
 
 
 
Figure  2.15.  Examples  of  aromatic  and  charged  amino  acid  R  groups;  Glycine  (G), 
Histindine (H), Arginine (R) and Tyrosine (Y).  
 
A range of peptides will initially be synthesized and investigated, starting with 
those carrying very little steric bulk. By gradually increasing the bulk of each peptide 
via an increase in the number of residues and adding amino acids that carry bulky R 
groups it will be possible to monitor the effect of sterics on the dwell time of these 
tagged oligonucleotide. Of the 20 natural amino acids available a number contain 
bulky aromatic substituents and positive or negative charge that would be ideal for  
  84 
this  application.  The  option  of  synthesizing  non  –  biogenic  amino  acids  and 
incorporating them into a peptide via solid phase synthesis is also available. This will, 
however, be time consuming and due to the range of natural residues available, not 
considered necessary.  
The nanopore recordings will be conducted just above physiological pH at 
around  8.0.  Therefore  residues  such  as  glutamic  and  aspartic  acid  with  a  pKa  of 
around 4 will carry a negative charge at this pH. Lysine and arginine with pKa’s of 
10.5 and 12 respectively will carry a positive charge. Since the voltage applied will 
pull negative charge through the pore, a negatively charged tag, as it is adding to the 
overall net charge of the molecule, may in fact pull the oligonucleotide through faster. 
However, as the tag, although flexible, is situated perpendicular to the main DNA 
backbone  it  may  well  be  pulled  into  the  pore  first.  This  could  cause  the 
oligonucleotide to block the pore, requiring the voltage to be switched. Alternatively a 
positive  charged  tag  will  cancel  out  an  equal  number  of  negative  charges  on  the 
backbone  of  the  strand.  This  should  lead  to  a  decrease  in  the  force  a  potential 
difference is able to exert onto the strand thus slowing it down (similar to decreasing 
the voltage of the system). Charges introduced via a tag may also associate with the 
same or opposite charges carried by the residues surrounding the constriction of the 
pore. The resulting attractive and repulsive forces may have a marked effect on the 
dwell time of the oligonucleotide. 
 
2.5.4  Glycine Series 
 
The initial aim of the project was to confirm that a single peptide tag is capable of 
retarding strand translocation. Oligonucleotide strand O1, of 27 bases in length, was 
modified with a series of Gly containing peptides (CysGlyx; x = 2, 4, 6) at an internal 
base. The resulting peptide-DNA conjugates GxC1-O1 were analyzed via nanopore 
recordings. Due to the relatively small size and neutral charge of the tags these oligos 
have  very  similar  retention  times  as  the  unmodified  oligos  on  AEC  making 
purification  a  challenge.  MALDI  MS  shows  mainly  a  modified  peak,  although 
unmodified strands may well be present as it is unlikely that the reaction is 100% 
effective.   
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Translocation of the Gly2-6 POCs (1000 – 1500 events, 3 traces analyzed) gave 
a τoff value of 0.53 – 0.56 ms (± 0.4 – 0.6) (Table 2.3) giving an increase of a little 
over  3  fold.  The  pore  blockage  (accounting  for  error)  is  unchanged  from  the 
unmodified oligonucleotide (approx. 91%). This is to be expected since no charge has 
been added and the sterics are not changed significantly hence the slight increase in 
τoff.  Therefore  peptides  carrying  charged  groups  and/or  bulkier  substituents  were 
analyzed. 
 
2.5.5  Histidine series 
 
Once  again  three  POCs  were  synthesised  each  carrying  a  peptide  with  2,  4  or  6 
Histidine residues. Two event types were observed during the translocation of these 
oligos; Type I is the usual event seen previously, the current is reduced by > 90% and 
returns to the open 200 pA level once the strand is through the pore. The second Type 
II events are stepped; the current is reduced to approx. 50% of the open level before 
increasing to 90% then back to the open current once the strand is through. This 
modulation is most likely caused by the oligonucleotide being held momentarily in 
the inner vestibule of the protein. This causes the flow of ions to be restricted before 
the rest of the strand threads through to complete the translocation.   
 
 
 
 
 
 
Figure 2.16. Current modulation characteristic of the His6 tagged oligonucleotide; variations 
of Type I and II seen. 
 
The first oligonucleotide carrying a H2C-O1 tag translocated with an average 
dwell time of 0.82 ± 0.16 ms with a pore blockage of 0.93 ± 0.7 %. This is close to a 
5-fold  increase  in  dwell  time  and  an  increase  in  2%  pore  blockage  over  the 
unmodified strand. Translocation of the H4C-O1 tagged strand led to an increase in 
dwell time to 1.57 ± 0.29 ms with a pore blockage of 96.0 ± 0.6 %. Finally the H6C1- 
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O1 modified strand was analyzed, this yielded typical events with a τoff duration of 
1.83 ± 0.26 ms and a high amplitude blockage of 96.8 ± 0.5 %.  
The type II events previously discussed were more prevalent during the H6C1-
O1 translocation. In these cases the event started with a mid-amplitude level, Am, of 
56.6  ±  2.6  %  with  a  duration,  τoff-m,  of  1.34  ±  0.36  ms.  This  medium  level  was 
followed by a high-amplitude blockade, Ah, of 97.4 ± 0.9 % and a duration, τoff-h, of 
1.96 ± 0.48 ms. As discussed the mid-amplitude blockade of type II events possibly 
stems from mis-folded strands which reside in the internal cavity reducing the current 
flow  by  50%  before  eventually  threading  into  the  inner  constriction.  Due  to  the 
uncertainty in the assignment of the mid-level blockade, the focus was shifted onto 
the  more  clearly  defined  type  I  events,  which  only  exhibited  high-amplitude 
blockades, for the remainder of this investigation. A comparison of type I events from 
H6C1-O1  with  unmodified  DNA  shows  that  the  histidine  tag  slowed  down 
translocation by a factor of 10 and increased the current amplitude by 5 %.  
Several lines of evidence support the notion that the current blockades of the 
histidine-modified strand are caused by the steric hindrance encountered when a wide 
peptide-DNA segment passes the narrow inner constriction. Firstly, histidine tags with 
six, four and two residues led to correspondingly shorter high-amplitude blockades in 
type  I  events  (Table  2.3,  HxC-O1,  x  =  6,  4,  2).  This  implies  that  the  peptide  is 
elongated  and  aligned  parallel  to  the  DNA  strand  while  being  translocated.  Tags 
composed  of  the  less  bulky  glycine  residues  did  not  exhibit  the  same  length-
dependence  indicating  that  this  small  amino  acid  does  not  reach  the  critical  size 
threshold  required  for  continually  slowing  down  the  DNA.  Secondly,  the  27mer 
strand O1 carrying a H6C1 tag at a terminal rather than an internal position did not 
greatly retard DNA passage as shown by a short event time of 0.23 ± 0.10 ms. The 
absence of a major retardation is attributed to the fact that the peptide can sequentially 
pass the pore after the DNA strand without the formation of a bulky peptide-DNA 
segment.  The  peptides  tags  are  certainly  the  molecular  reason  for  the  increase  in 
translocation  time  and  may  exert  their  effect  by  either  hindered  diffusion  or  an 
increase  in  friction  mediated  by  steric,  electrostatic,  polar,  and/or  hydrophobic 
interactions. 
Translocating  molecules  must  overcome  inherent  energetic  and  entropic 
barriers to successfully thread through the pore. The diameter of the inner constriction  
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of the αHL nanopore is approx 1.4 nm. The diameter of a single DNA strand is 
slightly less than 1 nm; therefore unmodified strands will not encounter much steric 
clash as they thread through the pore. By attaching bulky groups such as histidine to 
increase the diameter of the strands to approaching that of 1.4 nm we are increasing 
the likelihood of the strand encountering the sides of the protein. As the potential 
difference (Voltage) across the lipid bilayer forces the tagged oligonucleotide through 
the pore it will encounter friction as it pushes past the amino acid residues around the 
constriction. The larger the diameter of the strand the more energy will be needed to 
ensure it can pass though. If the tag is too big no amount of energy (Voltage) will 
allow the oligonucleotide to pass, as it would require the oligo to break through the 
covalent bonds of the actual protein to fit through and overcome the steric clash. The 
translocating oligonucleotide must also overcome an entropic barrier. To enter the 
inner constriction of the protein pore the strand must transition form a disordered to a 
semi-ordered state. The Voltage of the system is sufficient to overcome this barrier 
and force the strands through the pore. Entropic considerations are independent of 
chemical tags and so investigation of this variable is outside the remit of this thesis. 
  As well as being aromatic and therefore possessing more steric bulk than the 
glycine  series,  the  histidine  moieties  also  have  a  pKa  of  approx.  6.  Therefore  by 
altering the pH of the buffer used in the nanopore recordings it is possible to protonate 
the  backbone  of  the  poly-His  peptides.  This  positive  charge  may  influence  the 
translocation of the oligo. 
 
 
 
 
 
 
 
 
 
Figure 2.17. The O1 trace shows an actual current event observed from the translocation 
of  unmodified  oligonucleotide  strands.  The  others  illustrate  strands  tagged  with  2,  4  &  6 
histidine residues. Each τoff reading was obtained at pH 8.0 except for the indicated (*) result 
which was recorded at pH 6.4. 
   
H2-O1  
1.91 ms 
97%  
 
2.18 ms
* 
96%  
0.82 ms   1.57 ms  
93%  
H4-O1   H6-O1  
0.18 ms 
O1  
91% 
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To  investigate  the  effect  positive  charge  had  on  the  DNA  translocation, 
nanopore recordings of the H6C1-O1 POC were conducted at a pH of 6.4 (approaching 
the pKa for histidine). At this pH a greater proportion of the tag will be positively 
charged and an increase in the translocation dwell time from 1.91 ms to 2.18 ms is 
seen. Comparing this result with the tranlocation of the same POC at pH 8.0 it is clear 
that the extra positive charge slows the passage of the oligonucleotide through the 
pore (Figure 2.17). This can be explained by either the interaction of this charge with 
other  charged  amino  acids  that  encircle  the  inner  constriction  of  the  pore. 
Alternatively, His tagged oligos at this pH carrying positive charge may effectively 
cancel out the negative charges on the phosphodiester backbone of the DNA. Fewer 
negative charges on the molecule would equate to less force effected on the strand by 
the Voltage, thus slowing down the translocation. This effect will be discussed in 
greater detail in the following section. 
 
2.5.6  Arginine series 
 
The next series of peptides to be investigated was an arginine set to demonstrate that 
strand retardation is a general feature of bulky/charged amino acids and not only 
restricted to histidines. An additional aim was to identify tags that give rise to current 
signatures distinguishable from the potentially useful histidine blockades.  
The first peptide, R7C1-O1, was investigated; in the nanopore analysis, type I 
events of R7C1-O1 exhibited a duration of 25 ± 5 ms and an amplitude of 98.9 ± 0.6 
%. (Table 2.3). This blockade is much higher and longer than that of H6C1-O1. The 
more pronounced results of R7C1-O1 are possibly due to the charge carried by the 
peptide. Since the residues will carry a positive charge at pH 8.0 the tag may be more 
likely to fold back onto the DNA backbone resulting in a bulkier DNA – peptide 
segment. This may also account for the lack of noise associated with these events 
compared  to  H6C-O1  traces  (Figure  2.18).  The  histidine  R  groups  are  planer  in 
geometry whereas the guanidinium groups of the arginine will possesses a bulkier 
sphere of influence. The residual positive charge of these groups will also cancel out 
the same number of negative charges on the backbone, thus lessening the effect the 
potential difference has on the species and leading to a retardation of the translocation 
(as seen in the translocation of H6C-O1 at pH 6.4).   
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Figure 2.18. Current modulations for the R7C1-O1 POCs 
 
Due to the pronounced results obtained from the translocation of the R7 oligo 
we moved onto the investigation of smaller poly-Arg peptides using oligos conjugated 
to R3 and R5 peptides. During Nanopore recording of the R5 POC an average dwell 
time of 7 ms and a pore blockage of 98% was observed. The smaller R3 tag gave rise 
to a 1.9 ms τoff value with an Ah of 98%. These results again support our hypothesis 
that the length, sterics and charge are all involved in the translocation process.  
 
 
 
 
 
 
 
 
Figure 2.19. Summary of the arginine series current modulations. 
   
  The pronounced events associated with the Arg3-7 series of POCs provide a 
good system for the modeling of tagged DNA translocation. By plotting the data it 
was observed that the dwell time has an exponential dependence on the number of 
residues  that  the  tag  carries  (Figure  2.20).  Since  the  current  modulations  are 
dominated by the tag (i.e. the pore blockage and dwell time are far greater than those 
of the untagged strands) – these tags are observed to greatly exaggerate the processes 
of strand translocation. Compared to the other tags investigated the Arg series also 
appears to exaggerate the effects of a peptide tag. It is therefore possible to build up a 
realistic model system of tagged strand translocation based on these physical results. 
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Figure 2.20. Plot of dwell time vs residue number for the Arg series; data fitted with an 
exponential trend. 
 
  Previous  research  has  addressed  the  translocation  of  single  stranded  DNA 
through a nanopore.
108 However, since the results described in this thesis are, to the 
best of our knowledge, the first instance of tagged DNA being used in this context, 
the physical data set obtained from the arginine POC experiments could be used to 
build a model describing the events observed. 
  The mathematical modeling of this translocation data is outside the remit of 
this investigation.
109 It may be beneficial however, to postulate in more detail as to the 
effect  the  variables  of  sterics  and  charge  have  on  the  mechanism  of  DNA 
translocation. As described previously, the peptide tags increase the steric bulk of the 
oligonucleotide; this causes the molecule to require more potential energy to force it 
through the pore during translocation. The larger the strand the more steric interaction 
it will have with the residues around the pore and therefore the more energy it will 
require to overcome these steric interactions. However, in the case of the arginine 
tags, positive charge is also introduced to the strand.  
  The translocation of DNA is driven by the creation of a potential difference 
(Voltage)  across  the  lipid  bilayer.  This  potential  difference  causes  an  electrical 
potential gradient to be set up across the bilayer. This Voltage exerts force on all 
charged species causing ions to flow through the pore in the direction of the gradient 
thus creating a current, which is measured using the nanopore apparatus. The more 
negative charge a molecule carries, the more force the potential difference of the 
system can apply to this molecule. Therefore a species of net neutral charge will not  
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feel the potential gradient and therefore will not translocate through the pore. By 
increasing either the net negative charge of the compound or the Voltage of the circuit 
we can increase the force exerted on each charged molecule and therefore effectively 
increase  the  speed  of  translocation.  Conversely,  by  decreasing  the  Voltage  or 
decreasing the amount of negative charge on each strand we can slow the speed of 
translocation. Therefore it may be fair to presume that neutralizing a portion of the 
negatively charged DNA backbone with the positive charges on the peptide tag would 
decrease  the  force  acting  on  this  strand.  This  would  slow  the  progress  of  the 
oligonucleotide  through  the  pore.  However,  the  dramatic  retardation  of  the  Arg7 
tagged  strands  cannot  be  explained  simply  by  charge  reduction  alone.  Removing 
negative charge thus decreasing the net charge of the molecule does not have such a 
pronounced effect. For example a 20mer oligonucleotide has seven fewer negative 
charges than that of a 27mer. However the difference in τoff for these two strands is 
very slight. Therefore to build up an accurate model of the translocation of chemically 
tagged DNA strands we must marry the idea of steric hindrance and charge reduction 
to  give  us  a  realistic  representation  of  the  data.  Since  both  these  factors  must 
contribute to the dramatic current modulation observed using the Arg7 tags. 
 
2.5.7  Tyrosine series 
 
The  fourth  peptide  series  to  be  investigated  was  that  of  a  poly-tyrosine  peptide; 
initially the synthesis of a peptide carrying multiple phenylalanines was attempted. 
This peptide was, however, too insoluble to utilise. Tyrosine, which carries a phenol 
group, is more soluble in a buffered solution and so the peptide Y3C1 was prepared. 
Translocation of Y3C1-O1 through the nanopore led to type I events with two 
observed current levels (Figure 2.22, inset, dotted lines). The first level at an Ah of 
92.4 ± 0.6 % is similar to the blockade amplitude of unmodified DNA. It is therefore 
very  likely  that  this  level  stems  from  a  DNA  strand  threaded  into  the  inner 
constriction but kept from passing the β-barrel because the bulky peptide has not yet 
entered the narrow pore region.  
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Figure 2.21. Examples of current modulations from Tyr3 tagged oligonucleotides. 
 
The second Ah level at 97.8 ± 0.5 % is ascribed to a state where the peptide-
DNA segment has entered the inner constriction and translocates the β-barrel. The 
step signature was observed for 60 % of type I Y3C1-O1 events. In the remaining 
events, the transition between the two current levels resembled a slope (Figure 2.22, 
second inset).  
 
 
 
 
 
 
Figure 2.22. Two typical events present in the Tyr3 tagged oligonucleotide traces; stepped 
(left) and sloped (right). 
 
This  sloped  effect  could  reflect  a  peptide-DNA  segment  being  gradually, 
rather  than  abruptly,  pulled  into  the  inner  constriction.  Importantly,  the  step-like 
blocking effect of Y3C1 was independent of the DNA since same event characteristics 
were also seen for Y3C1-O2 with a different sequence (see Table 2.2 for sequence 
information and Table 2.3 for translocation data; Y3C1-O1 /step vs Y3C1-O2 /step).   
 
 
 
 
 
 
 
Figure 2.23. Details of the stepped events seen in the Y3-O1 traces and a schematic of the 
translocation of this tag. 
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Table 2 .3;  Summary  of  POC  translocation  and  pore  blockage;  [a]  The  recordings  were 
conducted at 2 M KCl, 20 mM Tris, pH 8.0, filtered at 10 kHz and sampled at 50 kHz unless 
stated otherwise. The number of events analyzed for each type of DNA was between 1500 
and 2000. n = 3. [b] The relative amplitude was calculated using A = (IOC - IBC) / IOC, where IOC 
and IBC are the conductance levels from the open and blocked channel, respectively. IOC and 
IBC were derived using all-point histograms. [c] The average duration represents the mono-
exponential fit of the dwell-time histogram. [d] Filtered at 30 kHz and sampled at 100 kHz. 
 
 
2.6  Sensing of Multiple Bases 
 
DNA strands with two separate chemical tags were tested to illustrate that tags act 
independently  and  give  rise  to  corresponding  distinct  current  modulations.  Two 
oligonucleotides sequences were modified with peptide tags, a 37mer and a 54mer 
(Table 2.1), both prepared using alternative procedures. Sensing of these multiple 
bases using nanopores allowed identification of the individual tags along the strand 
via characteristic current modulations. 
 
2.6.1  Synthesis of Oligonucleotides Containing Two Peptide Tags 
 
To  prepare  strands  carrying  two  peptide  tags  the  same  procedure  used  for  the 
synthesis  of  a  singularly  tagged  oligonucleotides  was  applied  to  a  slightly  longer 
Modified DNA 
 
Ah [%]
[b]  τoff-h [ms]
[c] 
O1
[d]  91.7 ± 1.1  0.18  ± 0.06 
H6C1-O1  96.8 ± 0.5  1.91  ± 0.23 
H4C1-O1  96.0 ± 0.6  1.57  ± 0.29 
H2C1-O1  93.0 ± 0.7               0.82  ± 0.16 
G6C1-O1  91.4 ± 0.6  0.56  ± 0.15 
G4C1-O1  92.5 ± 0.5  0.55  ± 0.12 
G2C1-O1  92.7 ± 0.4  0.53  ± 0.13 
H6C-O1-term.
[d]  93.9 ± 0.7  0.23  ± 0.10 
H6C1-O1 / pH 6.4  96.9 ± 0.7  2.18  ± 0.42 
R7C1-O1  98.9 ± 0.6  25 ± 5 
Y3C1-O1 /step  92.4 ± 0.6 / 97.8 ± 0.5  0.46  ± 0.15/ 0.35  ± 0.13 
Y3C1-O1 /slope  94.8 ± 0.7  1.00  ± 0.22 
Y3C1-O2 /step  91.8 ± 0.6 / 98.9 ± 0.7  0.43  ± 0.12 / 0.39  ± 0.08 
Y3C1-O2 /slope  96.7 ± 0.8  0.97  ± 0.13  
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37mer template carrying 2 non-biogenic thymines (see Table 2.2 for sequence). A 
37mer with two internal thymines carrying primary amine linkages was modified with 
the crosslinker SPDP and then conjugated to two CysTyr3Gly peptides as previously 
described.  
 
 
 
 
 
Scheme 2.13. Schematic of double modified oligonucleotide preparation; activation of the 
non-biogenic  primary  amine  bases  with t h e  h e t e r o b i f u n c t i o n a l  l i n k e r  S P D P  f o l l o w e d  b y  
conjugation with a cysteine containing peptide. 
 
  This  procedure  was  successful  and  after  purification  via  AEC  the  37mer 
carrying 2x CysTyr3 peptides was characterized using MALDI MS. 
 
 
 
 
 
 
 
 
Figure 2.24. AEC and MALDI of double modified 37mer; calc mass 13,105 Da; observed 
13,102 Da.  
 
The same method was then applied for the preparation of a 54mer carrying 
two non-biogenic thymines; this reaction was unsuccessful. It is assumed that due to 
the length of the strand sections of the oligonucleotide are prone to self-hybridization 
preventing the reaction from taking place. A doubly modified 54mer would also be a 
challenge to purify as the peptide tags had little effect on the retention time through an 
AEC  column.  Therefore,  in  this  case  it  was  more  effective  to  first  modify  two 
separate, smaller oligonucleotides and then ligate them using appropriate enzymes 
(Scheme  2.9).  Two  25mers  carrying  the  internal  amine  modified  thymine  were  
  95 
conjugated as detailed previously with the CysTyr3Gly peptide (see Table 2.2 for 
sequence information). The second oligonucleotide carried a phosphate group at its 5’ 
terminus  allowing  enzymatic  ligation.  Both  strands  were  hybridized  to  a  20mer 
oligonucleotide that was complementary to the last 10 bases on the first strand and the 
first  10  bases  on  the  second  allowing  it  to  bridge  the  two  by  forming  a  duplex 
bringing the two termini into close proximity. Using a T4 Ligase enzyme the two 
oligonucleotides were then ligated to form one continuous strand carrying two peptide 
tags.  
The resulting oligonucleotide was purified via denaturing gel electrophoresis 
(made up in 8M urea), the denaturing conditions of the gel resulted in the comp. 
20mer strand separating and migrating at a faster rate than the 54mer (Figure 2.26, 
lower band). The gel was then visualized under a UV lamp and the section containing 
the 54 mer strand cut from the gel. The cut out portion of the gel was then crushed 
and incubated in 5M ammonium acetate solution to elute the oligonucleotide. The 
slurry  was  filtered  through  a  QIAgen  column  and  desalted  to  yield  the  doubly 
modified 54mer single strand (see gel 2 of Figure 2.26). A second 54mer carrying two 
tyrosine  tags  was  also  synthesized  with  alternative  positioning  of  the  peptide 
modifications  (see  Table  2.2).  Both  oligonucleotides  (including  the  25mer 
intermediates, Figure 2.26) were characterized using AEC and MALDI to confirm 
successful modification. 
 
 
 
 
 
 
 
     
      1                            2 
 
Figure 2.25. (1) AEC and (2) MALDI analysis of the GlyTyr3Cys-O4A intermediate 25mer. 
Purity 96.2%, calc mass – 9029.6 m/z; observed mass – 9028.9 m/z 
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              1   2   3   4   5   6                  7   8   9 
                      
Figure 2.26. (A) 8M Urea PAGE of; (1) complementary 20mer; (2) Y3 modified 25mer; (3-6) 
2x  Y3  modified  54mer;  (B)  Native  PAGE  of;  (7)  complementary  20mer;  (8)  Y3  modified 
25mer; (9) 2x Y3 modified 54mer. 
 
2.6.2.  Nanopore Analysis of Double Modified Oligos 
 
The first strand to be analyzed was a 37-mer (O3) carrying Y3/Y3 tags in which the 
peptides are tethered to two modified bases separated by 13 nucleotides. Similar to a 
single modified Y3C1-O1 strand, double modified DNA gave rise to unresolved slope 
events as well as fully resolved step-like events (Figure 2.27). 
 
  
 
 
 
 
Figure  2.27.  Examples  of  the  current  modulations  resolving  two  individual  tags  from  a 
37mer oligo modified with two Tyr3 tags, 
 
In  the  latter  events,  the  blockade  amplitude  fluctuates  twice  between  two 
levels sequentially from event segments 1 to 4 (Figure 2.28, event segments numbered 
red). The average current levels for segments 1 and 3, and 2 and 4 were 92 and 99%, 
respectively (Table 2.4). 
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Figure 2.28. Example of a current modulation identifying 2 separate peptide tags.  
 
This step-like signature is in line with expectations for two Y3C1 peptides; one 
peptide is known to cause a blockade step from 92 % to 98 % (Table 2.3, Y3C1-1 
/step). The signature of Y3/Y3-O3 in Figure 2.28 strongly suggests that the current 
alterations  reflect  the  sequential  pulling  of  a  DNA  strand  through  the  pore  as 
illustrated schematically in Figure 2.29. 
 
 
 
 
 
 
 
Figure 2.29. Schematic representation of double modified oligos translocating through a 
nanopore; (1) first tag of translocating strand meets the inner constriction leading to a 92% 
blockage of the current; (2) the tag is pulled through to give a 98% blockage; (3) the second 
tag meets the inner constriction shown by the brief return to a 92% blockage; (4) it is then fully 
pulled though to give a second 98% blockage. 
 
These events consist of 4 sections; the first has a pore blockage of 92%, it is 
assumed that (similar to the singular Tyr3 events) this initial reduced current level is 
due to the first peptide tag reaching the inner constriction of the pore. Once the tag 
folds up onto the DNA backbone the strand is allowed to pass through the pore almost 
blocking it entirely; hence a reduction of the current level to 98% of its open state. 
Once this tag passes through the constriction the current level raises back to 92%  
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reflecting the unmodified bases between the peptide tags. As the second tag hits the 
inner constriction the current level again drops to 98%. 
This interpretation of the stepped events as the sequential pulling of both tags 
through the pore is supported by the finding that the 54-mer DNA strand Y3/Y3-O4 
with a separation of 27 nt between tags showed a similar set of current modulations. 
The two current levels were identical within experimental error to the values observed 
for Y3/Y3-O3 (Table 2.4). The duration of event segment 3 was, however, longer for 
Y3/Y3-O4 than for Y3/Y3-O3.  
      
2.6.3  Analysis of the Space Between Peptide Tags 
 
Since the third section of the event reflects the bases in-between the peptide tags the 
duration of this section should be representative of this gap. In Table 2.4 we compare 
the information gathered by manually analysing the events associated with each of the 
three doubly tagged strands. 
 
Segments  1  2  3  4 
O3 Ah  [%]
[b]  92.2 ± 1.1  99.7 ± 0.7  92.3 ± 0.9  99.7 ± 0.6 
O3 τoff-h [ms]
[c]  3.43 ±0.67  0.80 ±0.22  0.26 ±0.08  0.61 ±0.15 
O4 Ah  [%]
[b  92.8 ± 1.1  98.2 ± 0.8  91.1 ± 1.5  98 ± 0.7 
O4 τoff-h [ms]
[c]  1.34 ±0.75  0.64 ±0.26  0.67 ±0.21  0.74 ±0.37 
 
 
Table 2.4. τoff and amp data summary for 37 and 54 mer double modified oligos; [a] The 
recordings were conducted at 2 M KCl, 20 mM Tris, pH 8.0, filtered at 10 kHz and sampled at 
50 kHz. [b] and [c] are defined as in Table 2.3. 
 
  We  observe  that  the  spacing  for  the  O3  oligo,  that  of  13nt,  gives  us  a 
translocation section 3 lasting 0.26 ± 0.08 ms. Extending this gap to 27nt for the O4 
oligonucleotide increases the dwell time of this section to 0.67 ± 0.21 ms. A third 
strand (O5) was prepared; a 37mer with the same sequence as O4 carrying the Tyr 
tags  positioned  7nt  from  one  another.  The  double  modified  current  modulation 
observed for oligonucleotides O3 and O4 was not seen using this strand. This result 
was to be expected since the CysTyr3Gly peptide tag is long enough to bridge the 7nt 
gap between the tags (approx. 2 nm). Therefore, in this case, the two modified bases  
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cannot be resolved. The percentage of stepped events as well as the quality of the 
current steps was far lower than for Y3/Y3-O3 and Y3/Y3-O4 (42% seen for O3, 57% 
for O4 and only 5% for O5). This reduced resolution agrees with molecular models 
showing that the tag with an extended length of 2.8 nm bridges the gap between two 
tagged bases separated by 7nt or 2.2 nm. 
 
 
 
 
 
 
 
 
Figure 2.30. The τoff value representing the spacing in-between the tags increases from 
0.26 ms to 0.67 ms with a gap increase from 13 to 27 nt. 
 
  Although the increase in τoff for section 3 reflects the longer gap between the 
tags this is most likely a qualitative value. Although a relative increase in τoff indicates 
an  increased  gap  between  the  tags  this  value  this  most  likely  cannot  be  used  to 
identify the number of bases with any accuracy.  
 
2.7  Using  Chemically  Modified  Nucleotides  to  Tag  Biologically 
Relevant SNPs  
 
After establishing that chemical tags can slow the translocation of DNA through a 
biological nanopore, thereby fulfilling the first aim of this thesis, the next step was to 
apply the tagging technology in a biologically relevant context. This second aim was 
addressed by tagging bases that represent single nucleotide polymorphisms (SNPs) 
within important sections of DNA. 
 
 
Y3Y3-O3   Y3Y3-O4  
0.26 ms  0.67 ms 
92% 
98%   
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2.7.1  Single Nucleotide Polymorphisms (SNPs) 
 
Single Nucleotide Polymorphisms (SNPs) occur throughout the genome and reflect 
mistakes that are made when DNA is erroneously copied during cell division. As the 
majority of our DNA exists as regions that do not appear to contain genes many SNPs 
usually do not have any biological effect. However, if these errors occur in a sequence 
of DNA that regulates gene expression or encodes for a protein, then SNPs may have 
an impact on the cell and organism. For example, SNPs falling within the codons for a 
protein may cause amino-acid substitutions that can alter the folding, structure, and 
function of an enzyme, and thereby change the organism’s ability to react to a drug. 
The sensing of SNPs not only helps predict the response of humans to drugs but is 
also of interest in microbiology where SNPs may cause resistance against antibiotics 
or antivirals. Knowing the genetic make-up of infectious strains could inform about 
specific resistances and help tailor the selection of drugs to improve the efficacy of 
treatment. 
 
2.7.2  Sensing of SNPs 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.31. Schematic of SNP detection; tagging of SNP and IMAC purification using His-
dNTP and nanopore identification of primer tag using nanopores.  
 
For  the  nanopore  sensing  of  biologically  relevant  sequences,  two  SNPs  from  the 
protease gene of the human immunodeficiency virus (HIV) were selected. Codons 23 
and 90 confer resistance against the HIV drug Nelfinavir. The principle of the SNP  
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sensing  strategy  is  based  on  the  use  of  peptide-tagged  oligonucleotides  and 
nucleotides  to  encode  sequence  information  for  nanopore  read-out.  The  two-step 
strategy is summarized in Figure 2.31. First, two oligonucleotide probe strands that 
are complementary to a sequence stretch upstream the SNP site are hybridized to the 
SNP-containing template. Each primer has attached to it a peptide tag, which is either 
a Gly6 or Arg5 peptide. Importantly, the two tags are known from the previously 
reported results to give rise to two different current signatures. The two tags have 
therefore  the  potential  to  encode  sequence  information  based  on  different  current 
signatures. As illustrated in Figure 2.31, the primers are hybridized to templates that 
either  do  or  do  not  carry  the  target  SNPs.  Using  a  polymerase  enzyme,  only  the 
primers for the SNP-carrying templates are extended with the nucleotide analogue 
dUTP-His6  while  the  non-SNP  template  does  not  result  in  primer  extension.  The 
optionally incorporated nucleotide analogue carries a His6 tag attached to position 5 of 
the thymine base. The analogue dUTP-His6 (Figure 2.32) was previously prepared by 
Dr. Vinciane Borsenberger. Importantly, the His6 tag helps to purify the extended 
primers using immobilized metal affinity chromatography (IMAC). By contrast, in the 
absence of an SNP, the probe strand will not be retained on the IMAC column. The 
mere presence of the strand after purification of the solution is therefore an indication 
of  the  SNP  (Figure  2.33).  The  successful  primer  extension  and  the  His6-tag 
purification of the probe strands were confirmed by gel electrophoresis (Figure 2.34; 
experiments conducted by Dr. Borsenberger). 
 
 
 
 
 
 
 
Figure 2.32. His6 modified dUTP 
 
 
 
 
 
 
  
  102 
 
     
 
 
 
 
Figure  2.33.  SNP-dependent  enzymatic  extension  of  the  peptide-modified  DNA  probe 
strand with dUTP-His6; (1) the wild type 90 oligonucleotide; (2) the SNP-90 strand showing 
extension via an untagged oligonucleotide due to the presence of the SNP; (3) extention of 
the  SNP-90  strand  using  the  Gly6 t a g g e d  n u c l e o t i d e ;  ( 4 )  t h e  s t r a n d  i n  l a n e  3  p o s t  I M A C  
purification. 
 
    Once the extended DNA template was isolated it was subjected to nanopore 
recording (recording conducted by S. Howorka, analysis by N. Mitchell). Since the 
His6 tag is at the terminus of the oligo, it has little effect on the translocation. It is the 
characteristics  of  the  tag  attached  to  the  probe  strand  that  determine  the  current 
modulations. The characteristics for the Gly6 and Arg5 tags are, as concluded in the 
previous section, very different. Indeed, the current blockades of the Gly6 and Arg5 
modified  probe  strands  are  strikingly  different  (Figure  2.34)  in  their  average 
amplitudes  and  durations  (Table  2.5).  The  Gly6  peptide  resulted  in  an  oligo 
translocation value of τoff = 0.76 ms and an Ah of 91%. While the Arg5 tag gave a τoff 
value  of  9.33  ms  and  an  Ah  value  of  99%.  These  two  data  sets  can  be  easily 
differentiated via the plotted data allowing the two SNPs to readily be identified (see 
Figure 2.35). 
 
                 A            B                  C                    D  
 
 
 
 
 
Figure 2.34. Examples of current modulations resulting from Gly6 and Arg5 modified oligos; 
(A) Open-pore current trace; (B) current blockage resulting from translocation of unmodified 
oligonucleotide;  (C)  current  blockage  resulting  from  translocation  of  Gly6 t a g g e d  
oligonucleotide; (D) current blockage resulting from translocation of Arg5 oligonucleotide.   
  103 
 
Probe strand  τoff [ms]
a  A [%]
a,b 
23-R5-H6  9.33  99 
90-G6-H6  0.76  91 
  1.21 (13%) / 8.07 (87 %)
c  59 (80%) / 72 (20%)
c 
a Obtained as described in section2.3.18. The values are the average 
from three independent recordings each for 23-Arg5-His6 and 90-Gly6-
His6, and a recording in which both modified DNA probes were present. 
b 
Amplitude, A, was normalized to the conductance of the open unblocked 
channel. 
c τoff and A values for mid-level events of 90-G6-H6. Two values 
each are provided to reflect the two components in the respective 
distributions. The relative proportion of the components is given in 
brackets. 
 
Table 2.5. Results of the translocation of the peptide modified extended DNA templates. 
 
 
 
 
 
 
 
 
 
Figure 2.35. A scatter plot with 90-Gly6-His6 and 23-Arg5-His6 differentiated in blue and 
green respectively. 
   
 
2.8  Sensing Repeating Bases Using Alternative Tags 
 
The first preceding section of this chapter introduced peptides as useful chemical tags 
for the sensing of bases along a translocating DNA strand (aim 1). The nanopore 
approach  was  then  applied  in  a  biological  context  by  using  peptide-modified 
nucleotides  and  oligonucleotides  to  identify  SNPs  on  biologically  relevant  DNA 
templates  (aim  2).  In  the  final  aim,  a  series  of  nucleotides  analogues  were  to  be 
synthesized to help progress and develop the tagging approach into a technique that is 
able to compete with state-of-the-art DNA sensing strategies. As an attractive target 
analyte,  the  nucleotide  patterns  in  highly  repetitive  DNA  sequence  of  forensic  
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importance  were  chosen.  The  short  nucleotide  repeats  (tri,  tetra,  or  penta-repeats) 
occur in different regions of the genome, and the number of repeats in each region is 
characteristic for each person. While repeat sequences are routinely analyzed using 
conventional sequencing, it would be of benefit to quickly size the number of repeats 
within samples or suspects at the crime scene. The proposed nanopore strategy can 
potentially deliver a fast turn-around time.   
  The  proposed  approach  to  size  repetitive  DNA  strands  is  illustrated  in  the 
Figure  2.36.  DNA  strands  containing  multiple  trinucleotide  repeats  are  used  as  a 
template to direct the enzymatic synthesis of a DNA copy. The DNA polymerization 
is  conducted  using  a  nucleotide  analogue  that  carries  a  small  chemical  tag,  The 
resulting  DNA  copy  carries  a  defined  number  of  tags  that  mirror  the  number  of 
repeats in the template. The DNA copy is then analyzed using nanopore recordings. 
The  threading  of  the  tagged  strands  through  the  pore  is  expected  to  create  a 
characteristic comb-like blockade pattern in which the number of blockades reflects 
the number of tags in the translocating strand.  
 
 
 
 
 
 
 
 
Figure 2.36. Comb-like current modulations; PCR incorporation of tagged and untagged 
nucleotides into a DNA template and the electrical sensing of multiple chemical tags along the 
strand using nanopore techniques. 
   
  The  proposed  sensing  strategy  is  based  on  and  inspired  by  two  previous 
experimental  results,  namely  the  revelation  that  synthetic  DNA  strands  with  two 
GlyTyr3Cys peptide tags give rise to a two-tooth comb-like current signature, and the 
experimental demonstration that tagged DNA strands can be generated via enzymatic 
polymerization using a nucleotide analogue. The proposed strategy for trinucleotide 
repeats  cannot,  however,  use  the  same  tags  and  nucleotide  analogue  given  their 
unsuitable dimensions. In particular, the tyrosine-containing peptide tag is too long to  
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be used for e.g. a pentanucleotide sequence, as a distance of two nucleotide positions 
separated by four bases, is shorter than the size of the extended peptide tag. Indeed, 
problems were encountered in section 2.6.3 when two Tyr3-tags separated by 7 nt 
could not be resolved in nanopore recordings. Based on the known dimensions of 
DNA  repeats  as  well  as  the  nanopore  dimensions,  a  different  chemical  tag  was 
designed. 
 
2.8.1  Adamantane Tag 
 
Adamantane (C10H16) is a potentially ideal tag; it has dimensions of approx 5 Å cubed 
which will increase the diameter of a single stranded oligo to approx 1.4 nm, the size 
of the inner constriction of the nanopore. This should be large enough to temporarily 
block the pore to a sufficient extent. If a short linker is used between the tag and the 
base there should also be no issues with the masking of downstream bases.   
 
 
 
 
Figure 2.37. Chemical structure of adamantane.  
 
  A model system based on a synthetic DNA strand was first investigated to 
confirm  that  the  adamantane  would  be  appropriate.  The  coupling  of  aminomethyl 
adamantane  to  maleoyl-β-lanine  (see  section  2.3.14)  enabled  conjugation  of  the 
adamantane tag to the 27-mer oligonucleotide which had been previously used in the 
peptide-conjugation experiments. This oligonucleotide was first activated using the 
cross-linker  SPDP  as  detailed  previously  and  the  newly  installed  disulfide  group 
reduced using DTT. The maleimide modified adamantane compound 5a could then be 
conjugated onto the strand.  The nanopore analysis of the resulting adamantane tagged 
27-mer was conducted and analyzed. Both type I and II events were observed in the 
recorded trace. The type I events gave a τoff value of 0.64 ms and an average Ah value 
of 96.0 ± 1.9 %. These blockade characteristics are ideal as they alter the translocation 
of  the  modified  oligonucleotide  sufficiently  so  as  to  distinguish  from  unmodified 
strands. The linker between adamantane and the DNA is, however, 2 nm and therefore  
  106 
too long for the sensing approach. Another shortcoming of the strategy to modify 
commercially available DNA oligonucleotides are the few non-biogenic groups that 
are available, limiting the possible chemistry options. The strands can also only be 
obtained above a few hundred µg at high cost. This means that synthesis of individual 
nucleosides from small molecule starting materials is certainly a more viable option. 
 
2.8.2  Synthesis of the Adamantane-Tagged Nucleoside 
 
An appropriate target nucleotide analogue carrying the adamantane tag via a suitably 
short linker is illustrated in Figure 2.38; compound 7. 
 
   
 
 
 
 
        (5b)        (7) 
 
Figure 2.38. (1) alkyne modified adamantane; (2) 5-adamantane-2’-deoxyuridine. 
 
This compound can potentially be synthesized from the starting nucleoside 5-
iodo-2'-deoxyuridine  (see  Figure  2.38).  This  uracil/thymine  starting  material  has 
several  advantages.  It  is  cheap  compared  to  the  possible  alternative  purine  base 
analogues. In addition, it is also the least complicated to modify due to the absence of 
any exo amines (unlike the cytosine base). Finally, the iodo-functionality can be used 
to introduce a variety of groups at the 5 position of the base at high yields using the 
well-established Pd(II) cross-coupling chemistry.  
 
 
 
 
 
 
Figure 2.39. 5-Iodo-2’-deoxyuridine  
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The target nucleoside (7) was synthesized by coupling the acetylene-modified 
adamantane  (as  described  in  Sections  2.3.15  –  16)  to  a  5-iodo-2'-deoxyuridine 
nucleoside  via  the  Pd(II)-catalyzed  Sonogashira  reaction.  This  chemical 
transformation was successful; the desired product was isolated in 85% yield. This 
nucleoside is an important intermediate towards the synthesis of the corresponding 
phosphoramidite and triphosphate derivatives to generate adamantane-tagged DNA 
strands  via  solid  phase  chemical  synthesis  and  enzymatic  polymerization, 
respectively. 
 
2.8.3  Synthesis  of  Phosphoramidites  for  the  Generation  of  Tagged 
Oligonucleotide Strands via Solid-Phase 
 
Compound 7 is an important intermediate for the preparation of the dimethoxytrityl 
(DMT)-protected  phosphoramidite  derivative  (Figure  2.40)  via  reaction  of  the  5' 
hydroxyl group with dimethoxytrityl-chloride and the subsequent modification of the 
3'  hydroxyl  group  with  cyanoethoxy-N,N-diisopropyl-chlorophosphine  (CEP).  The 
protected phosphoramidite is the stepping-stone towards the preparation of synthetic 
oligonucleotides carrying the adamantane tag.   
 
 
 
 
 
 
 
Figure 2.40. Chemical structure of proposed Thymine derived phosphoramidite. 
 
The DMT-protected nucleoside was successfully synthesized and isolated albeit in a 
low  26%  yield.  This  value  may  possibly  be  due  to  the  steric  clash  of  the  bulky 
adamantane and DMT groups, caused by the inflexible linker at the 5ƹ′ position. A 
possible solution to address this (apart from utilizing a longer linker) could be the use 
of an SN2 catalyst such as DMAP
110 to achieve higher yields. 
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Scheme 2.14. Proposed synthesis of adamantane containing phosphoramidite. 
 
The  DMT-protected  nucleoside  was  then  subjected  to  the  phosphitylation 
reaction with CEP. TLC analysis established that the probable desired product was 
being formed but then degrading almost immediately. Most likely, the degradation is 
due  to  the  oxidation  of  the  phosphine.  This  result  was  surprising,  as  several 
precautions had been taken to avoid this undesired degradation. The phosphitylation 
reaction  had  been  conducted  under  inert  atmosphere  and  all  solutions  had  been 
purchased  in  anhydrous  form  and  thoroughly  degassed  beforehand.  Due  to  time 
constraints the reaction could not be repeated to resolve this issue. 
 
2.8.4  Enzymatic Incorporation of Modified Nucleotides into a DNA Template 
 
Compound  7  also  represents  a  starting  point  for  the  synthesis  of  the  triphosphate 
analogue  (Scheme  2.15),  which  is  proposed  to  be  used  for  the  generation  of 
adamantane-tagged DNA via template-directed enzymatic polymerization. It is known 
that  chemical  tags  at  position  5  of  deoxyuridine  triphosphate  analogues  can  be 
successfully accepted as substrates by DNA polymerase enzymes.
111 
 
 
 
 
 
 
Scheme 2.15. Proposed synthesis of 5-adamantane-5’-triphosphate-2’-deoxyuridine. 
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An  adapted  version  of  the  Yoshikawa  procedure
112,113  was  used  to 
phosphorylate compound 7. The 5' hydroxyl group was first modified with POCl3 in 
trimethyl  phosphate  at  -20  °C  for  20  min  to  generate  an  activated 
phosphorodichloridate species (not shown). This activated compound is then reacted 
with pyrophosphate to form the desired triphosphate. The reaction was conducted 
following the literature procedure but resulted in the mono-phosphorylated by-product 
(as  indicated  by  LC/MS);  the  triphosphate  could  not  be  isolated.  Due  to  time 
constraints, the reaction could unfortunately not be repeated to improve the results. 
 
 
2.9  Conclusions 
 
In  this  study,  a  new  nanopore-based  strategy  has  been  developed  to  enable  the 
detection  of  separate  bases  in  DNA  strands.  Using  a  model  system  of  DNA 
olignucleotides modified with peptides, chemical tags have been used to demonstrate 
that tags attached to the bases are capable of causing characteristic current signatures 
for strands translocating through nanopores. The proof-of-principle experiments show 
that blockade duration, amplitude and signature can be tuned by changing the length, 
charge  and  size  of  the  tags.  The  current  modulations  are  independent  of  the 
surrounding  DNA  sequence,  and  two  tags  on  a  strand  retain  their  characteristic 
signatures opening up the possibility of attaching multiple tags to DNA. This work 
therefore demonstrated for the first time that (i) pore recordings can detect one or two 
separate  bases  in  translocating  individual  DNA  strands,  and  that  (ii)  chemically 
modified DNA can be used to infer base-specific information. 
While  the  experiments  were  performed  with  synthetic  oligonucleotides,  the 
approach could potentially be applied to sense DNA from biological samples. This 
research illustrated that peptide tags can be incorporated into copied DNA strands 
using chemically modified nucleotides and sequence-specific primer extension. This 
approach  was  suitable  to  sense  the  presence  or  absence  of  single-nucleotide 
polymorphisms  by  incorporating  and  detecting  a  modified  base  only  if  the  target 
mutation is present. With further improvements on the tags, -e.g. decreasing the size 
of  the  linker  and  the  length  of  the  tags  - i t  may  also  be  possible  to  reduce  the 
nucleotide distance between the tags and thereby detect multiple bases in biologically  
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relevant DNA strand. For example, the highly repetitive trinucleotide repeat regions 
in forensically important sections of our DNA could be sized by labelling the same 
base in all repeats. Adamantane was identified as a viable tag for this purpose as 
initial nanopore experiments give encouraging results. A uracil nucleoside analogue 
was synthesized carrying this tag and reactions towards the preparation of both the 
phosphoramidite and triphosphate were investigated. 
The  extension  of  the  technology  towards  sequencing  by  measuring  the  ionic 
current modulation for each base would be very difficult to achieve due to the small 
distance  between  neighbouring  bases.  This  does,  however,  not  limit  its  potential, 
because the concept of slowing down DNA via chemical tags is novel and can be 
applied to various related nanopore approaches. These include fluorescence- or ionic 
current-based  sequencing  of  DNA-derived  design  polymers  where  the  spacing 
between individual bases has been increased, or strategies which detect tunnelling 
current.  
The general approach of using chemically modified bases is especially relevant 
for  DNA  sensing  with  solid-state  nanopores.  These  pores  exhibit  very  high 
mechanical stability, which makes them ideally suited for rugged electrical sensor 
devices.  Despite  progress  in  their  fabrication,  solid-state  nanopores  cannot  be 
engineered  to  the  same  atomic  precision  as  the  protein  pore  αHL.  For  example, 
inorganic pores are usually not narrow enough to discriminate between single and 
double stranded DNA thereby posing constraints on their ability to detect DNA via a 
hybridization approach. The use of chemically modified DNA strands can address this 
limitation  by  tuning  the  cross-sectional  diameter  of  ssDNA  to  existing  pore 
dimensions rather than matching the pore dimensions to the size of the DNA strand.  
In  summary,  our  strategy  represents  a  paradigm  shift  as  it  uses  the  chemical 
modification of the analyte rather than pore engineering to expand and enhance the 
sensing repertoire of nanopores. The concept can be applied to other bioanalytes. 
  The  results  described  in  this  chapter  have  been  published  in  Angewandte 
Chemie International Edition (Nick Mitchell & Stefan Howorka; 2008; 47; 5565 – 
5568) and Journal of the American Chemical Society (Vinciane Borsenberger, Nick 
Mitchell, Stefan Howorka; 2009; 131; 7530 - 7531). As second author of the second 
of these publications my involvement was limited to the analysis and interpretation of 
the nanopore traces. Synthesis of the His6-dUTP and the polymerase extension assays  
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were conducted by Dr. V. Borsenberger, and all nanopore recording was conducted 
by Dr. Stefan Howorka. 
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Chapter Three 
 
DNA based Nanoscale Tetrahedrons as Scaffold 
for the Spatial and Stoichiometric Positioning of 
Chemical Groups 
 
 
3.1  Summary 
 
In DNA nanobiotechnology, oligonucleotides are self-assembled via hybridization to 
generate higher-order structures of defined geometry. This chapter describes how the 
functional range of DNA nanostructures can be expanded by chemically modifying 
the  constituent  nucleic  acids.  DNA-based  tetrahedron-shaped  nanostructures  were 
equipped with different chemical groups. As their position within the DNA was pre-
determined, the nanostructure acted as a scaffold to arrange the different groups at 
tunable stoichiometry and at geometrically defined sites. The resulting chemically 
tagged molecular entities exhibited functional properties beneficial in biosensing and 
diagnostics. The new strategy for assembling chemical groups at the nanoscale may 
be expanded to endow other DNA structures with rationally designed functions.  
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3.2  Introduction 
 
DNA can be a versatile material in nanobiotechnology and chemical biology. Due to 
its high persistence length and sequence-specific assembly via Watson Crick base 
pairing, DNA strands can be used to assemble artificial higher-order structures.
114 
These  architectures  can  be  applied  in  areas  such  as  biotemplating
79,80,  bio-
computing
81, sensing
82, and biophysical studies
83. In chemical biology, hybridization 
of  chemically  modified  strands  into  DNA  duplexes  has  been  utilized  to  bring 
chemical groups into defined contact to e.g. enhance their reaction.
84  
Here a new approach is described which merges DNA-based nanostructures 
and  the  chemical  modification  of  DNA.  The  new  approach  exploits  DNA-based 
tetrahedrons as molecular scaffold to position functional chemical groups at defined 
geometry.  DNA  tetrahedra  are  nanostructures  with  edges  composed  of  double 
stranded DNA
94,95 (Figure 3.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Molecular model of a DNA tetrahedron (A); DNA tetrahedra functionalized via 
biotin  (blue)  and  disulphide  (red)  groups  (C);  Annealling  procedure  (B+D+G); 
Functionalisation of surfaces (E+F).  
  
Tetrahedra  are  obtained  by  annealing  four  single  stranded  DNA 
oligonucleotides (ssDNA), the 55-nt strands used here give rise to tetrahedron edges 
of 5.8 nm in length (Figure 3.1.A). Once assembled, the free 5' and 3' termini of the 
ssDNA are positioned at the vertices of the tetrahedron (Figure 3.1.B). This structural  
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characteristic was exploited by placing biotin (BT) and disulfide (DS) groups at the 
four  vertices  (Figure  3.1.C)  by  using  four  ssDNAs  carrying  the  chemical 
modifications at their 5' ends (Figure 3.1.D). By positioning three DS-groups and one 
BT group at the vertices, the rationally designed structures were expected to exhibit 
desirable  functional  properties.  In  particular,  the  tetrahedra  were  anticipated  to  (i) 
bind via three thiol legs with high affinity onto gold substrates, and - due to their 
oriented binding - (ii) present the BT moiety at a defined surface-distance exposed to 
the ambient (Figure 3.1.E) capable of capturing streptavidin at high density (Figure 
3.1.F).  The experimental strategy to analyze the DNA structures encompassed gel 
electrophoresis of solubilized tetrahedrons, and the surface characterization of DNA-
tetrahedron  films  with  X-ray  photoelectron  spectroscopy  (XPS),  atomic  force 
microscopy  (AFM),  and  fluorescence  microscopy,  along  with  spectrometric 
measurements on the binding of tetrahedrons onto gold particles. 
 
 
3.3  Materials and Methods 
 
3.3.1  Formation of a DNA Tetrahedral Structure  
 
DNA tetrahedra were generated using four DNA oligonucleotides 55 nt in length. The 
sequences  of  the  DNA  strands  were  derived  from  the  oligonucleotides  used  by 
Goodman et al.
94,95 and are summarized in Table 3.1. The four oligonucleotides were 
termed Oligo-1, Oligo-2, Oligo-3, and Oligo-4 and carried chemical modifications 
including a disulfide (DS), a biotin (BT), or a Cy3 group at the 5'-end, depending on 
which type of DNA tetrahedron was generated. Five tetrahedra were obtained using 
this procedure: DS3BT1, DS3, BT1, DS3Cy1, and DS2Cy1. Each contained disulfide 
groups at up to three vertices, and an optional biotin or Cy3 group at the forth vertex.  
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Figure 3.2. Step-wise hybridization of the oligonucleotides comprising the DNA tetrahedral. 
 
Oligonucleotides Oligo-1 to Oligo-4 (see Table 3.1), were dissolved in TE 
buffer (10mM Tris, 1mM EDTA, pH 8.0) to a conc. of 100µM.  1 nmol of each strand 
(10 µL) was combined with 20 µL of 0.1M Tris, 0.1M NaCl, 1mM EDTA, pH 8.0 
and heated to 95°C in a PCR block for 2 min before immediately being cooled on ice. 
A 12.5% PAGE gel was prepared, along with the appropriate controls (i.e. single 
strands and hybridisation products omitting one or two strands, see Figure 3.3) and 
the gel was run in a 4 °C cabinet. To prepare structures carrying disulfide, biotin and 
Cy3 modifications the appropriate oligonucleotides carrying 5’ modifications were 
substituted for the unmodified strands.  
 
DNA 
Oligo 
Sequence and Optional Modification 
Oligo-1  5'-ACA TTC CTA AGT CTG AAA CAT TAC AGC TTG CTA CAC GAG AAG AGC CGC CAT AGT A-3' 
Oligo-2  5'-TAT CAC CAG GCA GTT GAC AGT GTA GCA AGC TGT AAT AGA TGC GAG GGT CCA ATA C-3' 
Oligo-3  5'-TCA ACT GCC TGG TGA TAA AAC GAC ACT ACG TGG GAA TCT ACT ATG GCG GCT CTT C-3' 
Oligo-4  5'-TTC AGA CTT AGG AAT GTG CTT CCC ACG TAG TGT CGT TTG TAT TGG ACC CTC GCA T-3' 
Oligo-1-DS  Sequence of Oligo-1 carrying a disulfide group via a hexamethylene (C6) linker at the 5' end 
Oligo-2-BT  Sequence of Oligo-2 carrying a biotin group via a tri(ethylene glycol) (TEG) linker at the 5' end 
Oligo-2-Cy3  Sequence of Oligo-2 carrying a Cy3 group via a TEG linker at the 5' end 
Oligo-3-DS  Sequence of Oligo-3 carrying a disulfide group via a C6 linker at the 5' end 
Oligo-4-DS  Sequence of Oligo-4 carrying a disulfide group via a C6 linker at the 5' end 
 
Table 3.1. Names, Chemical Modifications, and Sequences of DNA Oligonucleotides Oligo-
1 to Oligo-4. 
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Tet.  # of Disulfide 
Groups 
# of Biotin or 
Cy3 Tags 
Oligonucleotides  Used  for  the  Preparation  of 
Tetrahedra 
       
DS3BT1  3  1  Oligo-1-DS, Oligo-2-BT, Oligo-3-DS, Oligo-4-DS 
DS3  3  0  Oligo-1-DS, Oligo-2, Oligo-3-DS, Oligo-4-DS 
BT1  0  1  Oligo-1, Oligo-2-BT, Oligo-3, Oligo-4 
DS3Cy1  3  1  Oligo-1-DS, Oligo-2-Cy3, Oligo-3-DS, Oligo-4-DS 
DS2Cy1  2  1  Oligo-1, Oligo-2-Cy3, Oligo-3-DS, Oligo-4-DS 
 
Table 3.2. Names and Composition of DNA Tetrahedra 
   
3.3.2  Streptavidin Conjugation 
 
Prior to analyzing biotin-tagged DNA tetrahedron DS3BT1 by the coupling  to the 
protein streptavidin, a simple biotin-modified ssDNA oligonucleotide was tested to 
confirm its ability to form a streptavidin-biotin bridge. Oligo-2-BT (200 pmol) of 55 
nt length carrying a biotin moiety was added to a 10 µL aliquot of streptavidin (1mg / 
ml). After incubation at room temp. for 10 mins the sample was run on a 15% TBE 
polyacrylamide  gel  in  addition  to  two  controls  consisting  of  Oligo-2-BT  without 
streptavidin protein, and the non-biontinylated Oligo-2 plus streptavidin. To confirm 
conjugation  of  BT  modified  structures  the  DNA  tetrahedra  was  formed  via  the 
procedure detailed in section 3.3.1 using three 5'-disulfide modified oligonucleotides 
Oligo-1-DS,  Oligo-3-DS,  Oligo-,4-DS  and  the  5'-biotin-modified  oligonucleotide 
Oligo-2-BT. Samples containing biotin-modified tetrahedron were mixed with 10 µL 
of a 1 mg/ml solution of steptavidin and allowed to incubate at RT for 10 mins. The 
samples were then run on a 12.5% PAGE.  
 
3.3.3  Au Nanoparticle Functionalization using DNA Tetrahedrons 
 
To 500 µL of a Au particle solution (4.5 x 10
10 particles/ml, 48.9 nm in diameter; 
67pM; Ted Pella Inc.) 5 nmol of 5'-thiolated DNA (29 nt; extinction coefficient = 290 
900 dm
3/mole.cm) was added and left overnight. The solution was then diluted up to 1 
mL with sodium phosphate buffer (5 mM Na2HPO4/NaH2PO4, 0.5 M NaCl, pH 7.0) 
and  left  overnight.  The  solution  was  concentrated  slowly  at  30  °C  in  a  vacuum 
centrifuge to 100 µL, resulting in a red precipitate. The particles were re-suspended in  
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Na2HPO4/NaH2PO4 buffer, followed by centrifugation, removal of the supernatant, 
resuspension of the particles in phosphate buffer, and centrifugation. The supernatants 
from two washing procedures were combined and concentrated, and the amount of 
DNA was determined via UV/Vis specroscopy.  
This procedure was repeated for an unmodified 29-nt control strand and for a 
tetrahedron  DS3  carrying  three  thiol  groups  at  the  apex  positions.  To  release  the 
particle-bound DNA material, 100 µL of a 100 mM aqueous solution of DTT was 
added to Au-DNA solution in 300 uL of buffer (10 mM phosphate buffer, 0.3 M 
NaCl, pH 7.0). Aliquots were taken at specific time intervals and scanned using a 
UV/Vis spectrophotometer from 800 – 200 nm. 
 
3.3.4  XPS  Analysis 
 
XPS analysis was conducted for gold surfaces cleaned with an ion beam and after 
incubation with DS3BT1. The surface analysis was performed using an ESCALAB 
200i-XL spectrometer operated using the large area-XL magnetic lens mode and an 
AlKa monochromated X-ray source operated with a 1 mm spot size. The take-off 
angle was maintained at 0° to the surface normal. Survey spectra were collected at a 
pass energy of 100 eV and detailed spectra at 20 eV pass energy. Removal of Shirley 
backgrounds and Gaussian peak fitting was performed using CasaXPS (Casa Software 
Ltd., U.K.).   
 
3.3.5  AFM Analysis 
 
Atomically flat template-stripped gold (TSG) was prepared as described by Hegner et 
al.
115 and used within two weeks of preparation. Gold surfaces were incubated with 
230 nM solutions of DNA tetrahedra DS3BT1, DS3 or BT1 in buffer TNE (50 mM 
Tris,  3  M  NaCl,  1  mM  EDTA,  pH  7.5)  for  one  hour  at  room  temperature.  The 
surfaces were then rinsed with PBS buffer (100 mM NaCl, 20 mM NaH2PO4, pH 7.5). 
For the optional coating with streptavidin, DS3BT1 and DS3 surfaces were incubated 
with a solution of streptavidin (0.1 mg/ml) in buffer PBS-SDS, composed of PBS 
supplemented with 0.1 % (w/v) sodium dodecylsulfate. After incubation for 1h, the 
surfaces were rinsed in PBS-SDS. Holes were scratched into the surface in contact  
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mode AFM using a cantilever (Sharpened MicroLever tips, Veeco Instruments S.A, 
Dourdan Cedex, France) with a nominal spring constant of 0.03 N/m. The force set 
point was 9V and scanning at a speed of 10 lines per second was repeated 4 times. All 
images were acquired at a speed of 1 line per second using the same cantilever in 
contact  mode.  Bare  and  DNA-coated  TSG  were  imaged  in  PBS,  while  surfaces 
incubated with streptavidin were analyzed in PBS-SDS.  
 
3.3.6  Fluorescence  Measurements  on  the  Affinity  of  Gold-Bound  DNA 
Tetrahedra  
 
Glass substrates bearing gold squares with a size of 50 x 50 µm and a height of 40 nm 
were prepared using standard photolithography. The substrates were then incubated 
with 500 nM solutions of DS3Cy1, DS2Cy1 and single stranded DNA oligonucleotide 
DS-DNA-Cy  in  TNM  buffer  (10  mM  Tris,  2  M  NaCl,  20  mM  MgCl2,  pH  8.0). 
Oligonucleotide  DS-DNA-Cy  has  the  sequence  5'-  CTAGACCGGTACAGATGC 
GTTCGAA-3' and carries a disulfide group via a hexamethylene (C6) linker at its 5' 
end, and a Cy3-C6 modification at its 3' end. After incubation for 3 h, slides were 
washed with TNM buffer for 15 min. The desorption of thiolated DNA tetrahedra or 
DS-DNA-Cy3  was  enhanced  by  incubating  the  samples  with  TNM  buffer 
supplemented with 10 mM dithiothreitol (DTT) for time periods ranging from two 
minutes to up to one day. Afterwards, the surfaces were rinsed in DTT-free TNM 
buffer and kept under liquid for fluorescence readout. A glass cover slip was placed 
over  the  sample  to  facilitate  the  fluorescence  analysis.  Fluorescence  images  were 
obtained  with  an  in-house  developed  fluorescence  scanning  device
116,117  which  is 
based on an inverted epifluorescence microscope (Axiovert 200, Zeiss, Oberkochen, 
Germany). For the measurements, a 100x objective (Zeiss, a Plan-FLUAR 100x/1.45) 
was  used.  Samples  were  mounted  upside-down  on  a  scanning  stage  (Märzhäuser, 
Wetzlar-Steindorf, Germany) and illuminated with a diode-pumped solid-state laser 
with an emission line of 532 nm (Millennia Iis, Spectra Physics, Irvine, CA). Images 
were  taken  with  a  Photometrics  CoolSnap  HQ  digital  camera  (Roper  Scientific, 
Trenton, NJ) (1392 x 1040-element CCD; pixel pitch, 6.45 x 6.45µm; 12-bit; QE, 0.6) 
using a time delayed integration mode. Image processing and analysis of the images 
were performed with V++ (Roper Scientific).  
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3.4  Formation and Analysis of DNA Tetrahedra 
 
The  formation  of  DNA  tetrahedron  DS3BT1  by  annealing  four  DNA 
oligonucleotides Oligo-1-DS, Oligo-3-DS, Oligo-4-DS, Oligo-2-BT was analyzed via 
polyacrylamide  gel  electrophoresis.  The  four  single  stranded  oligonucleotides 
migrated as single bands (lanes 1 – 4 figure 3.3). Lane 5 contains all four strands 
hybridized together resulting in a major high running band. The band of tetrahedron 
DS3BT1 migrated higher due to its increased mass and bulk.  The next few lanes are 
controls, each the product of annealing two or three of the oligonucleotides. In these 
cases, hybridization to smaller, and faster running by-products are seen but the high 
running tetrahedron band is missing. 
 
 
 
 
 
 
 
 
 
 
 
 
                                1   2   3   4   5    6  7  8  9  10 11 
 
Figure 3.3. PAGE analysis on the formation of DNA tetrahedron DS3BT1. Lanes 1 – 4; 
single strands; lane  5, DNA tetrahedron obtained by mixing all four oligonucleotides; lane  6 – 
11, omission of one or two strands from the annealing mixture. 
 
3.4.1  Biotin-Functionalized Tetrahedra 
 
The  molecular  recognition  of  the  biotin  moiety  at  the  apex  of  DNA  tetrahedron 
DS3BT1 was investigated using a gel-shift assay with streptavidin.  
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Figure 3.4. PAGE gels showing the results of the biotin pull down assay; (1) conjugation of 
a biotin – carrying ssDNA with Streptavidin (lane 3) versus the unmodified strand (lane 4); (2) 
conjugation of the biotin modified tet (lane 1) relative to the unmodified structure. 
 
Prior to analyzing DNA tetrahedrons, the assay was tested with biotinylated 
single  stranded  DNA.  As  would  be  expected,  incubation  of  streptavidin  with  the 
biotinylated DNA created a large complex, which did not enter the gel meshwork 
(Figure 3.4.1, lane 3) while non-biotinylated DNA in the presence of streptavidin 
migrated as a single band (Figure 3.4.2, lane 4). The same assay was repeated using 
biotin-modified tetrahedron DS3BT1. Incubation of this structure with the streptavidin 
solution led to a disappearance of the DNA band on the gel suggesting successful 
conjugation (Figure 3.4.2). 
 
 
3.5  Functionalization of Surfaces with DNA Tetrahedra 
 
The  DNA  tetrahedra  carrying  three  disulfide  groups  were  first  coupled  to  Au 
nanoparticles to provide evidence that the binding is mediated via the formation of 
disulfide-gold bonds. A film composed of the thiol-functionalized tetrahedra was then 
formed  on  Au  surfaces  and  characterized  via  XPS,  AFM  and  fluorescence 
microscopy. The specific aim of the latter two characterizations was to demonstrate 
that  the  three  anchoring  disulfide  points  would  bind  the  tetrahedron  in  a  directed 
orientation and with high affinity to the gold surface.  
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3.5.1  Au Nanoparticles 
 
Au nanoparticles were used to confirm that disulfide-tagged DNA tetrahedra bind 
specifically  via  the  thiol  group  to  the  gold  surface.  The  specificity  was  tested  by 
comparing the binding of disulfide-modified with non-modified DNA strands, and by 
releasing gold-bound thiol-modified DNA via incubation in a reducing enviroment.
118  
The disulfide modified DNA tetrahedron DS3 and 5'-modified ssDNA were 
annealed to the Au particles and concentrated (as detailed in section 3.3.3). At the 
chosen high nanoparticle and salt concentration, unmodified gold particles usually 
precipitate  but  the  DNA-modified  particles  are  held  in  suspension  due  to  the 
electrostatic repulsion of the negatively charged DNA coating. Suspended particles 
absorb at 530 nm giving rise to a red colour. Breaking the bond between thiolated 
DNA and gold via reducing agent DTT results in the aggregation of the particles, and 
a concomitant change in absorbance, turning the suspension from red to light purple. 
Since the DNA tetrahedrons carry three disulfide legs per structure they should resist 
reduction for longer than that of their single stranded counterparts. 
 
 
 
 
 
 
 
  
 
 
 
 
 
Figure 3.5. Absorbance curves of the tetrahedra-modified Au particles in the presence of 
DTT for increasing incubation times.  
 
A time-course experiment of the reduction was conducted by taking aliquots 
of the DNA/Au in a DTT solution at increasing intervals (Figure 3.5). A decrease in 
absorbance at 530 nm is clearly seen over the course of the 2 h. This experiment was  
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repeated using a single stranded 55-mer carrying a 5'-modified disulfide group. The 
decrease in the absorbance at 530 nm for both the single strand and tetrahedron was 
then normalized to the maximum and minimum absorbance range (Figure 3.6). 
 
 
Figure 3.6. Plot of the decreasing absorbance at 530 nm of the Au particle solutions over 
2h. 
 
A slower decline of absorbance at 530 nm is clearly seen for the tetrahedron 
sample compared to that of the ssDNA indicating it is indeed more stable towards 
cleavage. The difference in the initial decay of the graphs was approximately 5 fold, 
however a greater increase in stability was expected due to the three anchor points of 
the  structure  over  a  single  strand.  This  lowered  stability  may  be  attributed  to  the 
reduction of NaCl concentration in the solution during the annealing procedure. The 
salt concentration must be initially high to bind the DNA; during this procedure the 
NaCl conc. is increased from 0.5 M to over 1 M as the volume of the solution is 
reduced. However, the particles must then be re-suspended in buffer – if the conc. of 
NaCl is too high the absorbance of the DNA at 260 nm is masked and the absorbance 
at 530 nm interfered with. Therefore the salt levels are decreased to get an accurate 
read; this however will also decrease the Tm of the structures and thus weaken the 
binding of the tetrahedron to the particles, hence a lower than expected stability. This 
hypothesis can be tested by repeating the experiment once the structures are bound to 
a Au surface substrate for AFM analysis. Using the fluorescence of a Cy3 group at the 
apex of the structure we will not encounter the same issues that have arisen in this 
assay. 
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3.5.2  Characterization of DNA-Tetrahedron Films on Au Surfaces 
 
The  ability  of  DS3BT1 t o  bind  onto  gold  surfaces  was  assessed  using  X-ray 
photoelectron spectroscopy.
119 In XPS, a surface is irradiated with X-rays of defined 
energy, and the kinetic energy of the escaping electrons is measured. By calculating 
the  energy  difference,  information  relating  to  the  elemental  composition  and 
electronic state of the elements can be ascertained.  
Planar  gold  supports  were  coated  with  DNA-tetrahedron  DS3BT1  and 
subjected to XPS analysis to confirm the presence of a DNA film. Figure 3.8A shows 
the survey spectra of cleaned bare and DS3BT1-treated gold surfaces. The bare gold 
surface displays major peaks at 84, 87, 335, 353, and 546 eV which are characteristic 
for Au4f7/2, Au4f5/2, Au4d5/2, Au4d3/2 and Au4p3/2, respectively. Upon treatment with 
DNA- tetrahedron DS3BT1, the Au signals were reduced while peaks for P2p (135 
eV),  C1s  (285  eV),  N1s  (400  eV),  and  O1s  (530  eV)  appeared.  These  peaks  are 
consistent  with  the  formation  of  a  DNA  film.  The  changes  in  the  elemental 
composition of the Au surfaces upon DNA treatment are summarized in Table 3.3. 
Additionally, small quantities of Na, S and Zn were observed, again in agreement 
with the formation of a DNA film. XPS analysis also showed the attenuation of the 
Au4f signal as well as the appearance of peaks for C1s, N1s, O1s, and P2p at relative 
ratios expected for DNA. 
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Figure 3.7. XPS analysis of Au surfaces coated with a films of DNA tetrahedra. (A) Survey 
spectra  of  Au  substrates  before  and  after  incubation  with  DNA  tetrahedron  DS3BT1.  High 
resolution XPS spectra of (B) C1s, (C) N1s, and (D) O1s before and after treatment with 
DS3BT1. 
 
 
   Au  C  N  Na  O  P  S  Zn 
Bare Au  96.6  0.8  0.2  0  0.1  1.8  0.3  0.2 
Au / DS3BT1  19.3  44.8  10.7  0.6  20.7  2.5  0.9  0.4 
 
Table  3.3.  Full  chemical  quantification  of  bare  Au  surfaces  and  Au  surface  coated  with 
tetrahedron DS3BT1 as determined by XPS.  
   
  The detailed XPS spectra for C1s, N1s, and O1s of the uncoated and DNA-
treated  surfaces  (Figure  3.8B  to  Figure  3.8D,  respectively)  were  subjected  to  a 
detailed analysis to derive elemental ratios for the organic film. The analysis of the 
XPS region for C1s and O1s (Figure 3.8B) was performed by fitting Gaussian peaks  
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to the spectra. Four separate peaks were required in the deconvolution procedure for 
C1s to achieve a random residual. The four peaks were at 285.0, 286.6, 288.0 and 
289.2 eV with relative intensities of 46, 35, 14 and 5%, respectively (Figure 3.8B). 
The peak energies and relative intensities are similar to the detailed C1s spectrum for 
an oligothymidine strand of 25 nt in length. As the DNA tetrahedron DS3BT1 did, 
however, contain all four bases rather than just T, a simple scheme was utilized to 
predict the spectra of our DNA sample. This scheme accounted for changes in the 
energies of the carbon peaks caused by the complex structure of and the conjugation 
within the heteroaromatic base rings, as well as the electron-withdrawing phosphate 
groups in the deoxyribose. For example, a shift of +1.5 eV was applied for each C-O 
bond and a shift of +0.4 eV for each C-N bond. This procedure yielded nine unique 
binding energy peaks. To simplify the analysis and to allow a direct comparison to the 
experimental data, theoretically derived peaks of similar binding energy separated by 
less than 0.4 eV were combined to yield four peaks. The energies of the four peaks 
were 285.2, 286.3, 288.4 and 288.8 eV with estimated peak area ratios of 36, 43, 18 
and 3%, respectively. These calculated data compare to the experimental peaks at 
285.0,  286.6,  288.0  and  289.2  eV  with  relative  intensities  of  46,  35,  14  and  5%, 
respectively.  The  agreement  between  the  peak  positions  is  good  considering  the 
complexity  of  the  actual  DNA  structure.  Hydrocarbon  contamination  is  the  likely 
cause of the slightly elevated levels of the 285.0 eV peak in the measured spectra. The 
ratio of the two peak areas at 288.0 eV and 286.6 eV is 0.41, which is in excellent 
agreement  to  the  expected  value  of  0.41  for  DNA.  The  difference  of  2%  for  the 
energy peak at 289.2 eV is reasonable considering the low intensity of this signal. The 
detailed N1s region displayed a strong peak at 400 eV for the DNA surface but no 
signal prior to the treatment (Figure 3.8C). The small asymmetry of the peak is due to 
the multiplicity of binding environments in DNA bases. Similarly, upon addition of 
DNA the spectra for the expanded oxygen region (Figure 3.8D) showed two peaks at 
531.6 and 533.1 eV with relative peak intensities of 43 and 57%. The energies and 
relative areas of the two peaks are in excellent agreement with a report on the high-
resolution XPS analysis of DNA films with values of 531.7 eV and 533.3 eV, and 
peak  area  ratios  of  44  and  56%.  Table  3.4  summarizes  the  experimental  and  the 
theoretical ratios of the elemental signals. For example, the experimental O/N ratio 
with 1.9 is identical to the calculated ratio. Similarly, the determined O/P ratio of 8.3 
is  close  to  the  expected  value  of  7.0.  The  ratios  C/N,  C/O,  C/P,  and  C/S  were  
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corrected for the presence of a carbon contamination and yielded reasonable to good 
agreement with the predictions. Taken together, the XPS spectrum provides strong 
support for the presence of a DNA film on the Au surface. 
  
Elemental Ratio  C/N  C/O  C/P  O/N  O/P 
Experimental  4.2  2.1  17.9  1.9  8.3 
Theoretical  2.6  1.4  9.8  1.9  7.0 
 
Table 3.4. Elemental ratios of DS3BT1 films determined from XPS analysis compared to 
calculated ratios expected for DNA. 
 
Atomic Force Microscopy (AFM) was used to determine the extent of the DNA 
tetrahedra binding and its ability to conjugate to streptavidin whilst maintaining its 
adherence to the gold.
120 A DS3BT1 film was formed and incubated with streptavidin. 
Scratching of the surface revealed a profile step of 7 nm (Figure 3.8, panel 3), which 
is consistent with the formation of a monomolecular layer of streptavidin (size of 
protein, 4x8x7 nm) on top of a DNA film. The elevated, bright features around the 
hole (Figure 3.8, panel 3) represent streptavidin and DNA which had been removed 
from  the  film.  In  line  with  a  specific  biotin-streptavidin  interaction,  BT-free 
tetrahedron DS3 did not capture streptavidin as indicated by the smaller step size 
(Figure 3.8, panel 4). 
 
 
 
 
 
 
 
Figure 3.8. AFM analysis of Au surfaces coated in DNA tet layer and Streptavidin protein 
layer; (1) bare surface; (2) DNA tet layer; (3) DNA/Protein layer; (4) DNA tet minus biotin 
layer. 
 
As would be predicted for oriented and specific binding, tetrahedron DS3BT1 
yielded a monomolecular film in AFM analysis. For the topographic measurements, 
template-stripped gold (TSG) was used. TSG exhibited flat (rms noise, 0.3 nm) facets  
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of 100 to 1000 nm in size, which were separated by 2-10 nm deep trenches (Figure 
3.8,  panel  1).  By  comparison,  gold  surfaces  incubated  with  DS3BT1  displayed  an 
increased rms noise of 0.5 nm. In addition, a hole with a depth of 1.5 nm could be 
scratched into DS3BT1 surfaces (Figure 3.8, panel 2). This value is lower than the 
height of 4.5 nm of the DNA tetrahedron because soft biological material can be 
compressed in contact mode AFM. In agreement with the disulfide-specific tethering, 
gold surfaces incubated with DS-free tetrahedron BT1 did not form films according to 
AFM analysis. 
After confirming the oriented binding of DS3BT1, the affinity of the tetrahedra 
to the gold substrate was determined. Due to the anticipated multivalent enhancement 
of individual gold-thiol interactions, the DNA structures with three DS legs should 
bind tighter to the surface than constructs with two or a single leg. The differential 
affinity  was  experimentally  determined  by  first  forming  films  composed  of 
fluorescence-labeled tetrahedra DS3Cy1 or DS2Cy1, or single-stranded oligonucleotide 
DS-DNA-Cy,  and  then  monitoring  their  time-dependent  desorption  using 
fluorescence  microscopy.  Desorption  was  enhanced  by  incubating  the  DNA  films 
with  10  mM  dithiothreitol  (DTT)  which  displaces  thiolated  DNA  from  the  gold 
surface. The kinetics of fluorescence decrease are displayed in Figure 3.9.  
 
 
 
 
 
 
 
Figure 3.9. Plot of DNA release from DNA surface; fluorescence of Cy3 moiety plotted 
against time; blue triangles – DNA tetrahedra equipped with three disulphide ‘legs’; red circles 
– DNA tetrahedra with two disulphide legs; black squares – single stranded oligonucleotide 
with only one disulphide group. 
 
During an observation window of 120 min, DS3Cy1 was only slightly removed 
by 5% (Figure 3.9, blue triangles) while the coverage of DS2Cy1 with two thiol legs 
fell linearly to below 50% of the starting value (Figure 3.9, red circles). DNA with a 
single DS group exhibited the lowest affinity with the signal exponentially decaying  
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to 10% after 30 min (Figure 3.9, black squares). The residual constant signal is due to 
autofluorescence of gold and background fluorescence of desorbed and solvated DNA 
strands. Comparative analysis of the initial rates of desorption revealed that DS3Cy1 
with three legs bound with a 5000-fold higher affinity to gold than monothiolated 
DNA  confirming  our  previous  suspicions  of  sample  denaturation  during  the  Au 
nanoparticle investigation.  
 
A  B  C 
     
 
Figure  3.10.  Fluorescence  microscopic  analysis  on  the  binding  of  DS2Cy31 o n t o  g o l d  
squares and the DTT-mediated release of the fluorescence-labeled tetrahedra from the gold 
surface. Fluorescence images show glass substrates with a 50 x 50 µm gold square without 
DNA film (A) and with a freshly formed layer of DS2Cy1 bound to the gold surface (B). (C) 
displays a DS2Cy1-coated gold square after 60 min incubation with 10 mM DTT. 
 
3.6  Addressing  Individual  Biotinylated  DNA  Tetrahedra  with 
Scanning Probe Techniques 
 
DNA tetrahedra were investigated with two scanning probe techniques to confirm that 
individual DNA tetrahedra DS3BT1 were binding in an oriented fashion to the gold 
surface  thereby  presenting  the  biotin  moiety  to  the  ambient.  Two  single-molecule 
scanning probe techniques were used: atomic force microscopy (AFM) and molecular 
recognition  force  spectroscopy  (MRFS).  AFM  imaging  of  individual  molecules 
detects t o pographic  height  changes  when  a  cantilever  is  scanned  over  a  sample 
surface.  By  comparison,  force  microscopy  utilizes  cantilevers  whose  tips  are 
chemically modified with receptors. The tethered receptor can recognise a surface-
bound ligand leading to changes in the amplitude of an oscillating AFM tip. 
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3.6.1  Molecular Recognition Force Spectroscopy (MRFS) 
 
For the investigation of the biotin-carrying DNA tetrahedron DS3BT1 by recognition 
force spectroscopy, an AFM tip was coated with streptavidin proteins (Figure 3.11). 
The tip carrying primary amine groups was first reacted with the heterobifunctional 
linker NHS-PEG-aldehyde. The aldehyde group was then coupled to a streptavidin 
protein via reductive amination of surface accessible lysine groups. 
 
 
 
 
   
 
 
 
 
 
 
 
 
Figure 3.11. Functionalization of an AFM tip: (i) Attachment of an aldehyde linker via attack 
of an amine-functionalized tip to an activated ester linker; (ii+iii) attachment of a streptavidin 
protein via reductive amination. 
 
3.6.2  Application of MRFS and AFM to Analyze DNA Tetrahedrons 
 
MRFS was first used to characterize DS3BT1 tetrahedra on a Au surface. The MRFS 
experiment is illustrated in Figure 3.12. As the oscillating AFM tip passes over one of 
the biotin-modified DNA-tetrahedrons, streptavidin attached to the tip binds to the 
biotin moiety. As the oscillating tip is retracted, it is held back by the surface-tethered 
biotin-streptavidin bond. As the weakest component of the system, the non-covalent 
association of the biotin group and the protein ruptures once the tip is retracted far 
enough.  The  force  at  which  this  occurs  is  characteristic  to  the  biotin-streptavidin  
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complex and can be used to investigate the binding affinities of the substrate on the 
surface.  
 
 
 
Figure  3.12.  Identification  of  the  DNA  structure  via  molecular  recognition  force 
spectroscopy (MRFS). 
 
Figure 3.13 (left) shows the binding and rupture of the complexes visualized 
in  Figure  3.12.  After  repeating  the  binding  and  captured  cycles  1000  times,  the 
rupture forces were displayed in a histogram to reveal a typical force of 50 pN which 
is characteristic for biotin-streptavidin (Figure 3.13, right). Controls which block the 
specific  molecular  interaction  also  reduce  the  probability  of  recognition  in  the 
histograms (Figure 3.13, right). 
 
 
 
 
 
 
 
 
 
 
Figure  3.13.  MRFS  data  (left)  traces  showing  the  conjugation  and  release  of  protein-
modified  AFM  tip  and  (right)  probability  density  function  of  the  rupture  force  for  different 
conditions.   
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The ability of biotin-functionalized tetrahedra to bind individual streptavidin 
molecules  was  also  proven  by  AFM  imaging.  First,  DS3BT1  tetrahedra  were 
immobilized  on  a  gold  surface  via  their  disulfide  legs  (Figure  3.14A,  top).  The 
resulting  surface  density  of  DS3BT1  was  lower  than  in  the  previous  unbinding 
experiments in order to permit the unambiguous identification of individual tetrahedra 
(Figure 3.14A, bottom). Full and dotted circles mark individual DNA tetrahedra with 
a height of 2 nm and a diameter between 10-15 nm. The measured height is lower 
than the nominal height of the DNA tetrahedra due to the compression by the AFM 
tip.  In  the  second  step,  streptavidin  was  added  to  form  DS3BT1-streptavidin 
complexes  (Fig.  3.14B,  top).  Given  that  the  same  surface  area  was  imaged,  the 
enlarged topographical signals (Figure 3B, bottom, dashed circles) could be assigned 
to individual tetrahedron-streptavidin complexes. Only ~8% of all tetrahedra did not 
bind streptavidin (solid circles) whereas non-specific binding of streptavidin occurred 
even less frequently (dashed circle).  
 
 
 
 
 
 
 
 
Figure 3.14. AFM of individual DNA tetrahedral molecules on a Au surface (A) and imaging 
of protein conjugation (B).  
 
3.7  Conclusions 
 
This  chapter  presented  a  new  strategy,  which  exploits  DNA-nanostructures  as 
scaffolds to combine different chemical groups at defined geometrical distance and 
tunable stoichiometry. The rationally designed structures exhibit functional properties, 
which  may  be  exploited  for  the  immobilization  of  DNA  or  proteins  on  gold  for 
biosensing, diagnostics, and cell biological research. Given the great variety of DNA  
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nanostructures,  the  approach  for  chemical  enhancement  has  the  potential  to  be 
extended to other nanostructures and different bio-chemical tags. For example, it is 
envisioned that the structures may help prepare new templates for chemical reactions, 
create functional building blocks for defined multimeric enzyme complexes, or build 
labeling reagents carrying tunable numbers of tags.  
It  may  also  be  possible  use  thiolated  DNA  tetrahedrons  as  spacers  to 
immobilize cargo DNA onto surfaces in biochips. Compared to highly densely packed 
ssDNA, DNA on tetrahedrons would be spaced at greater intervals thereby improving 
steric accessibility and hybridization with an analyte DNA strand of complementary 
sequence.  Furthermore,  the  defined  position  of  the  DNA  cargo  at  the  top  of  the 
tetrahedron  and  distant  to  the  substrate  surface  would  also  improve  accessibility 
compared with the non-defined orientation of ssDNA resulting from the point-like 
attachment via single thiol group. 
The work described in this chapter has been published in Angewandte Chemie 
Int. Ed (Nick Mitchell, Robert Schlapak, Markus Kastner, David Armitage, Wojciech 
Chrzanowski,  Johannes  Riener,  Peter  Hinterdorfer,  Andreas  Ebner  and  Stefan 
Howorka;  2009;  48;  525  –  527).    My  contribution  to  this  publication  included 
investigation  of  DNA  tet  formation  and  design/inclusion  of  chemically  modified 
oligos.  I  carried  out  the  original  Au  nanoparticle  investigation  and  prepared  all 
samples subjected to surface analysis. The AFM analysis was conducted by Andreas 
Ebner and the X-ray photoelectron spectroscopy by Wojciech Chrzanowski. All other 
authors gave assistance with either the experimental work or the composition of the 
publication. 
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Chapter Four 
 
Chemical tags mediate the self-assembly of DNA 
strands into supramolecular structures 
 
 
4.1  Summary    
 
The following chapter shows that chemically tagged DNA strands can form defined 
higher-order structures via the formation of Ni(II)-mediated chelate bridges. Tags that 
are  capable  of  chelating  Ni(II)  ions  were  synthesized  and  conjugated  to  DNA 
duplexes. The selective interaction between duplexes via the metal-chelate bridges 
was proven using an assay capable of physically isolating the higher-order structures 
from  the  monomeric  duplexes.  In  addition,  chemically  tagged  helices  were 
synthesized  to  self—assemble  into  a  2D  array,  as  visualized  by  AFM  analysis. 
Finally,  chemically  tagged  DNA  rings  were  synthesized  with  the  aim  of  forming 
tubular stacks of rings held together via the chelate bridges. 
 
 
  
  134 
4.2  Introduction 
 
Self-assembly  is  an  important  functional  property  of  biological  biopolymers,  as 
illustrated  by  naturally  occurring  higher-order  structures  of  proteins  and 
DNA.
121,122,123  The  ability  to  engineer  self-assembly  into  monomeric  peptides  or 
proteins  via  rational  design  is  an  emerging  topic  in  supramolecular  chemistry, 
nanobiotechnology and synthetic biology due to the potential applications in basic 
science and technology.
124  
Existing approaches towards imparting self-assembly use the engineering of 
protein  surfaces,
125  the  bottom-up  design  of  linear  peptides,
126  or  selection  of 
complementary  DNA  sequences.
127  An  alternative  approach,  which  achieves  self-
assembly  independent  of  the  re-engineering  of  the  structural  framework  of  the 
subunits,  can  be  conceived.  The  new  approach  would  use  chemical  tags  that  are 
covalently attached to the bio-polymer subunits to form reversible yet tight metal 
chelate complexes resulting in designed supramolecular biopolymer structures.  
Here the new, generic approach, is tested by the creation of nanoarrays of 
DNA duplexes. Our strategy to impart self-assembly onto biomolecules exploited the 
two chemical tags bis-nitrilotriacetic acid (bisNTA) and a His6 peptide, which are able 
to form a metal chelate complex (Figure 4.1). In the bisNTA-Ni
2+-His6 complex, two 
nitrilo-triacetic acid (NTA) groups are bonded via two Ni
2+ ions to the imidazole 
moieties of a hexahistidine peptide. 
 
 
 
 
 
 
 
 
 
Figure 4.1. DNA bound via bisNTA – Ni(II) – His6 complex 
 
The ability to reversibly bind DNA duplexes using designed chemical tags 
could have interesting potential applications in biotechnology. By utilizing tags that  
  135 
are able to form reversible metal chelates it should be possible to bind either proteins 
or DNA to one another or to a solid support, for example, without the need to alter 
their specific sequence or structure. Importantly, this allows the biopolymers to retain 
their biological function. The NTA-Ni(II)-His6 complex is already used to good effect 
in  Immobilized  Metal  Affinity  Chromatography    (IMAC)  where  NTA  groups  are 
immobilized onto a solid support and loaded with Ni(II) ions. Proteins that have His6 
sequences  encoded  into  their  terminus  can  be  retained  on  the  column  due  to  the 
formation of the above complex and eluted via competitive binding by flooding the 
system with excess imidazole. 
The bisNTA tag has been developed to bind with a Kd of 10
8 M
-1 to the His6 
peptide.
128  In  addition  to  high  affinity,  a  linkage  via  bisNTA-Ni
2+-His6  features 
several other beneficial properties useful in the design of supramolecular structures. 
These  include  reversibility  and  controllability  by  adding  or  removing  Ni
2+,  and 
directional  binding  as  a  bisNTA  tag  can  only  interact  with  His6.  Reflecting  these 
advantages, our aim was to attach bisNTA and His6 tags to single base positions 
within DNA duplexes. Given the position of the tags at opposite sites of the duplex, 
they are expected to endow DNA with the ability to form parallel aligned nanoarrays 
(Figure 4.2). The array formation process is triggered by Ni
2+ while a metal chelating 
agent such as EDTA
4- (ethylenediamine tetraacetic acid) can revert the organisation 
and make the system regress back into a disordered state. 
 
 
 
 
 
 
 
 
Figure 4.2. Schematic diagram of Ni(II) mediated array formation via binding of chemically 
tagged duplexes. 
 
The bisNTA and CysHis6 peptide components were initially synthesized and 
conjugated to oligonucleotides that contained non-biogenic thymine bases carrying an 
amine linker. These chemically modified oligonucleotides were used in an assay to 
 
 
         bisNTA          His6             Ni(II) 
 
 
EDTA
4-  
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detect the formation of a Ni(II)-mediated dimer between a bisNTA and a His6-tagged 
duplex.  
 
4.3  Materials and Methods 
 
The  bisNTA  compound  carrying  a  maleimide  functionality  (compound  17)  was 
synthesized via a procedure adapted from Lata et al.
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Scheme  4.1.  Synthesis  of 
tBu  protected  mono-nitrilotriacetic  acid;  (i)  Cbz/tBu  protected 
Lysine, tert butyl bromo acetate, DIPEA, DMF, reflux; (ii) 10% Pd/C, H2(g), MeOH, RT. 
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Scheme 4.2; Synthesis of tBu protected bisNTA; (iii) mono-NTA, Cbz protected Glutamic 
Acid, TBTU, DIPEA, DCM; (iv) 10% Pd/C, H2(g), MeOH, RT. 
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Scheme 4.3; Synthesis of mal–bisNTA; (v) tBu protected bis NTA, Maloeyl – beta – alanine, 
TBTU, DIPEA, DCM; (vi) 50% TFA/DCM. 
 
4.3.1  Synthesis of Z-bisNTA (OtBu) (10)    
 
 
 
 
 
 
 
6-benzyloxycarbonylamino-2-(bis-tert-butoxycarbonylmethyl-amino)-hexanoic  acid 
(10) was synthesized via sequential addition of tert butyl bromoacetate (9; 7.91 mL; 
53.6 mmol) and diisopropylethylamine (DIPEA) (11.7 mL; 67 mmol) to a solution of 
N
ε-benzyloxycarbonyl-L-lysine  tert-butyl  ester  (8;  5  g;  13.4  mmol)  in  80  mL 
anhydrous DMF. The reaction was stirred magnetically at 55 °C overnight. After this 
period  the  solvent  was  removed  under  reduced  pressure.  Petroleum  ether  :  ethyl 
acetate (3:1) was added to the crude oil causing precipitation of the bromide salt of 
DIPEA. The slurry was filtered, and the precipitate washed multiple times with the 
petroleum  ether  :  ethyl  acetate  solution  until  the  light  brown  coloration  had  been 
removed. The crude was then purified via flash column chromatography using the 
solvent  system  petroleum  ether  :  ethyl  acetate  (5:1).  The  fractions  containing  the 
desired product were pooled, the solvent removed under reduced pressure and the 
resulting oil dried on a high vacuum line to yield the titled compound 10 as a yellow 
oil  (6.97  g,  12.35  mmol,  92  %).  Calculated  mass  (C30H48N2O8)  564.34  g.mol
-1; 
observed  mass  (ESI
+)  565.46  (MH
+)  &  587.50  (M  +  Na
+). 
1H  NMR  (300  MHz; 
CDCl3) δ/ppm 1.41 (18H, s), 1.44 (9H, s), 1.52 (4H, m), 1.62 (2H, m), 3.18 (2H, m),  
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3.29 (1H, t, J = 6.9), 3.37 (4H, dd, J = 17.1, 4.8), 5.07 (2H, s), 5.10 (1H, m), 7.33 (5H, 
m); 
13C NMR (75 MHz; CDCl3) δ/ppm 23.0, 28.1, 28.2, 29.2, 30.1, 40.8, 53.9, 65.1, 
66.4, 80.7, 81.1, 128.0, 128.1, 128.4, 136.8, 156.5, 170.7, 172.4. 
 
4.3.2  Deprotection of Z-bisNTA (O
tBu) yielding 11 
 
 
 
 
 
 
 
6-amino-2-(bis-tert-butoxycarbonylmethyl-amino)-hexanoic acid tert-butyl ester (11) 
was  synthesized  by  dissolving  compound  10  (2.5g;  4.43  mmol)  in  100  mL  of 
anhydrous methanol, 10% Pd/C (50 mg) was added, and the resulting solution was 
purged  with  Ar(g).  The  reaction  was  left  stirring  vigorously  for  5  hours  under  an 
atmosphere of H2(g) at room temperature. After this period the solution was filtered 
through celite, and the solvent was removed under reduced pressure. The resulting 
light yellow oil was dried on a high vacuum line to yield the titled compound 11 (1.82 
g; 4.24 mmol; 96%). Calculated mass (C22H42N2O6) 430.30 g.mol
-1; observed mass 
(ESI
+) 431.63 (MH
+). 
1H NMR (300 MHz; CDCl3) δ/ppm 1.42 (18H, s), 1.44 (9H, s), 
1.47 (4H, m), 1.64 (2H, m), 1.75 (2H, m), 2.67 (2H, t, J = 5.9), 3.29 (1H, t, J = 7.5), 
3.38 (4H, dd, J = 17.1, 7.5); 
13C NMR (75 MHz; CDCl3) δ/ppm 23.2, 28.1, 28.2, 30.5, 
33.2, 41.9, 53.8, 65.3, 80.7, 81.0, 170.7, 172.4. 
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4.3.3  Synthesis of Z-bisNTA (O
tBu) (13) 
 
 
 
 
 
 
 
 
6-{4-benzyloxycarbonylamino-4-[5-(bis-tert-butoxycarbonylmethyl-amino)-5-tert-
butoxycarbonyl-pentylcarbamoyl]  butyryl  amino}-2-(bis-tert-butoxycarbonylmethyl-
amino)-hexanoic acid tert-butyl ester was synthesized by dissolving compound 11 
(1.3 g; 3.02 mmol) in anhydrous DCM (50 mL) followed by addition of compound 12 
(386.5 mg; 1.374 mmol), TBTU (970 mg; 3.02 mmol) and DIPEA (956 µL; 5.49 
mmol).  The  slurry  was  purged  with  Ar(g)  and  allowed  to  stir  at  RT  under  Ar(g) 
overnight. After this period the solvent was removed under reduced pressure to yield a 
slurry. The crude product was dissolved in DCM and washed with water and brine. 
The  organic  phase  was  dried  over  anhydrous  magnesium  sulfate,  and  the  solvent 
removed under reduced pressure. The crude was purified via column chromatography 
using  a  solvent  system  of  petroleum  ether  :  ethyl  acetate  (4:1).  All  fractions 
containing the product were pooled and the solvent removed under reduced pressure 
to yield the titled compound 13 as a white solid (1.2 g; 1.09 mmol; 79%). Calculated 
mass (C57H95N5O16) 1105.68 g.mol
-1; observed mass (ESI
+) 1106.86 (MH
+), 1128.85 
(M + Na
+). 
1H NMR (300 MHz; CDCl3) δ/ppm 1.43 (36H, s), 1.45 (18H, s), 1.50 (8H, 
m), 1.64 (4H, m), 1.97 - 2.08 (2H, m), 2.27 - 2.39 (2H, m), 3.19 - 3.34 (6H, m), 3.38 
(8H, dd, J = 17.1, 6.4), 4.17 (1H, q, J = 7.0), 5.08 (2H, s), 6.37 (1H, d, J = 6.4), 6.57 
(1H, at), 7.05 (1H, at), 7.33 (5H, m). 
13C NMR (75 MHz; CDCl3) δ/ppm 22.8, 23.1, 
28.8, 29.3, 29.7, 30.0, 32.4, 39.3, 53.7, 54.0, 54.4, 64.9, 66.7, 80.8, 80.9, 81.1, 81.2, 
128.98, 128.0, 128.5, 170.7, 170.8, 171.3, 172.3, 173.0. 
 
 
  
  140 
4.3.4  Deprotection of Z-bisNTA (O
tBu)  yielding 14 
 
 
 
 
 
 
 
 
 
6-{4-amino-4-[5-(bis-tert-butoxycarbonylmethyl-amino)-5-tert-butoxycarbonyl-pent- 
ylcarbamoyl]-butyrylamino}-2-(bis-tert-butoxycarbonylmethyl-amino)-hexanoic  acid 
tert-butyl ester was synthesized by dissolving compound 13 (1.08 g; 0.98 mmol) in 50 
mL of anhydrous methanol, 10% Pd/C (20mg) was added, and the resulting solution 
was purged under Ar(g) and left stirring vigorously for 5 hours under an atmosphere of 
H2(g)  at  RT.  Analysis  using  LC/MS  showed  the  presence  of  tert  butyl  groups, 
therefore  a  further  100  mg  of  10%  Pd/C  added  to  the  solution.  The  flask  was 
evacuated and purged with Argon and then with a fresh H2(g) balloon. After a further 
2h the solution was filtered through celite, and the solvent removed under reduced 
pressure. The product was dried under high vacuum to yield the titled compound 14 
as a white foam (0.866 g; 0.92 mM; 94%). Calculated mass (C50H93N5O14) 971.64 
g.mol
-1; observed mass (ESI
+) 972.70 (MH
+) g.mol
-1, 994.60 (MH
+) g.mol
-1. 
1H NMR 
(300 MHz; d6-DMSO) δ/ppm 1.42 (36H, s), 1.44 (18H, s), 1.51 (8H, m), 1.63 (4H, 
m), 1.8 – 2.0 (2H, m), 2.2 – 2.39 (2H, m), 3.21 – 3.31 (6H, m), 3.43 (9H, ddd, J = 3.2, 
2.7), 3.46 (1H, s), 6.70 (1H, t. J = 9.3, 4.8), 7.48 (1H, t, J = 10.7, 5.4). 
13C NMR (75 
MHz; d6-DMSO) δ/ppm 23.3, 28.1, 28.2, 28.5, 30.2, 39.0, 53.8, 53.9, 80.7, 80.8, 81.1, 
170.7, 170.8, 172.4, 173.0. 
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4.3.5  Synthesis of mal-bisNTA (O
tBu) (16) 
 
 
 
 
 
 
 
 
 
2-(bis-tert-butoxycarbonylmethyl-amino)-6-{4-[5-(bis-tert-butoxycarbonylmethyl-
amino)-5-tert-butoxycarbonyl-pentylcarbamoyl]-4-[N-(2-carboxyethyl)maleimide]-
butyrylamino}-hexanoic  acid  tert-butyl  ester  16  was  synthesized  by  dissolving 
compound  15  (0.862  g,  0.888  mmol)  in  anhydrous  DCM  (15  mL)  and  adding  a 
solution of 0.165 g (0.98 mmol) N–maleoyl–β–alanine (in DCM) followed by 0.315 g 
of TBTU (0.98 mmol) and DIPEA (308.6 µL. 0.23 g, 1.78 mmol). The reaction was 
purged with Ar(g) and stirred overnight at RT under an Ar(g) atmosphere. Complete 
conversion to the desired product was monitored via LC/MS. Once the reaction had 
reached completion the solvent was removed under reduced pressure, and the crude 
solid purified via column chromatography using a solvent system of 4% methanol in 
DCM.  The  fractions  containing  the  desired  product  were  pooled,  and  the  solvent 
removed under reduced pressure to yield the titled compound as a white solid/gum 
(0.97  g;  0.863  mM;  97%).  Calculated  mass  (C56H94N6O17)  1123.6754  g.mol
-1; 
observed  mass  (ESI
+)  1123.6810  (MH
+)  g.mol
-1. 
1H  NMR  (300  MHz;  d6-DMSO) 
δ/ppm 1.42 (36H, s), 1.44 (18H, s), 1.50 – 2.55 (11H m), 3.17 – 3.32 (8H, m), 3.44 
(12H, m), 3.82 (3H, t, J = 6.4), 4.31 (1H q, J = 5.9), 6.70 (2H, s), 6.71 (1H, t, J = 5.4), 
7.2 (1H, t, J = 5.4); 7.7 (1H, d, J = 6.4). 
13C NMR (75 MHz; d6-DMSO) δ/ppm 28.1, 
28.2, 38.6, 39.4, 53.7, 54.0, 80.8, 81.0, 81.2, 134.3, 170.5, 170.6, 170.7, 171.0, 173.5.   
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4.3.6  Synthesis of mal-bisNTA (17) 
 
 
 
 
 
 
 
 
 
2-(bis-carboxymethyl-amino)-6-{4-[5-(bis-carboxymethyl-amino)-5-carboxy-pentyl 
carbamoyl]-4-[N-(2-carboxyethyl)male- imide]-butyrylamino}-hexanoic acid 17 was 
synthesized by dissolving compound 16 (200 mg) in 5 mL anhydrous DCM and 5 mL 
TFA. After stirring the solution magnetically for 5 hrs the solvent was removed under 
reduced pressure. The resulting oil was purified via preparative RP-HPLC using a (A) 
water (0.1% TFA) : (B) acetonitrile (0.1% TFA) gradient of 2 – 30% B over 20mins. 
The fractions containing the desired peak were pooled, the solvent removed under 
reduced pressure and the resulting product dried under high vacuum to yield the titled 
compound as a white solid (98.8 mg, 65.5%). Calculated mass (C32H46N6O17)  786.29 
g.mol
-1; observed mass (ESI
+) 787.50 (MH
+) g.mol
-1, 809.50 (M+Na
+) g.mol
-1. 
1H 
NMR (500 MHz; d6-DMSO) δ/ppm 1.36 (8H, m), 1.55 (2H, m), 1.63 (3H, m), 1.80 
(1H, m), 2.01 (2H, m), 2.38 (2H, t, J = 7.0), 2.98 (4H, m), 3.40 (2H, td, J = 7.3, 3.5), 
3.57 (10H, m), 4.09 (1H, td, J = 8.2, 5.7), 6.97 (2H, s), 7.74 (1H, t, J = 5.7), 7.80 (1H, 
t, J = 5.7), 8.06 (1H, d, J = 7.9), 12.29 (6H, bs); 
13C NMR (125 MHz; d6-DMSO) 
δ/ppm 23.2, 26.9, 27.0, 27.6, 28.2, 32.3, 34.6, 34.7, 38.5, 39.0, 39.1, 53.8, 54.6, 67.4, 
134.8, 169.6, 169.7, 171.1, 172.9, 173.3, 173.8, 175.0 
 
4.3.7  Coupling of Mal-bisNTA to SPDP-Activated DNA 
 
Compound  17  was  conjugated  to  an  oligonucleotide  which  contained  an  internal 
thymine base carrying a non-biogenic amino linker. The conjugation is outlined in 
Scheme  4.4.  Briefly,  the  oligonucleotide  was  first  activated  using  the 
heterobifunctional  cross-linker  SPDP  and  then  reduced  using  a  DTT  solution  to  
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generate a free thiol group, which was subsequently reacted with mal-bisNTA 17 to 
yield the DNA-conjugate. 
 
 
 
 
 
 
 
 
 
Scheme 4.4. Conjugation of the mal-bisNTA compound (17) to an oligonucleotide carrying 
an internal non-biogenic thymine. 
 
25  nmol  of  oligonucleotide  O1  carrying  an  internal  amine  modification  (1 
mM; 25 µL; 5′ – TCT CTA AAA AAT ATA TAA AAA – 3′, amine modified base 
bold  and  underlined)  (IDT-DNA,  Coralville,  IO)  was  diluted  in  65  µL  of  0.1  M 
NaHCO3, 50 mM NaCl, pH 9.0 and mixed with 10 µL of a 0.25 M DMSO solution of 
N-succinimidyl 3-(2-pyridyldithio)-propanoate (SPDP). After incubation the solution 
at RT for 30 min, unreacted SPDP was removed by size exclusion chromatography 
using an AKTA purification system, a Sephadex column with a volume of 5 mL and a 
sample loop of 100 µL. The mobile phase was buffer A (20 mM Tris, 50 mM NaCl, 
pH 8.0). An isocratic gradient at a flow rate of 5 mL/min was applied to collect the 
DNA containing fractions. The eluent was mixed with 85 µL of a 0.3 M aqueous 
solution of dithiothreitol (DTT) and incubated at 37 °C overnight. Excess DTT was 
removed  by  size  exclusion  chromatography  using  the  same  conditions  as  detailed 
above. The volume of the eluent was reduced to approx. 500 µL using spin columns 
with a molecular weight cut-off (MWCO) of 3 kD. The reduced oligo solution was 
mixed  with  12.5  µL  of  a  0.05  M  aqueous  solution  of  the  mal-bisNTA  17  and 
incubated under agitation at RT for 30 min. Anion exchange chromatography (AEC) 
was  conducted  on  an  AKTA  purifier  system  using  a  Resource  Q  column  with  a 
volume of 1 mL. A linear gradient was employed beginning with buffer B (20 mM  
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Tris, pH 8.0) to 60:40 buffer B / buffer C (buffer B plus 2 M NaCl) over 45 min at a 
flow rate of 1 mL/min. The oligonucleotide was then purified using a 15 – 30 % 
gradient  buffer  B  /  buffer  C  over  100  column  volumes  (CV)  and  the  fractions 
containing the desired peak collected and combined. The solution was desalted and 
concentrated through a 5 ml Amicon desalting column (cat # UFC800296) with a 
MWCO  of  3  kD.  The  purity  of  the  conjugate  was  confirmed  via  analytical  AEC 
(product eluted after 21.3 min at 96% purity), and the concentration was determined 
using UV/vis spectroscopy (Cary Eclipse, Varian). For analysis via MALDI MS, the 
oligonucleotide  was  first  desalted  via  aspiration  through  C18  ZipTip  pipette  tips 
(Millipore, cat # ZTC18S096); the tips were washed with both 50% acetonitrile in 
distilled  water  and  0.1  M  triethylammonium  bicarbonate  pH  8.0  buffer.  The 
oligonucleotide sample was aspirated through the tips, which were then washed using 
distilled water followed by the 0.1M TEAB buffer. Finally the strands were eluted 
using the 50% acetonitrile solution and the desalted DNA solution was mixed with 
matrix solution containing 2',4',6'-trihydroxyacetophenone (THAP) (4 µL, 50 mg/mL 
in methanol) and 1 µL of the co-matrix ammonium acetate (0.1 M). The mixture was 
spotted onto the MALDI plate, and the sample was allowed to crystallize before being 
analyzed  via  MALDI  MS  using  a  Waters  Micro  MX  machine;  calculated  mass  - 
7521.5 m/z, observed mass - 7521.8 m/z. 
  
4.3.8  Generation of the His6-Modified Oligonucleotide 
 
The scheme to generate a His6-modified oligonucleotide comprised the activation of 
an  oligonucleotide  carrying  an  internal  amine  by  reaction  with  heterobifunctional 
cross-linker  SPDP,  followed  by  the  coupling  of  the  thiol-reactive  portion  of  the 
tethered cross-linker with the peptide CysHis6. 
25  nmol  of  O1  oligonucleotide  carrying  an  internal  amine  modification  (1 
mM; 25 µL; 5' – TCT CTA AAA AAT ATA TAA AAA – 3') (IDT-DNA, Coralville, 
IO) was activated with SPDP and purified from excess reagent as described in section 
4.3.7. The eluent from the chromatographic purification was mixed with 10 µL of a 50 
mM solution of the peptide CysHis6 in 0.1% TFA/H2O. The mixture was agitated at 
RT for 2 hours followed by purification via anion exchange chromatography on an 
AKTA  purifier  system  using  a  Resource  Q  column  as  described  in  section  4.3.7.  
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Fractions  containing  the  conjugate  O1-His6  were  desalted  and  concentrated  to  a 
volume of 200 µL using ultrafiltration spin-columns (Amicon, 5 mL, MWCO of 3 
kDa).  The  concentration  of  the  purified  conjugates  was  determined  using  UV/vis 
spectroscopy (Cary Eclipse, Varian), and its purity was assessed using analytical AEC 
as  described  in  section  4.3.7.  The  purity  of  the  His6-tagged  conjugate  was  also 
controlled  via  immobilized  metal  affinity  chromatography  (IMAC)  on  an  AKTA 
system with a Ni-NTA containing His-Trap column (1 mL/min). The conjugate was 
loaded onto the column using ten column volumes of buffer D (0.1 M Na2HPO4, 50 
mM NaCl, pH 8.0) and eluted using a step gradient to buffer E (buffer D plus 1 M 
imidazole). The mass of conjugate O1-H was determined via MALDI MS analysis; 
calculated mass – 7678.5 m/z; observed mass – 7678.8 m/z. 
 
4.3.9   Formation of DNA Duplexes for the Metal-Chelate Pull-Down Assay  
 
Five DNA duplexes were prepared for the metal-chelate binding assay (Figure 4.3). 
Duplex 42 and duplex 42-H (the latter carrying two His6 tags) both have a length of 
42 bp. The remaining three duplexes had a length of 63 bp and comprised unmodified 
duplex 63, duplex 63B carrying a terminal biotin residue, and duplex 63B-N equipped 
with three bisNTA tags and a biotin tag. The duplexes were obtained via hybridization 
of corresponding single stranded DNA oligonucleotides as described in Figure 4.3 For 
example, duplex 42 was obtained by association of 42-mer O2 and two 21-mers O1. It 
is noted that the two His6 tags in 42-H and the three bisNTA tags in 63B-N face the 
same side within the duplex as the tags were separated by 21 nt or two full helical 
turns in the double stranded DNA. The sequences of the oligonucleotides used for the 
formation of the five duplexes are summarized in Table 1.  
 
 
 
 
 
 
 
Figure 4.3. Chemically tagged oligonucleotides used for the pull-down experiments. 
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Oligo  Sequence/Modification 
O1  5' – /5Phos/TCTCTAAAAAATATATAAAAA – 3'     
O1-H  Sequence of O1 carrying a His6 group at the internal amine-modified T 
O1-N  Sequence of O1 carrying a bisNTA6 group at the internal amine-modified T 
O2  5' – TTTTTATATATTTTTTAGAGATTTTTATATATTTTTTAGAGA – 3'   
O3  5' – TTTTTATATATTTTTTAGAGATTTTTATATATTTTTTAGAGATTTTTATATATTTTTTAGAGA – 3' 
O3B  Sequence of O3 carrying a biotin group via a tri(ethylene glycol) (TEG) linker at the 5' end 
 
Table 4.1. Summary of the DNA sequences of the oligos used for the metal-chelate assay. 
 
For  the  formation  of  duplexes  42  and  42-H,  100  pmol  of  42  nt  DNA 
oligonucleotide O2 and either 200 pmol 21 nt oligonucleotide O1 or 200 pmol O1-H 
were dissolved in 5 µL 20 mM Tris, 50 mM MgCl2, pH 8.0. For the generation of the 
63 bp duplexes, 100 pmol of DNA oligonucleotides 63 and 63B and 300 pmol of 
oligos  O1  or  O1-N  were  mixed,  as  specified  in  Figure  4.3.  The  mixtures  were 
thermally heated to 95 ºC for 2 min then cooled back down to 23 ºC. The samples 
were analyzed via non-denaturing polyacrylamide gel electrophoresis (PAGE) in TAE 
buffer followed by straining with Stains-all to confirm that the hybridization had gone 
to completion.  
 
4.3.10. Metal-Chelate Pull-Down Assay 
 
The metal chelate binding assay was conducted to test whether two bisNTA-Ni-His6 
metal chelate bonds can mediate the binding of two DNA duplexes. 100 pmol of the 
duplexes 63B-N and 42-H were combined with 0.25 µL of 2.5 M Ni
2+ and incubated 
for 10 mins. Similarly, negative controls 1 and 2 were prepared by mixing 63 and 42, 
and 63B and 42, respectively, with Ni
2+. The binding of duplex 42-H to biotin-tagged 
63B-N was probed using a pull-down assay with streptavidin-coated magnetic beads 
in combination with gel electrophoresis as a read-out. By analyzing the supernatant, 
the appearance or disappearance of a DNA band was used as an indicator for non-
binding  or  binding  of  DNA  to  the  beads,  respectively.  The  pull-down  assay  was 
conducted by combining duplexes 42 & 63, 42 & 63B, and 42-H & 63N-N with 10 
µL of as a suspension of streptavidin-coated magnetic beads (M-0444 Sigma) in PBS. 
The samples were agitated at RT for 10 min, mixed with 3 µL of 50% glycerol and 
analyzed via native PAGE in TAE followed by staining with ethidium-bromide.   
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4.3.11  Formation of Double Modified 50mers and Hybridization to Form Quad-
Modified 50bp Duplexes 
 
Using previously detailed procedures as described in section 4.3.7/4.3.8, the bisNTA-
modified oligonucleotides O5-N, O6-N, O8-N and O9-N and His6-tagged strands O5-
H, O6-H, O8-H, and O9-H were synthesized. Briefly 25-mer oligonucleotides O5, 
O6, O8 and O9 (sequences in Table 4.2) were activated with SPDP and coupled to 
mal-bisNTA, similarly, O5, O6, O8 and O9 were coupled to the His6 tag. The purity 
and  chemical  identity  of  the  bisNTA  and  His6-modified  25-mer  strands  was 
confirmed  via  AEC  and  MALDI-MS,  respectively.  The  results  of  the  chemical 
analysis are summarized in Table 4.3. 
  In order to form 50-mer strands O5-N/O6-N and O8-N/O9-N each carrying two 
bisNA tags, and the same sequences carrying His6 tags, 25-mers O5-N and O6-N, and 
O7- N and O10-N were ligated  using T4 Ligase (Scheme 4.5). 
 
 
 
Scheme  4.5.  Generation  of  double  modified  50mers  via  ligation  of  singularly  modified 
25mer strands. 
 
The enzymatic ligation was conducted with the bridging oligonucleotides O7 
and O10 for O5-N/O6-N, and O8-N/O9-N, respectively. The bridging oligonucleotide 
O7  (sequence  in  Table  4.2)  is  complementary  to  10  bases  at  the  3'  end  of 
oligonucleotide O5-N and 10 bases at the 5' end of oligonucleotide O6-N. Similarly, 
bridging oligonucleotides O10 is complementary to 10 bases at the 3' end of O8-N 
and 10 bases at the 5' end of O9-N. The ligation mix contained 6 nmol each of O5-N 
and O6-N (as an example), 50 µL of 10x T4 Ligase buffer (500 mM Tris, 100 mM 
MgCl2,  10  mM  ATP,  pH  7.4)  and  made  up  to  a  final  volume  of  500  µL  using  
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Ultrapure  water  (Fluka  95289).  The  5'-ends  of  the  oligonucleotides  were 
phosphorylated  by  adding  5  µL  of  PNK  (10,000  U/mL;  NEB  MO201S),  and 
incubating the mixture for 1 h at 37 °C. It is noted that prior to the phosphorylation 
reaction, any DTT in the enzyme stock was deactivated by adding a 5 mM aqueous 
solution of SPDP (the activated NHS group of this compound had been hydrolyzed by 
incubation in water for 20 min). After the phosphorylation, 6 nmol (6 µL; 1mM) of 
the bridging oligonucleotide O7 was added. The DNA solution was heated to 95 °C 
and allowed to cool to RT in the PCR block to 23 °C before 10 µL of T4 Ligase (NEB 
MO202S; 400, 000 U/mL) was added and left to ligate the oligonucleotides at 16 °C 
overnight. It is again noted that prior to the ligation reaction, any DTT in the enzyme 
stock  was  deactivated  by  adding  a  5  mM  aqueous  solution  of  SPDP.  A  similar 
procedure of phosophorylation and ligation was used to prepare O8-N/O9-N, and for 
His6-tagged 50-mer strands O5-H/O6-H and O8-H/O9-H. 
DNA  strands  O5-N/O9-N,  O8-N/O9-N,  O5-H/O9-H,  O8-H/O9-H,  were 
purified from the bridging oligonucleotides using preparative 15% PAGE in 8 M Urea 
and TBE. The DNA samples were prepared by reducing their volume using a spin 
column  with  a  MWCO  of  3  kDa.  50%  volume  of  8M  urea  was  added,  and  the 
solutions were briefly heated to 95 °C. After cooling, glycerol was added and the 
samples were loaded onto the preparative gels (0.75 mm thickness, slot width 0.5 cm). 
After completing the gel electrophoretic separation, the DNA bands were visualized 
via UV-shadowing. The higher migrating 50 mer bands were cut out and crushed in 
0.5 M ammonium acetate, frozen at -80°C and left to agitate at room temp. over-
night. The solubilized DNA was separated from the crushed gel slurry by filtration 
using QIAgen shredder filters (79654). The remaining slurry was washed once with 
ammonium acetate. The combined solutions were then reduced in volume and their 
concentration was determined via UV/Vis. Analytical denaturing PAGE analysis of 
gel-purified DNA strands O5-N/O9-N and O8-N/O9-N demonstrates the successful 
ligation  into  50-mer  oligonucleotides  as  well  as  the  removal  of  bridging 
oligonucleotides. 
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Oligo  Sequence  Modification 
O5  5' – TCGAACTCCCTCAGCACAATCAGTA – 3'  His6/bisNTA   
O6  5' – CCTATCAATCACCATATCTCAATAC – 3'  His6/bisNTA 
O7  5' – GATTGATAGGTACTGATTGT – 3'     n/a   
O8  5' – GTATTGAGATATGGTGATTGATAGG – 3'    His6/bisNTA   
O9  5' – TACTGATTGTGCTGAGGGAGTTCGA – 3'  His6/bisNTA 
O10  5' – ACAATCAGTACCTATCAATC – 3'  n/a 
 
Table 4.2. DNA sequences of the oligos used for the formation of DNA arrays. 
 
 
Oligonucleotide  AEC [min]  Purity [%]  Mass expected 
[m/z] 
Mass found  [m/z] 
O5-H  23.8  90.10  8739.2  8717.2 
O5-N  24.4  82.00  8583.5  8564.4 
O6-H  24.2  91.60  8673.2  8629.6 
O6-N  24.4  92.64  8517.5  8496.4 
O8-H  23.4  86.82  9015.3  9039.9 
O8-N  23.6  89.90  8859.6  8811.4 
O9-H  24.0  86.16  8952.3  8958.1 
O9-N  24.0  83.3  8796.6  8793.5 
 
Table 4.3. Summary of AEC and MALDI data for the modified oligonucleotides. 
  
4.3.12  Melting Point Measurements (TM) 
 
DNA  duplexes  50-N  and  50-H  were  obtained  by  hybridization  of  single  stranded 
DNA strands. 100 pmol of gel-purified 50-mers O5-N/O9-N and O8-N/O9-N, and 
O5-H/O9-H and O8-H/O9-H were diluted in 20 mM Tris, 20 mM MgCl2, pH 8.0 to a 
final volume of 80 µL, and heated in a PCR block to 95 ºC for 2 min followed by 
annealing  at  22  ºC  for  5  min.  Gel  electrophoresis  was  conducted  to  confirm  the 
formation of the duplex. The Tm measurements were made on a Cary UV/Vis system 
by denaturing and re-annealing using temperature ramps from 25 – 100 ºC and 100 – 
25 ºC, respectively, at a ramp speed of 2 ºC min
-1. The melting curves for modified 
duplexes  50-N  and  50-H,  and  for  unmodified  duplex  50.  The  Tm v alues  for  the 
chemically  modified  duplexes  were  4°C  lower  than  the  unmodified  duplex, 
suggesting that the tags only slightly affected the thermal stability of the duplex. 
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4.3.13  AFM Analysis 
 
DNA nanoarrays were prepared by diluting 10 µL of a 2.5 µM mixture of 50-N and 
50-H (1:1) into 300 µL of a freshly prepared buffer F (33 mM NiCl2, 33 mM Tris pH 
8). The mixture was immediately deposited onto mica surfaces. After incubation for 
30 min, the surface was rinsed with a total of 2 mL of buffer F. For acquiring images 
in  MAC  Mode,  a  magnetically  driven  dynamic  force  microscope  (Agilent 
Technologies,  Chandler,  AZ)  and  magnetically  coated  MacLevers  with  a  nominal 
spring constant of 0.292 N/m (Agilent Technologies) were used. During imaging, the 
vertical position of the cantilever was adjusted by using an electronic feedback loop in 
order to keep the amplitude of the oscillating tip constant. A scanning frequency of 
1.5 lines/sec was employed. To achieve gentle non-destructive imaging, the peak-to-
peak oscillation amplitude was set to 5 nm at 15 kHz oscillation frequency. Images 
were acquired in 1 mM Ni
2+, 10 mM Tris pH 8.0.  
 
4.3.14  Formation of Nanoscale DNA Rings 
 
Rings with a diameter of approximately 12 nm were formed by ligating three highly 
curved  duplexes  α,  β,  and  γ.  The  three  duplexes  had  terminal  single  stranded 
overhangs to facilitate their ligation into a ring. The three duplexes were obtained by 
hybridization of two oligonucleotides each, duplex α carried a single biotin residue. 
100 pmol of the two α strands (see Table 4.4 for sequence information) were 
combined in the buffer containing 20 mM Tris, 50 mM MgCl2, pH 8.0. The mixture 
was heated to 95 °C for 2 min and then rapidly cooled to RT.  The same procedure 
was conducted for the β and γ strands. After the hybridization, duplexes α and β were 
combined  with  8.5  µL  of  10  x  T4  Ligase  buffer  and  diluted  up  to  85  µL  with 
Ultrapure water.  0.5 µL of T4 Ligase was added, and the mixtures were incubated at 
RT for 30 min. The γ duplex was then added along with 1.5 µL of the 10 x ligase 
buffer and a further 0.5 µL of T4 Ligase. This solution was again allowed to incubate 
at room temp for 30 min. 25 µL of the solution was analyzed by a 15% TBE PAGE.  
To investigate the ability of the DNA rings to bind to streptavidin, samples of 
the duplex constructs α, ligated α/β, and α/β/γ were incubated with a 1 mg/ml solution 
of streptavidin at RT and analyzed using 15% TBE PAGE.   
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Name  Sequence 
   
α   5’/5Phos/TCTCTAAAAAATATATAAAAATCTCTAAAAAATATATAAAAA/iBiodT/CTCTAAAAAATAT-3’ 
  5’ – /5Phos/TTTATATATTTTTTAGAGATTTTTATATATTTTTTAGAGATTTTTATATATTTTT -3' 
β  5’ - /5Phos/ATAAAAATCTCTAAAAAATATATAAAAATCTCTAAAAAATATATAAAAATCTCTAA – 3’ 
  5’-/5Phos/ATTTTTTAGAGATTTTTATATATTTTTTAGAGATTTTTATATATTTTTTAGAGATT-3’ 
γ   5’/5Phos/AAAATATATAAAAA/iBiodT/CTCTAATAATTACTATCATGTCTGCGAAAAATATATAAAAA-3’ 
  5'- /5Phos/AGAGATTTTTATATATTTTTCGCAGACATGATAGTAATTATTAGAGATTTTTATAT -3' 
 
Table 4.4. Sequences of the oligonucleotides used to form the DNA rings.  
 
 
4.4  Reversible Ni(II) Mediated Binding of DNA Helices.    
 
A proof-of-principle experiment was conducted to demonstrate that two chemically 
tagged duplexes could interact via metal ion complexation. A pull-down assay based 
on the binding of biotinylated (BT) duplexes, carrying the appropriate NTA tags, with 
Streptavidin magnetic beads was used. Conjugation of the BT duplexes with the beads 
and the Ni(II) binding of the NTA groups to a smaller duplex carrying His tags clearly 
illustrated that the whole complex could be bound and removed from solution. 
 
4.4.1  Metal-Chelate Assay on the Formation of a Dimer of Duplexes 
 
The duplexes, 42-H and 63B-N, used for this experiment are shown in Figure 4.4A. 
The first duplex was 42 bp long and carried two His6 tags, while the second, 63 bp-
long duplex was equipped with three bisNTA groups. Based on rational design, His6 
and bisNTA tags were positioned on one side of the duplexes in order to facilitate the 
creation of heterodimers.  
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Figure  4.4.  Metal-chelate p u l l -down  assay;  the  successful  binding  of  DNA  duplexes  is 
demonstrated  by  the  removal  of  a  BT-63mer  duplex  conjugated  to  streptavidin-coated 
magnetic beads. 
 
Duplex 42-H was generated by hybridizing a 42 nt long single stranded DNA 
oligonucleotide to two 21-mer oligonucleotide O1-H carrying a His6 tags. Similarly, 
63B-N was prepared by association of a 63 nt long template carrying a 5' tri(ethylene 
glycol)-linked  biotin  group  and  three  21-mer  oligonucleotides  O1-N  carrying  a 
bisNTA  tag  (see  section  4.3.9).  The  successful  synthesis  of  the  single-stranded 
bioconjugates O1-H and O1-N was confirmed by ion exchange chromatography and 
mass  spectrometry  (Table  4.3).  Further  analysis  by  gel  electrophoresis  provided 
evidence that duplexes 42-H and 63B-N had successfully formed (Figure 4.5). 
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            1     2     3 
 
Figure 4.5. 15% TBE PAGE analysis of (1) single stranded 21-mer O1-N; (2) the single 
stranded 63-mer  used to form (3) the 63 bp duplex by mixing with a 3-fold molar excess of 
O1-N. 
 
The  proof-of-principle  experiment  illustrating  dimer  formation  is 
schematically  summarized  in  Figure  4.4A  and  is  based  on  a  heterodimer  forming 
between the bisNTA and His6-tagged DNA in the presence of Ni(II). In this assay, the 
duplex carrying the biotin and NTA tags (63B-N) is bound to streptavidin-coated 
magnetic beads. Addition of the 42 bp duplex carrying the His6 tags in the presence of 
Ni(II) should lead to the formation of the Ni-chelate complex and the binding of 42-H 
to the beads. Removal of the magnetic beads should therefore deplete the solution of 
42-H, and gel electrophoresis of the cleared supernatant can be used to follow the 
depletion of 42-H.  
The  metal-chelate  assay  was  performed  by  first  confirming  the  ability  of 
streptavidin  to  capture  the  biotinylated  DNA.  As  shown  by  gel  electrophoresis 
analysis of the cleared supernatant, non-biotinylated duplex 63 migrated as a defined 
band (Figure 4.4B, lane 3), while biotinylated 63B was depleted due to capture by the 
beads (Figure 4.4B, lane 2). Gel electrophoretic analysis also demonstrated that the 
63-mer and 42-mer duplex do not interact in the absence of bisNTA and His6 tags 
because  the  non-tagged  42  duplex  migrated  in  the  gel  (Figure  4.4B,  lane  2).  By 
contrast, when the fully tagged duplexes 63B-N and 42-H were incubated with beads 
in the presence of Ni
2+, the intensity of the 42-H band was reduced by over 95%  
(Figure  4.4B,  lane  1)  suggesting  successful  formation  of  a  heterodimer  via  two 
bisNTA-Ni
2+-His6 complexes (Figure 4.4A – 1). 
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4.5  Formation of 2D Arrays 
 
The convincing results of the pull-down assay prompted the construction of larger 
supramolecular structure as illustrated in Figure 4.6. For the design of the nanoarray, 
two different DNA duplexes 50-N and 50-H were generated. The two 50-mers contain 
either four bisNTA or four His6 tags, respectively (Figure 4.6). The duplexes were 
obtained from smaller units in a multi-step procedure. This method involved coupling 
the chemical tags to 25 nt-long single stranded DNA oligonucleotides, followed by 
the ligation of each two 25-mers to 50-mer strands carrying two chemical tags and the 
final hybridization of two complementary strands to yield duplexes with four tags 
each.  
 
 
 
 
 
 
 
 
Figure 4.6. Schematic of a DNA nanoarray formed via Ni(II) chelation of 50 bp duplexes 
carrying either four His6 or four bisNTA tags. 
 
4.5.1  Design of Arrays and DNA Sequences  
 
To ensure that a 2D array is able to form the tags within one duplex must be directly 
opposite one another (Fig. 4.6). If any of the tags are placed at angles other than 180° 
from one another then the assembly of multiple duplexes would not be planar but an 
undesired warped higher-order structure.  
One helical turn of a DNA duplex occurs approx. every 10 bases, therefore the 
internal  chemical  modification  within  a  DNA  oligonucleotide  was  designed  to  be 
placed  20  bases  apart.  To  improve  the  accuracy  in  determining  the  optimal  base 
position, an X-ray structure of a DNA helix composed of two complementary strands 
of the sequences 5'-CGCAAATTTGCG-3' and 5'-CGCAAATTTGCG-3' was used as  
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a model (Figure 4.7). Inspection of the duplex revealed that the 5 methyl group on one 
thymine  base  is  180°  from  the  methyl  group  on  another  thymine  four  bases 
downstream on the complementary strand. Given that the chemical tags are to be 
linked to position 5 of the pyrimidine base, the pattern of two thymines separated by 
four bases was used as the basis for the design of the 50-mer nanoarray strands (Table 
4.5).     
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7. Molecular model of a double helix illustrating a thymine on each strand in yellow 
with the methyl group at the 5 position in magenta. If tags are positioned in place of these 
methyl groups they should protrude at 180° from one another.  
 
 
5' –  TCG  AAC  TCC   CTC  AGC  ACA  ATC  AGT  ACC  TAT  CAA  TCA  CCA  TAT  CTC  AAT  AC  – 3' 
3' –  AGC  TTG  AGG  GAG  TCG  TGT  TAG  TCA  TGG  ATA  GTT  AGT  GGT  ATA  GAG  TTA  TG  – 5 
 
 
Table 4 . 5.  The  sequence  of  the  designed  50  mers u s e d  f o r  t h e  D N A  n a n o a r r a y . T h e  
position of the thymines carrying an internal amine modification are highlighted. 
 
4.5.2  Formation of Double Modified 50-mers for the DNA Nanoarray 
 
The 50 bp duplexes 50-N and 50-H, carrying four bisNTA or His6 modifications, 
respectively (Figure 4.8), were generated via a convergent procedure as previously 
discussed (4.3.11). The bisNTA compound and CysHis6 peptide were first synthesised 
separately  and  conjugated  to  25-mer  oligonucleotides  yielding  His6–tagged  O5-H, 
O6-H, O8-H and O9-H, and bisNTA-tagged O5-N, O6-N, O7-N and O8-N. Chemical  
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analysis by MS and AEC confirmed the successful coupling of the tags to the single-
stranded  DNA  (Table  4.5).  Each  two  of  the  modified  oligonucleotides  were  then 
ligated into a single stranded 50-mer using a bridging oligonucleotide O7 and O10 as 
shown in Fig. 4.8. The enzyme-mediated ligation products carrying two chemical tags 
were purified via denaturing PAGE.  
 
 
 
 
 
 
 
 
Figure 4.8. Nomenclature of oligonucleotides used for the formation of DNA arrays. The 
sequences are provided in Table 4.4. 
 
               A                      B 
 
   
 
 
   
         1     2    3    4    5    6                         7     8     9   
 
Figure 4.9. (A) Gel illustrating 25mer modification and 50 mer ligation; Lane 1) unmodified 
25mer; Lane 2) His6 modified 25mer; Lane 3) bis NTA modified 25mer; Lane 4) unmodified 
50mer; Lane 5) 2x His6 modified 50mer; Lane 6) 2x bisNTA modified 50mer. Gel (B); 50bp 
hybridisation; Lane 1) 50 mer A; Lane 2) 50 mer B; Lane 3) 50bp duplex. 
 
As  double  modified  strands  O5-H/O6-H  and  O8-H/O9-H  (Fig.  4.8)  are 
complementary, hybridization of the two 50-mers was used to generate His6-tagged 
target duplex 50-H. Similarly, the bisNTA-tagged target duplex 50-N was obtained by 
hybridization of O5-N/O6-N and O8-N/O9-N. Their formation was followed by gel 
electrophoresis and thermal denaturation profiles. A change in the thermal stability  
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can  be  expected  as  the  modifications  are  placed  within  internal  positions  of  the 
duplex. The melting temperature (Tm) derived from the melting profiles (Fig. 4.10) of 
both modified duplexes was slightly lower (75 ºC) than the Tm of unmodified duplex 
(79 ºC) (Table 4.6). This illustrates successful duplex formation and suggests that the 
tags only weakly affected the stability of the duplex. 
 
 
 
Figure 4.10. Melting profiles of unmodified 50-mer (black); His6-modified 50-H (red); and 
bisNTA-modified 50-N (blue). 
 
Duplex  Tm [ºC] 
50  79.6 ± 0.3 
50-H  75.3 ± 0.0 
50-N  75.6 ± 0.6 
 
Table 4.6. TM data for the modified 50-mers.  
 
 
4.6  Formation and AFM Analysis of DNA-Based Arrays 
 
The formation of the DNA nanoarray was confirmed by dynamic force atomic force 
microscopy (AFM). DNA arrays were generated on mica surfaces by incubating a 1:1 
mixture of 50-H and 50-N duplexes in Ni
2+ containing buffer followed by removal of 
unbound  DNA  by  gently  rinsing  with  buffer.  The  incubated  mica  surface  (Figure 
4.11) showed ~ 100 nm long strands which were aligned parallel into a regular 2D 
sheet. The height of the supramolecular structures (Figure 4.11 inset) was 1.35 ± 0.15 
nm, similar to the diameter of DNA duplexes in other AFM studies. Furthermore, the  
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distance  between  the  parallel  DNA  strands  was  3.0  ±  0.2  nm.  Importantly,  no 
nanostructures were observed in the absence of Ni
2+ or with DNA duplexes lacking 
the chemical tags. Taken together, these data strongly support the interpretation of the 
parallel  structures  as  a  nanoarray  composed  of  interlinked  DNA  duplexes  as 
schematically illustrated in Figure 4.6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11. AFM image of DNA based arrays.  
 
 
4.7  Formation of Circular DNA Rings 
 
The successful use of the bisNTA–Ni(II)–His6 complex in DNA-nanobiotechnology 
prompted  us  to  investigate  whether  the  complex  can  be  exploited  to  create  other 
DNA-based supramolecular structures from simple building blocks. One such block is 
a  DNA  loop  or  ring.  It  is  known  that  biological  DNA  can  have  a  highly  curved 
secondary structure which is important for the packaging of genetic material into viral 
capsides  or  around  proteins  such  as  histones.  Previous  research  has  utilized  this 
natural  design  principle  to  form  DNA  loops  from  smaller  highly  curved 
duplexes.
100,101,102 It is conceivable that chemical functionalization of the duplexes 
could  help  create  additional  structures.  By  chemically  modifying  oligonucleotides 
with the bisNTA and His6 tags and forming the ring structures, individual units could 
have the ability to bind via Ni(II)-mediated complexation leading to the formation of 
stacks of RNA rings (Figure 4.12).  
  159 
 
 
 
 
 
Figure 4.12. Formation of DNA rings with tags able to bind reversibly in the presence of 
Ni(II) ions. 
 
4.7.1  Formation of DNA Rings 
 
Initially it was attempted to form the DNA circles using 21 bp duplex monomers. It 
has been previously reported
100 that these 21 bp units can be annealed to form rings of 
varying diameters. However, no structures could be formed using these sequences. 
Alternative  duplexes
101  were  utilized  successfully  to  form  the  rings.  Three  63  bp 
duplexes (α, β, and γ) were formed by hybridization of two complementary single 
stranded  DNA  oligonucleotides  (see  Table  4.2  for  sequence  information).  The  α 
duplex  (seen  in  lane  2  in  Figure  4.14)  was  then  hybridized  to  the  β  duplex  via 
designed sticky ends and followed by formation of a covalent linked using T4 Ligase 
reaction. The ligation was partly successful as inferred from a higher migrating DNA 
band (Fig. 4.13, lane 3, α/β).  Addition of the third duplex γ and ligase reaction led to 
the formation of the even higher migrating band, likely composed of covalently linked 
α/β/γ (Fig. 4.13, lane 4). 
 
 
 
 
 
 
 
 
 
Figure 4.13. Stepwise formation of DNA rings; (1) DNA ladder; (2) alpha duplex; (3) alpha-
beta ligated duplex; (4) DNA loop. 
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It is noted that not all of the α and β duplexes seem to initially hybridize as an 
excess of 63 bp duplex is seen in lane 3. The lower excess band and mid α/β duplex 
band, however, disappear upon ligation with γ in lane 4. This is possibly due to the 
formation  of  longer  by-products  that  are  seen  in  the  well  of  the  gel.  In  the  gel 
illustrated in figure 4.13, a good yield of the ring product was observed. This was not 
repeatable  when  the  conditions  and  samples  were  exactly  replicated.  Several 
parameters were varied to improve the yield, such as dilution of the sample to avoid 
intermolecular ligation, favoring intramolecular, and a decrease in the amount of γ as 
a slight excess of the γ duplex may have caused the undesired formation of the long 
by-products to form. However, none of these approaches proved successful. 
 
4.7.2  AFM Analysis 
 
The DNA ring samples were analyzed by a collaborating AFM specialist
129 with the 
aim  to  confirm  the  formation  of  DNA  rings  in  the  low-to-average  yielding 
preparations.  Indeed,  mostly  long  linear  strands  were  observed  (Figure  4.14). 
However, fully circularized structures were also present (Figure 4.14; inset) indicating 
at  least  partially  successful  formation  of  the  rings.  The  images  of  the  covalently 
closed  and  open  structures  are  currently  being  analyzed  and  the  DNA  observed 
characterized using their curvature. As the curvature occurs for DNA molecules of 
specific sequence, a comparison between circular and linear structures can shed led 
light on the influence of sequence variation and understand the biophysical basis of 
circular DNA found in nucleosomes and replication sequences.   
 
 
 
 
 
 
 
 
Figure  4.14.  AFM  images  of  DNA  ring  as  well  as  non-ligated  loops a n d  l i g a t e d  
concatemers adsorbed on mica. 
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4.8  Possible Future Applications of Metal-Chelate Bridges 
 
In conclusion, following rational design the covalent attachment of His6 and bisNTA 
tags  was  shown  to  endow  DNA  duplexes  with  the  ability  to s e l f -assemble  via 
reversible  chelate  bonds.  This  work  represents  a  novel  way  to  form  nanoscale 
structures which do not require the redesign of underlying structural framework of the 
constituent monomeric units. We expect that the new approach can be extended to 
protein arrays with defined functional properties. In general, the ability to engineer 
self-assembly  into  monomeric  peptides  or  proteins  is  an  emerging  topic  in 
supramolecular  chemistry,  nanobiotechnology  and  synthetic  biology  due  to  the 
potential  applications  of  the  protein  and  peptide  networks  in  basic  science  and 
technology.  By  covalently  attaching  a  small  tag  onto  a  single  position  within  a 
biomolecule,  this  new  approach  has  the  potential  to  address  the  shortcomings  of 
existing  approaches  towards  imparting  self-assembly.  In  particular,  while  current 
approaches use the re-engineering of whole protein surfaces or the bottom-up design 
of  linear  peptides,  the  new  generic  approach  is  independent  of  reengineering  the 
structural framework of the subunits. 
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Chemical  Tags  Facilitate  the  Sensing  of  Individual  DNA  Strands  with 
Nanopores; Nick Mitchell, Stefan Howorka; Angew. Chem. Int. Ed.; 2008; 47; 5565 
– 5568.  
 
A DNA Nanostructure for the Functional Assembly of Chemical Groups with 
Tunable Stoichiometry and Defined Nanoscale Geometry; Nick Mitchell, Robert 
Schlapak,  Markus  Kastner,  David  Armitage,  Wojciech  Chrzanowski,  Johannes 
Riener, Peter Hinterdorfer, Andreas Ebner, Stefan Howorka; Angew. Chem. Int. Ed.; 
2009; 48; 525 – 527.  
 
Chemically Labeled Nucleotides and Oligonucleotides Encode DNA for Sensing 
with Nanopores; Vinciane Borsenberger, Nick Mitchell and Stefan Howorka; J. Am. 
Chem. Soc.; 2009; 131 (22); 7530 – 7531.  
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